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ABSTRACT 
Purpose: The main focus of this study is to explore the relationship between body mass 
index (BMI) as a reflection of obesity its association with chronic disease, health 
services utilization and its impact on direct co ts to the health system, in the province of 
Newfoundland and Labrador. 
Methods: In a secondary analysis of the provincial component ofthe Canadian 
Community Health Survey version 1.1 (2000/01 ), survey records for respondents aged 
20-64 (n=2345) were linked to provincial physician and hospitalization data in order to 
obtain objective measures of longitudinal health services utilization. Regress ion models 
were used to examine whether BMIIevel was an independent predictor of family 
physician (GP) visits, hospitalization and costs. 
Results: Of the study sample 37%, 39% and 17% and 6% were classified as nonnal , 
overweight, obese, and morbidly obese respectively. The obese (including morbidly 
obese) were more likely to report having serious chronic conditions after adjusting for 
age and gender. Analyses identified the morbidly obese group (BMI 2 35kg/m2) as 
having a significantly higher number of GP visits over a 5-year period when compared 
with the normal weight group (BMI 18.5-24.9kglm\ [median 22.0 vs. 17.0, p<.05], and 
as having significantly higher average costs ofGP (p< .OOl) and speciali st services 
(p<.05). Controlling for number of chronic conditions and other covariates, being 
morbidly obese remained a significant independent predictor of family physician visits (p 
< .00 I) and total physician costs (p < .0 I) , but was not a predictor of ho pi tal ization. 
Conclusions: Morbid obesity is independently associated with increased GP utilization 
and total physician costs but not with hospital utilizat ion. Some future health 
promotion/education and weight loss interventions should be targeted at this high-risk 
!:,rt·oup; however a population health approach must be developed in order to have an 
impact on the prevalence of obesity in this population. 
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CHAPTER 1 Introduction 
1.1 Introduction 
In 2005, most industrialized countries spent on average 8.6% of their Gross Domestic 
Product (GOP) on healthcare serv ices. During this time Canada spent 9.9% compared to 
7.7% in the United Kingdom, 10.1 % in France, and 15% in the United States. In most of 
these countries, the proportion of GOP spent on healthcare has been risi ng steadily since 
the 1980 ' s and continues to rise. Similar trends have been noted in Gennany, Australia 
and New Zealand. The main drivers of increased expenditure in healthcare include new 
technologies, drug therapies and increasing consumer demand or utilization.1 Within 
these expenditures, a large proportion is directed towards the increa ing prevalence of 
chronic illness and its management.2 
ln 2007, according to the Canadian Institute fo r Health lnfom1ation (CIH I), an 
independent pan-Canadian, not-fo r-profit organization, total healthcare expenditure by 
use of funds was categorized as fo llows. The maj ority of public expenditures were 
directed towards: hospitals (28.4%), physicians ( 13.4%), drugs ( L 0.4%), and other health 
professionals ( I 0.8%) while the remaining funds were directed towards capital, publ ic 
health, administration and other institutions.3 
Chroni c conditions have been identifi ed as a key challenge fo r healthcare in the 2 1st 
century. According to the World Health Organization (WHO), chronic di seases a re the 
m ajor cause of death and disability worldwide and are reaching epidemic proportions in 
both developed and underdeveloped countries. Non communicab le diseases have 
surpassed communicable diseases in developed countries a the most serious problem for 
governments in this century; once diagnosed they become a daily, ongoi ng concern for 
the individual , the community and the provision of health services. Chronic conditions 
affect a significant proportion of the population and range from allergie and skin 
di sorders to recuJTent depression and cardiovascular disease, diabetes, congestive heat1 
failure, hypertension, renal failure and chronic obstructive pulmonary disease. Chronic 
diseases are projected to account for 89% of all deaths by year 20 15 in Canada. 2 
According to Health Canada and based on the 1998 Economic Burden of Illness 
Rep011, the Cost of Illness (COl) in Canada was approximately $160 billion. Direct costs 
and indirect costs accounted for 52.7%, and 43.3%, respectively.4 Direct co ts repot1ed in 
monetary tetms are defined as the value of goods and services for which payment was 
made for the following: treatment, care and rehabilitation, hospita l expenditures, drugs, 
physician services, other institutions, other professionals, public health and health 
research. Indirect costs are defined as the estimated value of economic output lost 
because of illness, sick leave, absence from work, disability or premature death.5 In 2007, 
the Public Health Agency of Canada estimated that up to 67% of direct healthcare costs 
were spent on chronic conditions.6 
Based on this report, the top five most costly diseases in Canada are predominantly 
chronic in nature. The top five in rank order were: cardiovascular disea es, 
muscul oskeletal diseases, cancer, injuries and respiratory diseases. Cardiovascular 
di seases have consistently represented the number one category. Jn Newfoundland and 
Labrador (NL), the comparable figure for COl was approximately $3. 1 billion with the 
order of disea es being slightly di fferent with the add ition of diseases of the digestive 
2 
system in place of injuries. The top five chronic diseases in NL included; musculoskeletal 
conditions (12.9%), cardiovascular diseases (1 2%), cancers (9%), respiratory diseases 
(5.3%) and diseases of the digestive system (3.7%). 
As a result, research on the utilization of healthcare services and factors predicting 
health services utilization is of increasing value to governments, health boards and 
hospital administrators because of the hi gh and rising expenditures in healthcare and the 
limited resources available. Providing thi s info rmation to policy-makers and decision-
makers will aid in decision-making concerning the emerging health needs of the 
population and the changing patterns of the population's health services use. This 
information will help to assist in improved planning and a more efficient a llocation of 
scarce resources through the provision of services and the development of health and 
social policies. 
It is well known that health services utilization results from a complex, interrelated 
set offactors, and many model s have been developed to aid in the identification of these 
factors and explain how they impact healthcare utili zation.7-9 In the early 1960' s, Ronald 
Andersen developed a conceptual Behavioral Model of Health Services Utilization, with 
the goal of identifying factors that influenced the use of healthcare service . Thi s seminal 
work was conducted in the United States and was meant to assist in the analysis of 
national survey data coll ected by the Centre for Health Administration Studies, 
University of Chicago. Interestingly, Andersen ' s initi al framework was developed in 
response to what policy-makers felt was an underutilization of healthcare services in the 
United States by certain sub-groups of the population. It was hoped that this model would 
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enlighten policy-makers as to what factors dete1mined whether an individual would seek 
health services and, was meant to guide the development of policies to increase health 
services utilization in certain sub-groups, given that cost was not the concern that it is 
today.9 
Andersen ' s initial model was later modified by many other researchers, but the most 
commonly used adaptation was by Andersen & Newman and published in 1973 .8 Thi 
model suggests that in the context of a particular Environment and Health System, health 
services utilization is detennined by Population Characteristics classified as three main 
types: predisposing factors, enabling factors and need factors. According to the author, in 
order for the use of health services to take place ( 1) an individual must be predisposed to 
receive medical care (2) there must be in place enabling cond itions that allow the 
individual to obtain health services and (3) the individual must perceive a need for these 
services. Predisposing factors include variables such as gender, age and socia l status. 
Enabling factors include conditions that facilitate or inhibit the use of physician services, 
e.g. the distance to the health centre, the type of municipality, working time, fami ly size 
and health insurance coverage. Need vari ables include the presence or absence of chronic 
di sea es, disability days, illness conditions and psychological well-being. According to 
this model a combination of these factors influences an individual' s Health Behavior or 
more specificall y their use of health services.8 More recentl y, personal health choices 
have been included in the use ofhealth services (e.g., the decision to take part in 
creening initi ative for cancer) . 9 
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Over the last 40 years, this model has been tested, modified and adapted by 
researchers who have set out to better understand the complexity around an individual's 
use ofhealthcare services.9 The most recent model, the Emerging Model of Health 
Services Utilization (1995) includes an additional category; Outcomes which include 
variables that describe an individual 's self perceived health status, evaluated health status 
and satisfaction with the health service received (Appendix A). It is suggested that these 
Outcome variables by way of a feedback loop play a role in whether or not an individual 
having accessed health services for the first time will continue to access these services in 
the future. The model suggests that self perceived health status, evaluated health statu 
and satisfaction with the health services received may influence this deci ion.9 
Andersen's models have been used extensively nationally and internationally as a 
framework for utilization and cost studies of general populations as well as specia l 
studies of minoriti es, low income groups, children, women, the elderl y, oral health, the 
homeless and the HIV -positive population.10- 15 The cunent thesis uses an adapted ver ion 
of Andersen's 1995 Behavioral Model of Health Services Utilization. 
1.2 Backg•·ound 
In general, the development of chronic disease results from a variety of per anal, 
environmental and social factors. These diseases include cardiovascul ar diseases such as 
hypertension, chronic respiratory diseases such as asthma and chronic ob tructive 
pulmonary disease, di abetes, mental illness and musculoskeletal diseases such as arthritis. 
Some of the main ri k factors for chronic eli ease include smoking, sedentary 
lifestyle, insuffic ient consumption of fruits and vegetables and excess body weight.2 For 
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example fruits and vegetables are important components of a healthy diet. Accumulating 
evidence suggests that they could help prevent major diseases such as cardiovascular 
diseases, and certain cancers, principally of the digestive system. Low intake of fruit and 
vegetables is estimated to cause about 19% of gastrointestinal cancer, 31% of ischemic 
heati disease and 11% of strokes worldwide. Approximately 2.7 million deaths annually 
are attiibutable to low fruit and vegetable intake across the globe. 16 Excessive overweight 
or obesity is another important tisk factor for the development of chronic diseases, 
namely those associated with cardiovascular diseases, diabetes and musculoskeletal 
diseases. Over the last 30 years, using body mass index (BMI) as a reflection of excess 
weight, there has been an increase in adult obesity from approximately 10% in 1975 to 
20%- 30% in 2005 in most developed countries. 17 The cun·ent study will focus on 
whether obesity as a risk factor for the development of chronic diseases plays a role in 
increased utilization of health services. 
The word 'obesity' is derived from the Latin ' obesus' meaning 'very fat'. 18 
According to the WHO, obesity is characterized as excessive body fat or adipose tissue or 
an increased body weight beyond skeletal and physical standards as the result of an 
excessive accumulation of fat in the body. More than two times the normal weight is 
considered to be obese. 19 Obesity is a complex disorder of endocrinological, genetic and 
environmental aetiology. Excess adipose tissue increa es the work of the heart, alters 
pulmonary, endocrine and immunological functions and may result directly in obstructive 
sleep apnea, osteoarthritis and psycho ocial dysfunction. Enlarged fat cells increase the 
secretion of inflammatory and coagulation molecules, and may cause increased risks of 
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diabetes, gallbladder disease, high blood pressure, hyperlipidemia, liver disease, coronary 
artery disease, cerebrovascular disease, and certain types of cancer. 2•16•17 
There are a va1iety of methods for assessing an individual's body fat and these will be 
discussed in Chapter 3. The current study uses BMI as a reflection of excess body weight 
and will be discussed in the following section. BMI is the most commonly used non-
invasive method for classifying body weight associated with health risk in population 
studies. BMI is calculated by dividing the weight of an individual in kilograms by the 
height of an individual in metres quared (kg/m2). BMI con·elates strongly with direct 
measures of fatness or adiposity (r = 0.82-0.91) in adults.20 BMI is endorsed by the 
WHO, the International Obesity Task Force (lOTF) and Health Canada as a reflection of 
body fat , and has become an accepted index for international comparisons at a population 
level. The current recommendations for BMI classification in Canada are the same as the 
standardized WHO classification ofBM T: underweight (<18.5), n01mal weight (18.5-
24.9), overweight or preobese (25-29.9), obesity class I (30-34.9), obesity class II (35-
39.9) and obesity class Ill or morbid obesity (2:40). For the purpose of this thesis due to 
the small number of individuals cia sified as class Ill or morbid obesity, obesity class II 
and obesity class III were combined and described as morbid obesity. 
BMI can be calculated using either self reported height and weights or measured 
heights and weights. The analysi in this thesis is based exclusively on BM I calculated 
from self reported heights and weights. Calculating BMI using the mea ured height and 
weight approach can provide a more accurate description of weight status in the 
population, however it is costly to obtain and not always feasible for population studies. 
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Studies using the measured height and weight approach have been limited, due to the lack 
of the measured data in Canada and in many other countries. When conducting 
population studies, estimating BMI based on self repo1ied heights and weights is often 
the only method available. 
A plethora of research suggests that obesity is a health state associated with chronic 
diseases (e.g., cardiovascular disease, hypertension, cancer, diabetes mellitus), endocrine 
and metabolic disturbances (e.g., insulin resistance, dyslipidemia), debilitating health 
problems (e.g., osteoarthritis, gout, pulmonary diseases), psychological issues (e.g., social 
bias, prejudice, disc1imination, psychological effects and eating disordersi 1 and early 
death.22'23 Obesity is considered to be the second leading avoidable cause of mortality 
for adults in developed countries. Smoking is considered the first. 24 
Based on the established relationship between obesity and chronic disease it is 
impmiant to study the impact of increasing levels of BMI on health services utilization to 
detennine whether obesity is an independent predictor of utilization in the health care 
system or whether the relationship is mediated by chronic disease. Understanding thi s 
relationship may assist policy makers in making effective resource allocation decisions. 
In Canada, over the past two decades, there has been a dramatic increase in the 
prevalence of obesity as measured by a BMI 2: 30kg/m2. Some of the earliest data 
published on weight distribution in Canada comes from the Health Promotion Survey 
conducted in 1985. This survey was representative of the national population. Based on 
self repmied heights and weights, the authors reported a prevalence of adult obesity in 
Canada of 5.6%.25 
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Ten years later, according to the National Population Health Survey conducted by 
Statistics Canada in 1994/ 1995, the self reported prevalence of adult obesity in Canada 
had increased to 12.7%25 and the corresponding prevalence of obesity in NL increased to 
15.6%.26 The 2005 Canadian Community Health Survey repotied that the prevalence of 
self reported obesity in Canada had fmiher increased to 16% and the cotTesponding 
prevalence of adult obe ity in NL had increased to 27%. Using measured heights and 
weights from the 2004 Canadian Community Health Survey, Statistics Canada repotied 
24% of the Canadian adult population and 34% of the NL adult population to be obese.27 
Consequently, it would appear that NL is a particularly relevant place to study the 
re lationship between obesity and its impact on the healthcare system. 
Using Andersen's Behavioral Model of Health Services Utilization (1995) as a guide, 
the relationship between increasing category of BMI as a reflection of excessive body fat , 
chronic disease and health services utilization is explored. To this authors knowledge 
BMI as a reflection of health status has no t been included in the Andersen model as a 
factor that influences either directly or indirectly the use of health services.9 
1.3 Problem Statement 
The level of chronic disease is increasing in most populations in the world as is the 
propotiion of healthcare budgets spent on the treatment and management of chronic 
illnesses. Excessive bodyweight or obesity is one risk factor contributing to the 
development of chronic disease. Due to the increasing prevalence and the large 
proportion of people affected, obe ity has become a public health issue.17'21 The public 
health concern over the increasing prevalence of obesity is both medical in terms of 
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morbidity and economic in tenns of costs to the healthcare system. Limited research has 
been conducted to date in Canada on the problem of adult obesity and its impact on the 
healthcare system. Newfoundland and Labrador has the highest provincial prevalence of 
obese adults in Canada. In this province, approximately three out of every ten adults are 
obese (BM1 2: 30), four out of every ten are overweight (25 <BMI <30) and three out of 
ten have a BMI in the normal range, which is associated with the least risk of ill health 
( 18.5 ~ BMI <25). Less than 1% are considered to be underweight (BMI < 18.5). 
The main research hypothesis in this study is that increasing levels of BMI will 
impact the healthcare system in terms of increased utilization and direct cost. The 
purpose ofthis study was to examine and quantify the relationship between level ofBMI, 
chronic disease and the impact on healthcare service utilization. 
The study sample was representative of the adult population living in 
Newfoundland and Labrador in 2001. The following components were measured (i) self 
reported chronic disease (ii) self reported health service utilization (iii) objective health 
service utilization over a five-year period and (iv) an estimate of the associated direct cost 
to the healthcare system. 
An innovative methodological approach was undertaken to study these 
relationships. A random representative sample from the Newfoundland and Labrador 
portion ofthe 2001 Canadian Community Health Survey was used to ascertain the study 
population. This sample was linked via a unique identifier, the health insurance number, 
(the MCP number in NL) to two longitudinal administrative databases, the Medical Care 
Plan [MCP] database which is the physician claims database and the Clinical Database 
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Management System [CDMS] which is the hospital separation discharge database. 
Through these databases, it was possible to obtain actual health service utilization and 
direct costs for the study sample betweenl998-2003. 
1.4 Research Questions and Objectives 
The author of this thesis studied individuals responding to the 2001 Canadian 
Community Health Survey. The author examined the relationships between category of 
BMI and chronic disease, category of BMI and health services utilization and the 
relationship between chronic disease and health services utilization. Andersen' s 
Behavioral Model of Health Services Utilization was used to guide the research. 
The objectives of the study were: 
1. to detennine the factors associated with being classified as obese or morbidly 
obese 
2. to determine whether increasing category of BM I is associated with an increase 
in the self reported prevalence of chronic disease 
3. to detennine ifthere are significant differences in self reported health services 
utilization across categories of BMl 
4. to determine whether individuals with certain characteristics (e.g., demographics, 
health status or lifestyle variables) are more likely to be either obese or morbidly 
obese 
5. to determine if individuals reporting the existence of chronic diseases are more 
likely to be classified as overweight, obese or morbidly obese 
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6. to detennine ifthere are significant differences between self reported and 
objective measures of physician utilization 
7. to detem1ine if there are significant increases in the use of objective health 
services and associated direct costs with increasing category ofBMI (the shape of 
the relationship is not known) 
8. to evaluate using multivariate models the relative importance of increasing 
category of BMI and the level of chronic comorbidity on health services 
utilization and direct costs 
9. to examine the relationships between obesity, chronic di ease and health services 
utili zation using the Andersen model of Health Services. 
1.5 Rationale 
Provincial governments in Canada spend a large proportion of their budgets on 
the healthcare system. According to data published by CIHI , this proportion varies across 
Canada from a low of7.2% ofGDP in the North West Territories to a high of 13.3% of 
GOP in Prince Edward Island. Newfoundland and Labrador spent l 0.9% of its GOP on 
healthcare in 2004_28 With the majori ty of funds being directed towards medications, 
hospital and physician services it is becoming increasingly important for policy makers to 
no t only have information on health services utili zation but to also understand what 
factors drive utili zation. Due to the considerable evidence that overweight and obesity 
are related to the increased ri sk of chronic disease, it is suggested that being overwei ght 
and or obese may be a large contributor to increased utilization of health services and 
therefore rising healthcare costs in many countries. 
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As a result, studies have been conducted to explore the relationship between (i) 
the level of BMI and health services utilization 29-38 and (ii) the economic burden placed 
on healthcare systems associated with different levels of BMI.39-57 These relationships 
have not been studied extensively in Canada w hich is surprising given the reported 
increase in the prevalence of obesity since the 1980's. 
In one of the early studies conducted in Canada, researchers perfonned a 
secondary analysis of the 1994 National Population Health Survey which was a cross-
sectional survey representative of the Canadian population. Using mul tivariate logistic 
regression models researchers examined the relationship between obesity and the use of 
health services, including medications, comparing it to the non-obese population. The 
authors controll ed for age, sex, mari tal status, income, level of physical activity and 
smoking status in the models. The findings, based on self reported health serv ices 
utilization, and using the previous Health Canada guidelines (which changed in 2003) fo r 
classifying obesity (BMI 2: 27 kg/m2) , indicated that being obese was associated with 
increased physician visits. Furthermore, obese respondents when compared to non-obese 
respondents were more likely to have repotied suffering from a number of chronic 
comorbiditi es (e.g., diabetes and cardiovascular disorders), to have been prescribed a 
larger number of medications (e.g., heart medication, antihypertensive pills, diuretics, 
pain reli evers fo r arthritis and back pain) and to have sought out mental health services. 
In contrast, obese respondents had fewer hospita l admissions than no n-obese 
respondents. 31 
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In 2005, the Canadian Institute for Health Jnformation (ClHl), an independent 
pan-Canadian, not-for-profit organization published a report based on the Canadian Joint 
Replacement Registry. BMI values were available fo r over 17,000 patients, which 
accounted for 65% of hip and knee replacements reported in the study. Adj usting fo r age 
and gender, people who were obese (BMI ?.30 kg/m2) were three times more likely to 
have received a hip or knee joint replacement, compared to people w ith nom1al weight. 
Overweight individuals (BMI 25-29.9 kg/m2) were twice as li kely to have needed a joint 
replacement. These findings add support to the link between obesity as a risk factor fo r 
the development of osteoarthritis, a key diagnosis leading to joint replacement surgery. In 
addition, the authors reported that being obese increased the necessity for repeat urgeries 
or modifi cations or replacements of the artific ial joints, because the extra weight added 
more wear and tear on the individual' s prosthesis .37 
It appears that during a time when obesity is increasing in the population, the 
number of j oint replacements has also been increasing suggesting a positive association 
between the two. The re lationship may be causal; e ither the hip or knee problems have 
caused decreased mobility resulting in increased weight gai n, or the weight gain may 
have caused the knee and hip problems and subsequently, the number of joint 
replacements being perfonned. 
A number of studies have been conducted outs ide Canada, ex ploring the 
re lationship between obesity and healthcare utili zation. Authors conducted a secondary 
analys is of the Health Survey for England, a cross-sectional survey designed to coll ect 
informati on about the health of the Engli sh population.35 The relationship between 
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obesity and the use of healthcare services in a population 50 to 69 years of age was 
examined. The authors reported an association between obesity (BMI ~30 kg/m2) and the 
increased use of outpatient services such as surgical daycare over the previous 12-month 
pe1iod compared to the normal weight group (BMI > 18.5 and <25), having controlled for 
age, gender, smoking status, alcohol intake, socioeconomic status, ethnic groups and 
education groups. There were no significant relationships reported between obesi ty and 
physician visits in the pervious 2 weeks or between obesity and the use of inpatient 
services in the previous 12 months. The authors did not control for the existence of 
chronic diseases and did not examine different levels of obesity. It may be that a 
significant relationship between BMI and increased utilization of physician and or 
hospital services did exist, but only with those individuals classified as being morbidly 
obese that is with a BMI ~35 kg/m2. 
In a study in the USA, researchers randomly allocated 506 new patients to 
resident family physicians and followed their health service utilization patterns for a 
period of 12 consecutive months.38 Analyzing the findings by BMI class ification using 
measured heights and weights, the authors found that obese patients (BMI ~30 kg/m2) 
compared to non obese patients (BMI <30 kg/m2) had a significantly higher mean 
number of visits to both primary care and specialty care clinics, and had a higher mean 
number of diagnostic services. Controlling for health status, depression, age, education, 
income and sex, obesity remained significantly associated with the use of primary care 
serv ices and diagnostic services. When the level of morbidity was controll ed for in the 
analysis, obesity was associated with primary care visits only. 
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A further study limited to women investigated health services utili zation in the 
previous 12 months in a primary care setting. The authors reported that being obese 
(n=83) with a BMI 2 30 kg/m2 , compared to being non-obese (n= lll) with a BMI <30, 
was associated with a greater number of diagnoses, contacts with the medical facility 
(including telephone contact), the total number of prescriptions ordered and number of 
physicians seen.33 Having controlled for the number of di agnoses, BMI remained a 
predictor of the number of physicians seen suggesting that the higher uti lization of obese 
patients is due to the higher level of morbidity. 
In a study examining more than I 7,000 members of a large health maintenance 
organization (HMO) in the United States, secondary analy is was conducted on 
computerized databases that included information on hospitalizations, laboratory 
services, outpatient visits, outpatient phann acy and radiology services during 1993.The 
authors reported that an increase in BMI was as ociated with more frequent outpatient 
visits as well as increased inpatient days, which was most likely due to obesity-related 
comorbiditi es such as hypertension, coronary heart disease and diabetes.41 
Associated healthcare costs for obesity related comorbidi t ies have been estimated 
to be between 2-7% of total healthcare spending in most industrialized countries. 39-54· 56-57 
In Canada in 1999, it was estimated that the total direct heal thcare cost of obesity was 
over $ 1.8 billion annually, or approximately 2.4% of the total healthcare expenditures for 
all diseases in Canada.46 
The findings from many of these studies are consistent at the macro level; obese 
individua ls (BMI 2 30 kg/m2) use more of' ome' types of healthcare services when 
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compared to non-obese or normal weight individuals. However, there are inconsistencies 
in a number of the study findings . While some authors reported increased utilization of 
primary care services, specialty clinics, hospital outpatient and inpatient visits and 
number of diagnostic tests, other authors reported increases in only some of these 
services by obese populations. These inconsistencies may be due to the di fferences in 
study methodology. These included the choice of study population (i.e., pati ents versu 
population survey respondents and age-groups studied) as well as the outcome variables 
being examined (i.e., self reported versus actual health services utilization). In addi tion 
the study results may be inconsistent depending on whether BMI was calculated using 
self reported or measured heights and weights. This difference in methodology may lead 
to the misclassification of BMI status. For example overweight and obe e individuals are 
more likely to underestimate their weights resulting in an undere timation of BMI. Often 
this misclassification will result in fewer differences being found between the groups. 
Finally, a di fference in the time period of fo llow-up and the choice of statistical analysis, 
including decisions to adjust for confounding vari ables m ay have impacted the study 
results. 
This thesis addresses a number of methodological limitati ons rai ed in other 
studies. First, despite the fact that several studies have been conducted in thi s area of 
research very few studies have been Canadian in nature. Different healthcare systems, 
varying degrees of access to care, population demographics such as the changing age 
structure and geography (e.g., rural versu urban) as well as cultural i sue and illness 
behavior ar unique to different populat ions. These factors may limit the gcncrali zabi lity 
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of prior study findings to Canadian populations. Second, although other studies may have 
used national population health surveys to ascertain a sample population, very few have 
focused on a particular provincial population. This is important because as the prevalence 
of overweight and obesity varies across the country, so does the likelihood of chronic 
diseases and the potential reasons for healthcare services utilization. Among Canadians, 
the prevalence of overweight and obesity is the highest in NL. Using National data to 
draw conclusions about specific provinces may not be valid. To overcome this issue, this 
thesis used the NL component of the 200 1 Canadian Communi ty Health Survey; a 
population based cross-sectional survey of randomly selected respondents. Third, 
previous studies have not consistently controlled fo r factors known to have an impact on 
health services utilization. For example, in a study in the United States described earl ier 
where 506 new patients were randoml y allocated to fami ly physicians and followed for a 
period of 12 consecutive months, the authors did not adjust for obesity associated 
comorbid conditions such as hypertension and type 11 diabetes in their analysis. The 
authors argued that stati stically adjusting for comorb idities was inappropriate as many of 
these conditions are intermediates along the causal pathway between increased BMI and 
increased health services use and therefore constitute over adjustment.38 The author of 
this thesis agrees that chronic conditions may be the link between obesity and increased 
health services utilization, but suggests that it may be valuable in terms of pol icy 
development to better understand if obesity on its own is independently predictive of 
health services utilization, or whether it i primarily the relationship as a risk factor with 
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chronic disease that is driving healthcare utilization and the increased cost of healthcare 
services. 
Fourth, the majority of previous studies have relied solely on self reported health 
services utilization data obtai ned from health surveys, with varying time periods for the 
purposes of recall. Although, this study utilized health survey data to obtain the study 
population, self reported chronic disease and health services utili zation, a well as other 
variables important to the study; it also linked each survey respondent via a unique 
identifier to actual health services utilization collected over a 5-year period. 
The final methodological limitation raised i that the majority of tudies published 
on the cost of obesity to the health care system have used a top-down prevalence-based 
approach. While population-based data are valuable, it is also important and useful to 
quantify the association of obesity and healthcare resource cost at the patient or 
individual level. Linkage at the individual-l evel to healthcare utilization and ubsequent 
costs a llows for examination of the relationship between obesity and health services 
utilization whi le controlling for known confounders such as patient health status, 
socioeconomic status, age and gender. This study utilized individ ual- level data, 
controlling for factors known to have an impact on health services utilization and 
estimates the cost of actual physician and hospita l services using the physician ' claim 
database and a hospital costing methodology developed by CIHI. 
Finally, this thesis uses Andersen' s Behavioral Model of Health Services 
Utilization (1995) as a guide in the design and the analysis ofthe study. The author 
attempts to understand the relationship between category ofBM I and its impact on health 
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services utilization as a Health Behavior. As well, the study explores the associabon 
between category of BMI and chronic disease, and whether BMI on its own is identified 
as a predisposing or need variable in tenns of the model. 
1.6 Thesis Outline 
Chapter 1 presented an introduction to the research, a rationale for the study, the 
research hypothesis and the specific research questions. Chapter 2 provides an 
introduction to the theoretical model used in the thesis and a literature review of the 
relationship between obesity and health services utilization. Chapter 3 provides the 
context for a study in obesity including a review of obesity related topics, the measures of 
obesity and its association with the burden of illness and its epidemiology. Chapter 4 
presents a discussion of the methods used in this study including the use of individual-
level data, details of data sources, the data linkage process and the data analysis. Chapter 
5 presents the results from the analyses. Chapter 6 provides a discussion of the findings, 
the conclusions and policy implications as well as the study limitations and potential 
areas for future research. 
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CHAPTER 2 Theoretical Model and Literature Review 
2.1 Healthcare Utilization 
Health services are part of the largest sector of the economy and these services 
continue to grow. The provision of health services is purported to maintain and improve 
the health status of the population. 
Utilization ofhealthcare services can be defined by purpose: primary care has to do 
with preventive measures of illness; secondary care refers to the process of treatment in 
an attempt to return an individual to a previous state of functioning while tertiary care 
describes services for acute care health problems such as a ruptured aneurysm or 
myocardial infarction as well as for the stabilization of long-tenn irreversible illness such 
as heart disease or diabetes. These services are often provided in large, well staffed, 
equipped facilities. 7 
A number of approaches have been developed to help explain an individual's 
decision to access and use healthcare services. The socio-demographic approach suggests 
that variations in healthcare utilization are related to variables such as age, sex , education, 
occupation, ethnicity, socioeconomic status, income as well as the structure of the health 
system and the external environment. The social-psychological approach sets out to 
explain factors that influence the seeking of care, suggesting that three main factors 
influence a patient's decision to seek help: knowledge, beliefs and attitudes concerning 
symptoms; attitudes and expectations regarding physicians and health services in general 
and a definition of sickness and detennination of the necessity for professional care. The 
organizational approach examines the structure of the healthcare delivery system in order 
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to account for differential health and illness behavior. For example whether the 
healthcare system is privately or publicly funded will impact the provision of health care 
services and who has access to them. Finally, the social systems approach views the 
healthcare system as consisting of inteJTelated components such as physicians, faci li ties 
and populations within the healthcare system. This approach suggests that these 
components interact with one another and the population they serve. It postulates that 
there is an interconnected relationship between the social structure of the population, the 
health services provided and the health status of the population and that these factors in 
turn impact healthcare utilization.7 
Each of these approaches provide insight into the type of factors that influence the 
utilization ofhealthcare services and several models have been developed that have 
included and integrated different components of each approach in an attempt to 
understand what specific factors influence an individuals use of healthcare services. One 
such model is the Behavioral Model ofHealth Services Utilization developed by 
Andersen in 1968 as pa1i of his doctoral di sse1iation. Andersen viewed the use of 
healthcare services as another forn1 of human behavior or human activi ty. One of the 
earlier adaptations ofthis model by Andersen & Newman (1973) integrated variables that 
might be found in the socio demographic and the organizational approaches. The latest 
model published in 1995 integrates many of the factors included in the Social Systems 
Approach and takes a much broader v iew of factors impacting health behavior, 
recognizing the complexity of health services utilization. The Andersen & Newman 
Model has often been used to guide research and evaluation studi es on healthcare access 
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and utilization, I0- 15 and has been used to explain the utilization of physician services, 
ambulatory care, psychiatric care, emergency room care, dental care as well as preventive 
services.8- 15 This model has been applied to specific groups such as veterans, the urban 
poor, the homeless, Hispanic immigran ts and the elderly.58-62 As well , in Canada, thi s 
model has been used to compare the use of emergency room services and services 
provided by allied health professionals.63-64 
2.2 Andersen's Behavioral Model of Health Services Utilization 
Andersen' s Behavioral Model of Health Services Utilization (1 995) is a complex 
model. The main purpose of the model is to aid in understanding variables impacting 
healthcare utilization in either a positive or negative manner (Appendix A).9 The model 
suggests that Health Outcomes defined as perceived and evaluated health status, as well 
as consumer satisfaction are the result of the interaction of Environmental factors, 
Population Characteristi cs and Health Behaviors. A description of the model fo llows. For 
the purpose of the current thesis the outcome of interest i Health Behavior not Health 
Outcomes. 
2.2.1 Environmental Factors 
Environmental factors describe the context in which utilization takes place and 
can be separated at an aggregate level into two main headings: the health system and the 
external environment. Health system vari ables refer to policies, provider organizations 
and the methods offinance. The external environment includes: the economy at the time 
including the societal norms and structures found in the population. At an ind ivid ual 
level, environmental factors include measures of the community and the provider. 
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Community variables relate to the geographical locations such as where individuals live 
and where they receive healthcare services (e.g., rural versus urban residence). Provider 
characteristics relate to the way in which services are provided with a focus on payment 
systems. Variables describing the Environment were not directly examined in this study 
as there was limited information in the health survey available in this context. 
2.2.2 Population Characteristics 
Population Characteristics describe three groups of vmiables classified under 
three main headings: predi sposing, enabling and need. The variables found under these 
headings have been found to demonstrate an impact the use of health services. 
2.2.2.1 Predisposing Factors 
Predisposing factors refer to individual characteristics which create a greater 
propensity in some individuals to use more services than others.8 These characteristics 
are not directly responsible for health service use but predict ei ther directly or indirectly 
utilization. The 1995 model describes five groups of Predisposing variables: 
demographic, soc ial structure, health beliefs, psycho-social attitudes and genetic tra its.9 
Demographic factors include variables such as age and gender. These variables 
are related to the use ofhealthcare services.9 For example, age has been found to be a 
significant predictor of health services utilization; as age increases so does the likelihood 
of ill -health . Gender is also associated with specific utilization pattems. For example 
women are much more likely to avail of health services during their reproductive years 
and through menopause. 65 
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Social structure describes the living conditions of an individual and provides 
some context for their individual choices. Social structure variables consist of vruiables 
such as mruital status, family size, residential mobility and occupation and tend to have a 
small impact on overall health services utilization.9 
Health related beliefs describe individual atti tudes towru·d healthcare services, 
physicians and disease. They also reflect individual knowledge about illness and the 
health care system. It is suggested that these facto rs are important predictors of health 
behavior, for example what an individual thinks about health may ultimately influence 
health and illness behavior. In addition an individual's psycho-social attributes such as 
problem-solving and coping skills are also recognized as significant predisposing 
vatiables.9•66.67 More recently, with the advances in the diagnosis and the treatment of 
genetic diseases, Andersen has recognized the significant role that genetics may have on 
health and subsequent service utilization and has suggested that it be included as a 
Predisposing variable in the mode1.9 According to Andersen and others, Predisposing 
factors are not directly linked to utilization, but are related indirectly through their 
relationship w ith the other Population and Need characteristics.8• 9 
2.2.2.2 Enabling Factors 
Enabling factors refer to those variables that represent an individual's ability to 
access healthcare services such as income level, heal th insurance and regional access. For 
example, in the United States individuals must have some fonn of insurance or pay out-
of-pocket for health services used. 
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In Canada, Medicare, the national healthcare system, ensures uni versal heal thcare 
coverage for all residents of Canada that is free at the point of entry for physician and 
hospital services and as a result it is unlikely that enabling variables play a large role 
within Canada in an individual 's ability to access these particular services. 
2.2.2.3 Need Factors 
Provided that predisposing and enabling conditions exist, the individual must 
have a need in order for the use of health servi ces to take place. Need vari ables include 
health status or measures of illness 8, 9 and they are often described as the most important 
cause of healthcare utilization.9'58,60 Need can be measured in a variety of ways including: 
measures of subjective health, restricted activity days or disabili ty days, the presence of 
chronic disease, the health utility index (HUI) which is a derived vari able that measures 
several indicators of physical health such as vision, mobility and hearing as well as health 
status. Need factors have been shown to be associated with the use of health services. 8' 9 
In the current thesis, Need is operationalized by the total number of self reported chronic 
conditions that an individual rep01is having being diagnosed with by a health professional 
as well several indicators of health status. 
2.2.3 Health Behavior- Outcome of Interest 
In Andersen's Behavioral Model ofHealth Services Uti lization, the component 
described as health behavior refers to the type and volume of healthcare ervice 
utilization such as the utilization of services provided by physicians. Jn the cuiTent thesis, 
two outcomes of interest were described as Health Behavior. These included: ( I) self 
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reported utilization of physician and hospital services (2) objective util ization of 
physician and hospital services and associated costs. 
2.2.4 Outcomes 
More recently, in Andersen's model (1995), a final category was added describing 
Outcomes associated with healthcare use. These Outcomes include variables describing 
perceived health status, evaluated health status and consumer satisfaction. Perceived 
health status is the individual's impression of the severity ofthe health issue 
incorporating an individual 's health beliefs, values and attitudes, 8•9 and may change 
based on changing level of education, illness behavior and expectations of the health 
system. Evaluated health needs describe the health professional's clinical diagnosis and 
expe1i advice on what is needed in the provision of medical services. For example 
whether further follow-up, treatment or diagnostic testing is required.9 Consumer 
satisfaction refers to how satisfied a patient or client is with the health service provided 
by a health professional and is unique to each individual based on their own set of 
experiences and expectations as well as the effectiveness of the service provided. ln the 
cun-ent thesis the Outcomes described in Andersen's model was not evaluated . 
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2.3 Obesity and Health Services Utilization 
The prevalence of overweight and obesity is increasing in most developed 
countries and its association as a risk factor for the development of chronic diseases has 
prompted researchers to examine its impact on the healthcare system in terms of 
healthcare utilization and costs. 
According to the latest OECD data (2006), the United States when compared to 
other developed countries repo1is the highest prevalence of overweight and obesity, and 
therefore it is not surp1ising that many of the studies assessing the relationship between 
obesity and its impact on the healthcare system have been published u ing American 
data. 24·30·34·36·38·41·44-45•68-69 Given the differences in health systems between the United 
States and Canada, it is not entire ly clear whether the study results are generalizable to 
the Canadian population. In Canada, under a national system of Medicare all residents in 
provinces and ten·itories have universal access to both physician and hospital service 
free at the point of entry. In the United States, access is limited to those individuals 
covered by some form of health insurance with a bias towards those individuals who are 
employed. As well , severa l studi es asse sing the relationship between obesity and its 
impact on the healthcare system have a lso been conducted in European countries where 
h h I I . f . d bl" . . 33 35 70-76 t e ea t 1 systems are a mix o pnvate an pu 1c prov1s1on. · · 
Th . d h f , . . h. d . c d 31 46-47 77 d ere IS a eart o 1terature 1n t IS area to raw upon 111 ana a. · · an 
although the Canadian system is s imilar in some ways to European healthcare systems in 
its method of public finance, provision and universal coverage, it i not known whether 
the results of these forei gn studies are truly generalizable to the Canadian population 
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given the difference in culture, illness behaviour, ethnicity and access. These studie have 
been conducted in the context of different countties, with different healthcare systems, on 
a variety of populations with varying age-ranges, different timelines and various 
methodologies. Therefore there is a need to conduct regional studies in Canada to 
examine this relationship to ensure its generalizability to the population and to provide 
robust conclusions for the development of policy. 
2.3.1 Obesity and Visits to a Primary Care Provider 
A number of studies conducted in several countries have reported a significant 
relationship between obesity and the increased use of ambulatory care services and visit 
to a general practitioner (GP).31 •34•38• 4 1•44•69•7 1•73 These have included studies that stratified 
their study populations by gender,32•45•70 as well as those studies whose focus was women 
only.33•72 Many of these studies found a signifi cant relationship between obesity and 
increased utilization of GP services, however these particular stud ies did not control for 
the presence of chronic diseases.31 •38•71 Jt may be that it is the pre ence of chronic disease 
and not obesity per se that demonstrates the direct effect on the need for healthcare 
services and although obesity is a risk factor for the development of chron ic disease its 
impact may be indirect. 
A secondary analysis of the cross-sectional component of the 1994 National 
Population Health Survey data was conducted. This longitudinal survey was 
representative of the Canadian population. Based on self reported infom1ation, the 
findings indicated that being obese (BMl ~ 27) was associated wi th increased visits to a 
G P. The following variab les were controll ed for in the regression analysi ; age, sex , 
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marital status, income, level of physical activity and smoking statu . The existence of 
chronic disease was not controlled for. The prevalence of chronic co morbidities such as 
diabetes and cardiovascular disorders was higher in the obese population compared to the 
non obese population.31 
In the study described earlier in Chapter I, 506 new patients (either obese or non-
obese) at the Davis Medical Centre Primary Care Center, University of California were 
randomly assigned to 105 Ptimary Care resident physicians and their subsequent 
healthcare utilization patterns were compared.38 Information was collected on socio 
demographics and the heights and weights were mea ured. As well other information was 
collected on the use of medical services during a prospective 12- month period and was 
determined by a review of medical records. The authors reported that obese patients had a 
higher mean number of visits to both primary care and specialty care clinics, and a higher 
mean number of diagnostic services ordered compared to non-obese individuals (BMI 
<30). The authors reported that being obese remained significantly related to the use of 
primary care and diagnostic services after controlling for health status, depression, age, 
education, income and sex. The authors did not adjust for obesity associated comorbid 
conditions such as hypertension or type JI diabetes. They argued that statistically 
adjusting for comorbidities was inapproptiate as many of these conditions are 
intem1ediates along the causal pathway between increased BMI and increased health 
services use and therefore including them in the statistical model would constitute over 
adjustment. The authors included a surrogate for comorbid conditions, a variable that 
measure phy ical health (MOS SF-36) and one that measures the impact of 
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comorbidities on self-reported health. Although thi s study was a prospective study design 
in contrast to many of the other studies reviewed, there were several limitations. It was 
conducted at a university medical centre with primary care residents, therefore the care 
provided and the population serviced may be somewhat different from what is found in 
the community. In addition due to the prospective nature of the study the resident 
physicians were not blinded. It is possible that ome bias exi sted in that resident doctors 
knowing the documented adverse affects of excess body weight may have unconsciously 
seen their obese patients more often and ordered more diagnostic tests for conditions such 
as hypertension, high cholesterol and type 2 diabetes. 
In a study on the German population, the authors analyzed responses to the 
KORA-survey 1999/200 l , a health survey administered to the adult population 25 to 74 
years of age in the Augsburg region. The study included 947 respondents. T he number of 
visits to a GP was analyzed and BMI was based on measured heights and weights. 
Having controlled for sex, age, place of residence, social class and sickness fund which is 
a type of health insurance fund for those ind ividuals employed (these vari ables were 
described as predisposing and enabling variables as per Andersen's model), obese 
individuals with a BM1 2: 35 were as ociated with more frequent utili zation ofG P 
services compared to nonnal weight individuals. Chronic diseases were not adjusted fo r 
in thi s analysi .71 
Studies stratified by gender found similar results; in general, obesity was 
associated with increased ambulatory care, including visits to a GP a lthough the results 
were not always consistent between gcndcrs.32• 45' 70 An Australian National Health 
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Survey was conducted in 1995. Survey responses were available for 17,033 men and 
17,174 women older than 20 years of age on health-related issues. Secondary analysis of 
this data was perfo1med. Having controlled for age and income, a positive relationship 
was reported between BMI based on self rep01ied heights and weights and some 
measures ofhealthcare service use for both men and women. Obese men and women 
were more likely to have made a v isit to a primary care doctor and obese women only 
were more likely to have made a visit to a speciali st. Both obese men and women were 
more likely to have reported visiting an outpatient clinic in the two weeks before the 
. . 32 
111 terv1 ew. 
Data from the Health and Retirement Study was examined in order to estimate the 
effect of weight class on healthcare use. This study was a nationwide biennial 
longitudinal survey representative of American adults between 50 and 69 years of age. 
Analysis of the data demonstrated a monotonic relationship between weight etas 
measured by BMI, based on self reported heights and weights (overweight, moderate 
obesity and severe obesity) and an increase in outpatient heatthcare services for women 
only. Men classified with severe obesity were associated with increased outpatient visits 
only. No specific services were mentioned. The authors controll ed for socio demographic 
factors (e.g., age, race, insurance status, marital status, education, family income, region) 
and health risk behaviours (e.g. , current tobacco smoking and heavy alcohol drinking). 
The authors stated that the intention was to evaluate the effects of varying degrees of 
obesity on heatthcare use and because increased risk of many chronic di seases are related 
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to obesity, other health conditions or level of general health were not considered as 
factors in these models.45 
Authors examined data from a prospective cohort study (200 1-2003) of non-
institutionalized individual s ~ 60 years of age and older which were repre en tative of the 
Spanish population. Having controlled for age, education, place of re idence, tobacco 
use, alcohol consumption and presence of chronic disease, the authors found that obesity 
based on self reporied heights and weight was associated with a greater number of visits 
to a primary care physician, for women only.70 Other studies considering women found 
similar results .33•72 
2.3.2 Obesity and Visits to a Specialist 
There were very few studi es that examined the relationship between obesity and 
its impact on speciali st services. For those studies referring to outpatient erv ices, the 
services provided by a pecialist were not described. In a review of the tud ies published 
the re lationship between obesity and specialist services was fo und to be 
inconsistent. 38•70·74 
2.3.3 Obesity and Hospitalization 
T he r lationship between increa ing BMI and increa ed util ization of hospital 
ervices uch a inpatient admissions length of stay and resources used while in ho pi tal 
is found to be incon istent. Although many authors reported a tati ti ca ll y ins ign ifican t 
relationship between obesity and increased hospital ization,3 1·33•34·35•38 .45·7 1•72 o ther authors 
reported a signifi cant finding that obe ity increased the use of ho pita! 
services . .t i ,44 ,70. 75-77 
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One explanation for the inconsistent findings of many of these studies i that hospi tal 
inpatient admissions may not be correlated with disease prevalence.78 Hospital 
admissions may be more reflective of the level of serve1ity (e.g., more acute) and level 
of access. This may be a limitation associated with hospitalization studie of this nature 
as rates of hospitalization may not be good indicators of the general level of morbidity in 
a population but indicative of other detenninants. 
Having reviewed the studi es, it appears that the positive studies were similar in 
that they had large sample sizes and primmily examined an elderly population over long 
pe1iods of follow-up. For example in a more recent study in 2006, the authors had 
conducted a prospective cohort study of approx imately 15,000 men and women who 
were in the age range of 45-64 years old in 1972. These survey respondents had taken 
part in the Renfrew/Paisley study in Scotland. Fo llow-up continued until 2004. The 
authors concluded that those who were overweight and obese at baseline had higher than 
expected rates for hospital admission and women who were overweight and obese at 
baseline demonstrated a u-shaped relationship between BMI and hospital admission 
rates. 75 
The healthcare utilization patterns of the members of the Kaiser Pe1manente of 
Colorado, America's largest HMO were examined. This HMO has an average of 8.4 
million members enrolled. Using a retrospective matched study design, obese 
individuals were matched with non-obese individuals by age, sex, outpat ient medical 
office and the absence of selected diagnosis such as pregnancy, coronary artery di ease, 
congestive heart failure and cardi ac arrhythmia. The healthcare utili zation was 
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determined for these individuals for the previous 12 months. The authors found that 
obese individuals had more hospitalizations, prescriptions drugs, professional claims and 
outpatient visits when compared to those who were considered nom1al weight. 44 
A study on the First National Health and Examination Survey was conducted in 
the USA between 1971 and 1975 on adults 25 years or older. Follow-Up Surveys took 
place between 1982 and 1992 (n= 14,407). The authors looked at BMI classification and 
length of stay in hospital. The authors rep01ted the following results. Individuals with a 
BMI 2 35 (moderate obesity), a BMI between 30 and 34.9 (obe e), and a BMl between 
25 and 29 (overweight) had inpatient crude length-of-stay (LOS) rates greater than those 
individuals classified as normal weight (BMI 18.5 - 24.9). The authors concluded obe e 
individuals experienced longer hospital stays when compared to those with a normal 
weight.36 
The Medicare Beneficiary Longitudinal Survey examined the healthcare 
utilization of an elderly population (n= 8,754) between 65 and I 00 years of age. This 
study was limited to hospitalization. The authors reported individuals in the lowest BMI 
quintile had a higher risk of hospitalization than those in the middle BMI quintile. 
Underweight, overweight, mild obe ity and moderate to severe obe ity were related to a 
higher risk of hospita lization when compared to nonnal weight individuals between 65 
and 75 years of age. For individuals o lder than 75 years of age, underweight, overweight 
and mild obesity were not related to a higher risk of hospitali zations.34 
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2.3.4 Obesity and Medication Use 
Medications constitute a large proportion of the direct healthcare costs to any 
healthcare system.3 As stated earlier in Chapter 1, medications account for 10.4% of tota l 
health care spending in Canada. 3 T herefore, it is of interest to researchers, policy makers 
and hospital administrators, especially those funded by global budgets, to better 
understand the allocation of funds being spent on medications. Given the relationship 
between excessive overweight and the increased ri sk of chronic disease, one might expect 
to see more medications being taken by this population. Many of the studies on obesity 
and health servi ces utilization examined whether excessive overweight and its association 
with chronic di sease influenced the use of medications. In a review of several studies, the 
results demonstrated that an increasing number of medications were taken by the 
excessively overweight population when compared to the nonn al weight population and 
these medication were often associated w ith the existence of chronic diseases such as 
hypetiension or high cholesterol.24,3 1,32•33•35·4 1'44 '73 -74 
The current thesis was not able to collect info rmation on medication use, as there 
were no questions on medication use included in the health survey. As medications are a 
large proportion of direct costs to the hea lthcare system, this was felt to be an 
unavoidable limi tation of the study. In NL, a pha rmacy network is being developed that 
will allow thi s type of analysis in the fu ture, however it wi ll be a prospective database 
and therefore retrospective studies before the date of initiation will not be possible. 
T here is some consistency in the studies reviewed; that is increasing BM I appears 
to be a sociated w ith an increased u e of GP erv ice , some outpatient services, the 
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consumption of medications and to a lesser extent hospital services. However there are 
several limitations and or biases inherent in this body of literature . Very few studies have 
been conducted in Canada or on a specific provincial population. Many of the studies 
reviewed were American or European in nature. Given the differences in the prevalence 
of obesity, chronic disease and the health systems across countries, the findings from 
these studies may not be generalizable to Canadian populations. Many of the studies 
reviewed did not control for factors known to have an impact on health services 
utilization such as age and sex, smoking, education level. In the current study a number 
of models were developed to examine the specifi c impact of BMI and several covariates 
on its own on health services utilization and BMI and chronic disease on health services 
utilization. In addition many of the studies reviewed relied solely on self reported health 
services utilization data obtained from health surveys, over varyi ng time pe1iods. The 
current study used both self reported data collected from a health survey and its linkage 
to health administrative databases to obtain actual infonnation on health services 
utilization over a five-year period. 
2.4 Obesity and the Behavioral Model of Health Services Utilization 
According to Andersen's model, as discussed in detail in Chapter 2 Section 2.2, a 
multitude of factors impact the utilization of healthcare serv ices. As a b1ief summary the 
model is categorized into four main umbrella headings: the Environment, Population 
Characte1istics, Health Behavior and Outcomes. 
The literature review for the current thesis focused primarily on the relationship 
between obesity and its impact on the utilization of health services as a Health Behavior. 
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Very few of the studies reviewed used a model as a guide in their examination of the 
relationship between obesity and health ervices utilization,69 although a few papers did 
refer to variable as predisposing or enabling factors without any further explanation. 
However, variables found in the Andersen model were often controlled for at the analysis 
stage of the studies reviewed as many of these variables such as age, gender, level of 
education and income and smoking behavior are known to have an impact on health 
services utilization. 
Studies controlling for socio-demographic, lifestyle, and socioeconomic factors 
(described as predisposing and enabling factors in Andersen's model) apa1i fi·om chronic 
disease tended to find a positive relation hip between obesity and increased use of 
healthcare services?3• 31•32.35,45 Other studies found an inconsistent relationship between 
obesity and increased use of healthcare ervices. In one study the authors concluded that 
obesity class I and II were associated with increased inpatient, outpatient and total costs 
when age and sex were controlled for. When comorbidities were added to the analysis 
(e.g., diabetes and hype1iension), the impact of obesity class I and lion increased use of 
healthcare services was eliminated. There remained a significant relationship between the 
presence of comorbidities and increased utilization.41 In contrast, several studies 
concluded that obesity remained an independent predictor of health services utilization, 
controlling for chronic comorbidity. The authors suggested one reason for this 
independent relationship may be that phy icians view obese individuals as more likely to 
develop comorbidities and therefore set up a different physician visit regime (i.e., more 
regular appointments). Alternatively, other re earchers argue that obese individuals often 
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report lower scores on indexes that measure health tatus and self perceived health,31 •38 
and may perceive themselves as less healthy and therefore visi t the physician more 
frequently. 33• 44 
In another study in 2002, the authors reported that Spanish overweight and obese 
women had increased healthcare service use; vis ited the physician, used hospital 
emergency services and took more medication compared to the normal weight group. 
These relationships did not change having controlled for age, education and the presence 
of chronic disease. The sample in this study were more educated, had a higher social 
class and were younger then non responders, potentially biasing the results as individuals 
with higher levels of socioeconomic status may access preventive services more in an 
effort to remain healthy. As well the treatment of obesity itself may lead to greater 
utilization as this study reported that obese women reported worse subjective health 
compared to non-obese women even without chronic disease.33 In addition, in a study in 
2004, the authors reported that having controlled for age, sex and chronic disease score, 
BMl remained a significant predictor of total healthcare costs, but only marginally. For 
each increase in chronic disease score the costs increased by 52.9% while for each 
increase in BMI, costs increased by 2.3%. Age contributed only 1.3% increase in costs 
for each year.44 
Some authors argued that excess overweight is a ri sk factor for the development 
of chronic disease and controlling for the level of comorid ity consti tutes over adj ustment. 
For example in a study in 2002, the authors fo und a relationship between obesity and 
increased likelihood of hospitalization. The authors did not adj u t for specific diseases 
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associated with what they termed modifiable risk factors (i.e., overweight), as these are 
described as ' intervening variables', that is those between the risk factors and ill- health 
outcomes such as hospitalization, mortality and di sability.69 
Based on this review of the available literature, it is not clear whether obesity is 
associated with increased healthcare utilization either directly or indirectl y through the 
existence of chronic disease. Some of the studies reviewed took into account what might 
be considered to be predisposing variables such as age, sex, education and income, as 
well as region of residence considered to be enabling factors in the Andersen model. 
Some studies took level of comorbidity or chronic disease into account (the need 
variables) while others argued that obesity is associated with chronic disease and 
therefore controlling for these diseases amounts to over adjustment. 
2.5 Cost of Obesity 
Over the last decade researchers have provided many estimates of the cost of 
overweight and obesity to the healthcare system. Numerous studies have been undertaken 
in order to estimate the costs associated with obesity. The majority of these studies have 
used a prevalence based cost-of-illness (COl) methodology, 42• 4?-S I .. '('-7') while the current 
study and others have used individual-level data.40-41 •45 
Cost-of- illness studies are a type of economic analysis often used in health 
research. The aim is to identify and measure all costs attributabl to a disease which 
include direct health care costs and indirect costs such as losses in productivity. Using 
these estimates, the overall impact i presented in monetary tem1s. This ana lysis provide 
health po li cy makers and decision-makers with information on which to make deci sions 
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on resource allocation. There are two types of Cost-of- Illness studies; the prevalence-
based and the incidence-based approach. The prevalence-based approach is the most 
common approach used to study the impact of obesity on healthcare costs from the 
perspective of the healthcare system. This approach identifies the costs incuned during a 
specific time period by individuals with a particular disease.48 It is difficult to quantify 
the long-tenn consequences of a chronic disease uch as obesity using the prevalence-
based approach, as the information used in this type of analysis is most often based on 
information collected using cross-sectional study designs. The incidence-based approach 
follows newly classified cases of obese individuals and is more appropriate for studyi ng 
the impact of obesi ty on healthcare costs. This approach as well estimates the lifetime 
cost of new cases of obesity diagnosed in a given year. However, this approach is more 
difficult to apply and it is very data intensive. Individuals are selected when first 
diagnosed or classified with obesity, and these individuals are fol lowed for many years to 
determine the development of associated co morbidities. 
2.5.1 Prevalence-Based Approach 
The prevalence-based approach uses a top-down method calcu lating the 
Population Att1ibutable Risk Fraction (PAF). Thi s approach uses the relative risk 
associated with obesity and the development of associated chroni c diseases as well as 
using the prevalence of obesity in the relevant population. The PAF detennine the 
percentage of di sease prevalence due to obesity and estimates the total co ts of obesity 
using published data on national healthcare expenditures associated with particular 
diseases. The calculated proportion of cases and costs of a given disease attributable to 
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excess weight is greatly influenced by the accuracy of epidemiologic evidence about 
disease prevalence and relative risk. It is also influenced by the presence of confounding 
factors affecting tisk such as age, sex, race and the presence of co-morbid conditions. In 
addition, factors detennined by the investigator such as the BMI, affect the relative and 
attributable risk estimates and are often different in different populations. 
Using the prevalence-based approach, direct healthcare costs attributable to being 
obese have been shown to be relatively consistent from country to country contributing to 
between 2-7% of the total healthcare expenditures.56 
There has been limited research conducted on the economic burden of obesity in 
Canada.46-47 One study however estimated the direct and indirect economic costs of 
obesity in Canada. The authors identified the relative tisks of diseases associated with 
obesity from a meta-analysis of existing prospective studies using a prevalence-based 
approach. These risks were applied to the calculation of the P AF and then taken as a 
percentage of the healthcare costs of the associated diseases. Estimates were derived for 
both the direct healthcare expenditures and the indirect costs, which included the value of 
economic output lost due to illness, injury-related work disability, or premature death. 
The economic burden associated with obesity was estimated to be $4.3 billion which 
included $1.6 billion in direct costs and $2.7 billion in indirect costs representing an 
average of 2.2% of the total healthcare costs in Canada.47 These calculations and 
estimates are based on various sources of information that are briefly desctibed below 
and which have their own methodological limitations. A detailed discussion of these 
assumptions is outside the scope of the current thesis. 
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The relative risk estimates used to conduct the P AF were based on a meta-
analysis of original prospective studies that examined the relationship between excess 
body weight and the risk of developing certain di seases. The total healthcare costs 
associated with these specific diseases were obtained from the 1998 Economic Burden of 
lllness in Canada (Health Canada 2002)4 and the estimated prevalence of overweight and 
obesity in Canada obtained from the Canadian Community Health Survey 2000/200 l. 
Another study used a similar approach and estimated the total ' direct' healthcare 
cost of obesity to be over $1.8 billion annually, or approximately 2.4% of the total 
healthcare expenditures for all associated diseases in Canada. The following obesity-
related medical conditions were included; type II di abetes, hyperten ion, stroke, coronary 
artery disease, hyperlipidaemia, pulmonary embolism, gallbladder disease, 
postmenopausal brea t cancer, colorectal cancer and endometrial cancer.46 
The prevalence-based cost of obesity has been investigated internationally: in the 
USA,45'48-50,53 Australia, 56 Finland, 54 France39 and the Netherlands.29 One of the first 
studies using a prevalence-based approach estimating the economic cost of obesity wa 
conducted in the USA. This study focused on the following obesity-related medical 
conditions: type JJ diabetes, gallbladder disease, cardiovascular disea e, hypertension and 
some cancers. The cost of treating each of these medical conditions was calculated by 
estimating that a proportion of cases occurred in obese individuals. The author identified 
a certain propotiion of these cases to be attributable to obesity. For example, 27% of 
CVD was diagnosed in obese individuals and 70% of these CVD case were attributable 
to obesity. Therefore, 19% (27% of 70%) of the estimated aggregate costs of treating 
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CVD in the US could be attributed to obesity. The total costs attributable to obesity for 
these medical conditions were estimated at US$39.9 billion representing 5.5% of the total 
cost-of-illness in 1986. It was suggested that this may be an underestimate, as other 
obesity-related medical conditions not included in this estimate, such as musculoskeletal 
disorders could raise the estimate substantially. Indirect costs were estimated to be 
US$23 billion.48 It should be noted that the COl method for estimating the burden of 
illness is based on several assumptions and it is valid only as long as the information used 
to calculate the assumptions is correct. 
The same author has conducted several other studies on the economic cost of 
obesity and associated medical conditions in the USA. A similar study was repeated in 
1994, and included musculoskeletal disease as a medical condition associated with 
obesity. The earlier 1986 estimate ofUS$39.9 billion increased to $45.8 billion or 6.8% 
in 1994 of overall healthcare spending.49 A further study conducted in L 998 by the same 
authors, included several more obesity-associated medical conditions such as breast 
cancer, colon cancer and osteoarthritis. The estimate for direct costs increased to 
US$51.6 billion in 1995 or to 5.7% of overall direct healthcare spending. 5° In 1999 and 
using the revised BMl classification (BMI >30) , the total cost of obesity was estimated 
to be US$70 billion or 7.0% of overall healthcare spending. 5 1 
A similar methodology was used in Australia. The comorbidities included were; 
type II diabetes, coronary heart disease, hypertension, gallbladder disease, breast cancer 
and colon cancer The authors estimated the healthcare cost of obesity to be AUS$395 
million for a period 1989- 1990 or 2.0% of overall healthcare spending. 56 
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The same methodology was used in New Zealand to estimate healthcare co ts 
associated with obesity. The obesity associated co morbidities included in the analysis 
were: type II diabetes, coronary heart disease, hypertension, gallbladder disease, brea t 
cancer and colon cancer. Using a BMI 2:30, the authors estimated the cost to beNZ $ 135 
million in 1991 or 2.5% of overall healthcare spending. 57 
The total healthcare cost of obesity in France was estimated to be FF I1.9 billion 
or 2.0% of overall healthcare spending for 1995. This study included hypertension, 
gallbladder disease, breast cancer and colon cancer, osteoarthritis, genitourinary cancer, 
gout, myocardial infarction, dyslipidaemias as obesity-related medical conditions. The 
BMI 2:27 was used in this study.39 
There are differences in these countries in the way healthcare is funded and how it 
is delivered. The estimates of the total cost of obe ity to the healthcare sy tern, however 
are very similar, and may be due to the prevalence-based approach being used to estimate 
these costs. 
The following limitations are inherent in the prevalence-based approach making 
compari ons across studies almost impossible: (i) the reliance on estimates of obesity 
prevalence and relative risks from published studies to calculate the population 
attributable risk fraction (ii) the basis for the choice of medical conditions known to be 
associated with excess body weight is not alway clear and (iii) the use of different BMI 
cut-off points to classify overweight and obesity and (iv) the estimate of costs associated 
with diseases often provided by National govemments of health agencies. In conclusion, 
the prevalence-based approach is a high level top-down approach relying on many 
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estimates which may or may not be credible in order to determine the resources spent on 
a risk factor. It is not possible to detem1ine what is happening at a grass roots level in 
tem1s of health services utilization and the burden placed on individual health 
professionals in the healthcare system. 
2.5.2 Individual-Level Approach 
As discussed earlier in the Introduction, few studies have u ed individual-level 
data to ascertain health services utilization and the direct cost of obesity. While 
population-based data are valuable, it is also important and useful to quantify the 
association of obesity and healthcare resource cost at the patient level. Linkage at the 
individual-level to healthcare utilization and subsequent costs allows for examination of 
the determinants or predictors of health services utilization while controlling for known 
confounders such as patient health status, socioeconomic status, age and gender. 56•80-85 
A number of studies were conducted using healthcare records or other secondary 
sources to examine differences in overall healthcare costs by levels ofBMI comparing 
. h b I . h 40-42 45 56 Tl d. . overwerg tor o ese persons to norma werg t persons. ' ' 1ese stu res estrmate 
healthcare cost across levels of BMI over a time period at the patient level averaging the 
cost per patient. 
The influence of BMI on the utilization of healthcare ervices and associated 
average annual healthcare expenditures was assessed in a study on a population of 
16,217 Americans that responded to the National Expenditure Survey. A strong positive 
relationship existed for both men and women between the level of BMJ and healthcare 
utilization and expenditures.40 
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Studies using this approach have reported associations between self reported 
weight and height and the costs of outpati ent, inpatient health services and annual 
healthcare costs.4 1 -'~2 Of these two studies, one controlled fo r comorbid conditions,41 
while the other did not adjust for any variables. The author of this latter s tudy reported 
that the comorbid conditions were critical links in the pathway by which obesity leads to 
increased health services utilization, and therefore should not be included in the 
I . 42 ana ys1s. 
In the cunent thesis, an analysis of individual-level data allowing for the 
adjustment for confounders wa conducted, rather than the more commonly used CO l 
prevalence-based approach. The individual-level survey data were li nked to physician 
and hospital databases. This linkage enabled the author to examine objective util ization 
and average healthcare costs over a five-year period and to identify whether obes ity acts 
as an independent predicto r of either health services use or direct healthcare costs. The 
ability to access health survey data representative of the provincial population and to link 
survey responses to objective health services util ization data allows fo r the control of 
potential confounders and may provide a better understanding and a more reliable 
estimate of the healthcare utilization and its associated cost by the obese population. 
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CHAPTER 3 Obesity Literature Review 
3.1 Introduction 
The purpose of this chapter is to provide the context fo r a study on obesity and its 
impact on the healthcare system. It is well established that excess body fat is a risk factor 
for a number of chronic diseases 17• 2 1 but, until recently in historical tem1s excess body 
weight was not of concem either at a societal or political level. Due to the increased 
availability of data on anthropometric measures, it is clear that there ha been an 
increased prevalence of excess body weight in most populations. While it is clear that 
excess body weight has an associated impact on the health of the individual , it is not clear 
whether there is an associated impact on the healthcare system. Many researchers have 
repmi ed that overweight and obese individuals are more likely to suffer fi·om associated 
chronic d iseases thereby utilizing healthcare services more often than their lean 
counterparts. Future p rojections suggest that this population will place a large financial 
burden on the health system and many govemments. 
3.1.1 Measures of Obesity 
T he most common method fo r classifyi ng excessive body weight at a popu lation 
level is by measuring BMI endorsed by the World Health Organization (Wl-10).17•2 1 
Obesity is characteti zed by excessive body fat or adi pose ti ssue (BM I 2: 30) accumulated 
to such an extent that hea lth may be adversely affected (see Table 3. 1 ) .86 
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Table 3. 1 BMI and Associated Health Risks 
Body mass index WHO classification Risk of co-morbidities 17•21 
< 18.5 Underweight Increased 
18.5-24.9 Nonnal Average 
25-29.9 Overweight Increased 
30-34.9 Class I obe e Moderate 
35-39.9 Class II obese Severe 
~ 40 Class III obese Very evere 
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3.1.2 How is Body Fat Measured? 
Body fa t can be estimated using direct and indirect measurements of body 
composition. Direct measurements such as magnetic resonance imaging (MRI), d ual x-
ray absorpitometry (DEXA) computed tomography (CT) or hydrodensitometry 
(underwater weighing) can accurately estimate body fat content. Indirect measurements 
ofbody fat or body composition obtained using non-i nvasive measures (e.g. , waist 
circumference, waist-to-hip ratio, skin-fold thickness, bioimpedance, and body mass 
index) provide crude SUITogate markers of body fatness. 
3.1.2.1 Direct Measurements of Body Fat 
Until recently the 'gold standard ' fo r estimating body fat has been 
hydrodensitometry (underwater weighing). Dual-energy x-ray absorptiometry is now 
replacing hydrodensitometry as a gold standard because of its high precision and its ease 
of application for the subject.87 The DEXA body scan determines bone mineral content, 
body fat, and lean tis ue mass by a precise computer contro lled x-ray beam. The x-ray 
penetrates deep inside the body and is useful in detenn ining visceral or intra-abdominal 
fat. In addition an MRl or aCT scan can provide high quality images of the inside of the 
body and an accurate measure of visceral adipo ity or intra-abdominal fat. 88 These direct 
measures are used primaril y in clinical settings and are not usuall y avail able for large 
population studies, due to their associated high operational costs and the practical 
di ffi culties involved in their application. However these direct methods play a very 
important ro le in re earch. They are used to validate other indirect method of estimating 
body fa t such as wa ist circumference or BMI.89 
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3.1.2.2 Indirect Measurements of Body Fat 
Anthropometric measures (e.g., waist circumference, waist-to-hip ratio, BMT) are 
the most common methods used to estimate individual body fat and body composition in 
the clinical setting and when conducting epidemiologic studies. T he measurements of 
body circumference using waist circumference and waist-to-hip ratio have become more 
common over the last 20 years due to the inte rest in visceral fat (abdominal fa t) as a 
potential independent risk factor for chronic disease.87 Waist circumference is a simple 
measurement unrelated to height that correlates closely with other indirect measurements 
of body fat such as BMI and waist-to-hip ratio.2 1 It is an estimate of visceral or intra-
abdominal fat mass,21•90•91 and upper body fat. 92 Visceral fa t is considered to be 
metabolically different from subcutaneous fa t (i .e., all over fat) in its responsiveness to 
dietary changes and its metabolic and honnonal output. Excessive visceral fat has been 
associated with the metabolic syndrome. This syndrome include a collection of 
metabolic disturbance such as hypertension, dyslipidaemia, impaired glucose tolerance 
and insulin resistance which can lead to the development of cardiovascular disease.93 
Researchers report that waist circumference is a more accurate indicator of 
increased health risk when compared to BMI and should be included in assessments of 
obesity. 94-96 In addition; changes in waist circumference refl ect changes in risk factors for 
cardiovascular disease, 94 and other fom1s of chronic disease. Health Canada in 2003 
adopted specific cut-off points for abdominal girth measurement in both men and women. 
For men, a waist girth greater than I 02 em or 40 inches and fo r women a waist girth 
greater than 88 em or 35 inches, is associated with an increased risk of type II diabetes, 
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coronary heart disease and hypertension.97•98 There is difficulty in drawing international 
comparisons using these measurements. Canada accepts these recommended thresholds 
for waist girth, however other countries do not. Although the accumulation of abdominal 
fat is associated with a number of comorbidities, cross-sectional population studies 
conducted in Africa, the Caribbean, the United States and Canada report that the 
relationship between waist circumference and chronic disease varies by region.99- 102 
Consequently, international comparisons are limited due to the cut-off points being 
population specific and dependent on the regional prevalence of obesity and 
cardiovascular risk factors. An additional challenge for researchers is the proposal of 
different cut-off points for waist girth based on a person ' s age and sex.21 When defining 
the problem of overweight and obesity, the WHO in 1995, recommended that waist 
circumference should be measured concurrently with BMI. 103 
It has been suggested that combining the waist-to-hip ratio with the measurement 
of waist circumference will more accurately reflect health risk, especially in women. The 
waist-to-hip ratio is often equated with the apple and pear body shape. In general men 
tend to be apple shaped and women pear shaped. Typically men distribute fat around 
their abdomen and women deposit high amounts of fat around their hips, buttocks and 
thighs. The additional measurement of the waist-to-hip ratio indicates the degree of fat 
accumulation around the hips. Extra fat around the hips may be protective of adverse 
health consequences for the individual. 104 
The waist-to-hip ratio is not often used as a measure of obesity. However, a recent 
case control study published in the Lancet in 2005 and conducted by the lnterheart Study 
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Group suggested that the waist-to-hip ratio may be more accurate when determining the 
risk of myocardial infarction. The authors compared the waist-to-hip ratio with BMI and 
the odds of an individual having experienced a myocardial infarction, for 27 098 
pa1iicipants across 52 countries. Body mass index showed a modest and graded 
association with myocardial infarction. When comparing the top quintile to the bottom 
quintile before adjustment, the resulting odds ratio (OR) was 1.44 [95%CI (1.32-1.57)]. 
Adjusting for the measure of the waist-to-hip ratio substantially reduced the OR to 1.12 
[95%CT ( 1.03-1.22)] . Having adjusted for other risk factors, the relationship between 
BMI and myocardial infarction was not significant; OR 0.98 [95%Cl (0.88-1.09)]. For 
waist-to-hip ratio, the odds ratios for every successive quintile were significantly greater 
than that of the previous one, adjusting for age, sex, region, and smoking (2nd quintile: 
OR 1.15 [95% Cl ( 1.05-1.26)]; 3rd quintile: OR 1.39 [95% Cl(1 .28-1.52)]; 4th quintile: 
OR 1.90[95% CI (1.74-2.07)]; and the 5th quintile: OR 2.52 [95% CJ (2.31-2.74)]. The 
waist-to-hip ratio showed a graded and highly significant association with myocardial 
infarction risk worldwide suggesting obesity based on waist-to-hip ratio as a replacement 
for BMI increased the accuracy of estimating the likelihood of myocardial infarction. 105 
One major limitation of this study is its retrospective case control study design, which is 
weak in its ability to suggest a causal relationship. In addition, this method of estimating 
body fat is associated with measurement erTor, due to the unreliable measurement of both 
the hips and the abdomen. 
Using skin-fold measurements, the percentage of subcutaneous body fat can be 
measured by body-fat calipers. This instrument measures body fat in specific sites such as 
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the triceps, the shoulder blade and waist. The measurement error associated with this 
technique limits its use in research. As well, these measurements do not provide 
information about the existence of abdominal or intramuscular fat. 106 
3.1.3 Body Mass Index and Associated Health Risk 
The most common non-invasive method for indirectly estimating body fat and its 
associated health risks is through the calculation ofthe Quetelet's or BMI 21 , defined as 
weight in kilograms divided by height in metres squared: 
BMI = weight (kgs)/height (m2) 
According to the WHO, BMI is the most approptiate measure by which weight 
adjusted for height can be related to health outcome. The BMI index is easy to calculate 
and correlates strongly with direct measures of fatness or adiposity (r=0.82-0.91) in 
adults.20 BMI has greater reproducibility than other measures of adiposity such as skin 
fold thickness, waist circumference and waist-to-hip ratio.21 
Body mass index is simple to calculate and is a useful measure for indirectly 
estimating body fat. The graded BMl classification system of underweight, nonnal , 
overweight and obese permits (a) comparisons of weight status within and between 
populations (b) identification of individuals and groups at increased risk of morbidity and 
mortality (c) priorities to be identified for intervention at individual and community 
levels and (d) a basis for the evaluation of interventions. 
54 
- -- · -~--~---
Body mass index provides a useful crude population-level measure of obesity. 
This measure can be used to estimate prevalence of obesity within a population and the 
associated health risks. Body mass index provides a reasonably reliable screening tool 
that is easy and inexpensive to use on large populations.2 1 
3.1.4 Body Mass Index as a Measure of Body Fat 
Although BMI is the most commonly used method to classify weight status and 
health tisk, there are many disadvantages inherent in its calculation. Different ethnic 
groups have substantially different proportions of body fat at the arne value of BMJ.2 1 
For example, the ratio of fat to lean tissue is highest in Indian people, intennediate for 
Chinese people and low for Caucasians. 107 In addition Polynesians have a relatively high 
proportion of lean tissue. 108~ 1 09 It is also documented that women have substantial ly more 
fat tissue than men, 110 and that both men and women lose lean tissue at different rates 
throughout the life cycle. 111 As well , the BMI values associated with increased health risk 
I. h . . 11 2~ 11 3 vary accorc mg to et mctty. 
Body Mass Index does not distinguish between increased body weight due to 
adiposity or fluid retention. As an index, BMI fails to distinguish between muscle, body 
fat , or bone. Men and women with the same BMI may have a different percentage of 
body fat o r fat mass compared to lean mass. As well, BMI doe not indicate the location 
or the di stribution of excess fat. BM I does not account for the wide variation in body fat 
distribution and may not correspond to the same degree of fatness or associated health 
risks in different individuals or populations. 103' 11 4 Obese individuals with exces fat in the 
intra-abdominal area are at risk for the development of adverse health consequences. 115 
55 
The calculation ofBMI measures overall fat, but will not provide information on the 
location of the fat. Also, when measuring individuals who demonstrate extreme height or 
muscle mass, the accuracy of the BMI value may vary. A health professional using BMI 
as an indicator to measure body fat, may conclude incoiTectly that an individual is obese. 
Although, a high BMI may suggest an increased risk of an associated disease, this 
measure may also indicate a very muscular individual. An individual with a high 
proportion of muscle relative to height may have a high BMI value, yet not be obese. 116 
As well BMI is less accurate for estimating body fat in very short individuals. 11 7 
3.1.5 Health Canada and Changing BMI Guidelines 
In 2003, Health Canada updated its body weight classification system based on 
research conducted by the WHO. This classification has been widely adapted 
intem ationally. 11 8 There were some similarities between the old and new classification 
system, however, the differences in the updated version are significant (Tab le 3.2). The 
updated classification system included changes to certain cut-off points in the BMJ 
categories. The introduction of a waist circumference as a measure of body fat and 
associated health risk was also introduced. The range for nom1al weight has increased to 
include a BMI in the range of 18.5-24.9 whereas in the old system nonnal weight 
included BMJ 's in the range of20 - 25 . The relationship between BMI and mortality was 
examined in a representative sample of the American population.22 Researchers 
suggested that a j-shaped relationship existed between BMI and mortality (having 
adjusted for underlying illness) with increased risk of mortality at a BMI below 18.5 
relative to a BMI in the nonnal range of 18.5 - 24.9. In 1988, researchers suggested that 
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a BMI between 25 and 27 led to an increased risk of health problems in some individuals, 
while a BMI > 27 was associated with increasing risk of developing health problems in 
many individuals. Since then, more research has been conducted on the relationship 
between BMI and moriality and morbidity risk. 17•22•86 The mortality curves generated 
from these studies illustrate the relative ri k of mortality begins to increase at a BMI of 
25, and there is a marked increase of moriality risk at a BMJ >30 and a BMI < 18.5. 
Based on these findings, the WHO describes the BMI range of25 to 29.9 as preobese. In 
Canada, this BMI range is described as overweight. Both the WHO and Health Canada 
use a BMI >30 to classify individuals as obe e. The obese classification is further broken 
down into three groups (Table 3.2). 
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Table 3.2 Comparison ofBMI Classification Systems 1998-2003 
Canada 1988 118 WHO 200021 Canada 2003 118 
Zone A BMI < 20 
May be associated with 
health problems in some 
people 
Zone B: BMJ 20-25 
Good weight for most 
people 
Zone C: Between 25 and 27 
May lead to health 
problems in some people 
ZoneD: BMI > 27 
Increasing risk of 
developing health problems 
Underweight 
BMI < 18.5 
Nonnal range 
18.5-24.99 
Preobese 
25.0 - 29.99 
Obese Class l 
30.0 - 34.99 
Obese Class II 
35.0 - 39.99 
Obese Class III 
2:40.0 
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Underweight 
BMI < 18.5 
Nonnal range 
18.5-24.99 
Overweight 
25.0 - 29.99 
Obese Class I 
30.0 - 34.99 
Obese Class II 
35.0 - 39.99 
Obese Class lri 
2:40.0 
,------------------------ --------- -----------
Nevertheless, international convention, represented by a major WHO Technical 
Consultation endorsed the use of a common BMI scheme for adults irrespective of sex 
and age? ' As a result, in 1995 the WHO, in collaboration with the International Obesity 
Task Force designed a global BMI classification system for the identification of 
underweight, normal weight, overweight and obese individuals. This new classification 
system allows for meaningful comparisons within and between populations. 
3.2 Obesity and its Burden of IIJness 
Obesity is often referred to as a chronic disease, that is purported to be related 
causally to setious medical illnesses.11 9 These chronic illnesses may not be fatal but may 
be debilitating in nature and have an adverse effect on an individual ' s quality of life. As 
well, these obesity related illnesses may increase the risk of mortality. Obesity increases 
the risk of the development of several chronic conditions such as cardiovascular diseases, 
hyperiension, coronary heart disease (CHD), cerebrovascular disease, cancer and type ll 
diabetes. As well, obesity is associated with metabolic syndrome and endocrine 
disturbances and other debilitating conditions. In industrialized countries, it has been 
reported that obesity has a psychosocial impact on individuals through prejudice, bias and 
. I . 21 socra stigma. 
3.2.1 Hypertension 
Many studies have repmied a positive association between BMI and hypertension. 
As BMI increases, the risk of developing hypertension increases.120- 123 Based on the 
Framingham study, a large longitudinal cohort study in the USA started in the 1950's in 
the USA, the relationship between BMI and blood pressure has been examined over time. 
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Authors have reported an increase of 6.5 mmHg in blood pressure with every l 0% 
increase in body weigh for this population 120 and other longi tudinal studies have 
demonstrated similar results.12 1-123 
In addition cross-sectional studies have demonstrated that the prevalence of 
hypertension is increased in overweight and/or obese individuals. Using cross-sectional 
data from the Third National Health and Nuttition Examination Survey (NHANES 111), 
the age-adjusted prevalence of hypertension was 42% and 38% in obese men and women 
respectively. This was twice as high as the repotied prevalence of hypetiension for men 
and women classified as normal (BMJ < 25) which was approximately 15% in both men 
and women. In this study, hypertension was defined as systoli c blood pressure > 140mm 
Hg, diastolic blood pressure >90mm Hg, or the need for hypertensive medication.124 
3.2.2 Coronary Heart Disease 
The authors of a meta-analysis, including 2 1 cohort tudies repotied on a 
combined sample size of 300,000 individuals and their related 18,000 CHD events. The 
adverse effects of high blood pressure and cholesterol levels associated with ovetweight 
and obesity accounted for 45% of the increased CHD risk. Adjusting fo r age, physical 
activity and smoking, the relati ve ti ks and 95% confidence intervals for moderate 
overweight and obesity compared with nonnal weight were 1.32 [95% CI ( 1.24- 1.40)] 
and 1.81 [95% CI (1 .56-2.2 1)] respectively. The relative risk as ociated with a 5-unit 
BMI increment was 1.29 [95% CI ( 1.22- 1.35)]. Gender was not examined separately in 
h. . 124 t ts revtew. 
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Longitudinal studies report an increasing relative risk of developing CHD with 
increasing levels ofBMI. 125•126 Findings from the Nurses Health Study, a large scale 
prospective study of women (n= 115,886), suggest that the relative risk of non-fatal 
myocardial infarction, increased as BMI increased. Women in the heaviest weight 
category (BMI >29) were approximately 3.5 times more likely to develop CHD as 
compared to women in the lightest weight category (BMI of <2 1 ). 126 Another study 
examined the relationship between BMJ and CHD risk factors in 314 non diabetic, 
nonnotensive, healthy volunteers, and reported obesity to be a powerful predictor of 
CHD risk. 125 
3.2.3 Cerebrovascular Disease 
The authors of a prospective cohort study using the Nurses Health Survey 
examined the associations between BMJ and weight changes with the tisk of stroke in 
women. The study population (n= l 16,759), included women 30 to 55 years of age in 
1976, free from diagnosed CHD, stroke, and cancer. Dming 16 years offollow-up, it was 
reported, 866 total strokes, including 403 ischemic strokes and 269 hemorrhagic strokes 
occurred. Using multivariate analysis, adjusting for age, smoking, postmenopausal 
hormone use, and menopausal status, women with increasing (BMl ?:.27) had 
significantly increased risk of ischemic stroke. The authors reported increasing relative 
risks of 1.75 [95% CI (1.17-2.59)] for individuals with a BMI between 27 to 28.9 kg/m2 ; 
1.90 [95% Cf (1.28-2.82)] for individuals with a BMI between 29 to 31.9 kg/m2, and 2.37 
[95% Cl (1 .60-3.50)] for individuals with a BMI > 32 kg/m2 (P for trend<.OO I ). These 
groups were compared to individuals with a BM l < 2 1 kg/m2. The risk of fatal and non-
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fatal ischemic stroke was more than twice as high in obese persons than in lean persons 
and the risk of stroke appeared to increase with increasing BMI. 127 
The association between excess weight and increased risk of s troke in men does 
not appear to be as strong as in women. In one study, the association of BMI with stroke 
incidence was examined. As w ell , the association between abdominal obesity and stroke 
incidence was examined using the waist-to-hip ratio. This study examined 28,643 US 
male health professionals, aged 40-75 years in 1986. This group did not have a history of 
cardiovascular di sease or stroke. In a 5-year foll ow-up, there were 11 8 cases of stroke of 
which 80 were ischemic. Comparing men in the lowest and hi ghest quintil e of BMI, the 
results were not s ignificant. In contrast, the age-adjusted relative ri k fo r extreme 
quintiles of waist-to-hip ratio was 2.33 [95% Cl (1.25-4.37)] was found to be significant. 
This relative ti sk was not substantially altered in a multivariate model including BMI, 
height, and other potential risk facto rs. When waist circumference alone was used as a 
measurement of excess body fat, there was no significant relationship w ith men in the 
highest quintile (> 1 02cm) and the incidence of stroke compared with men in the lowest 
quintile (~ 88cm). These results suggest that abdominal obesi ty measured by waist-to-hip 
ratio ratio, but not BMI or waist circumference, predi ct the risk of stroke in men. In 
addition for men, the ri sk of developing venous stasis, deep vein thrombosis and 
pulmonary emboli m also increased w ith abdominal o besity.128 
3.2.4 Cancer 
There is evidence to su ggest overweight and obesity are associated with an 
increased risk of vario us types of cancer such as esophagus, gall bladder, co lon, breast, 
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endometrial, uterus, cervix and prostate. Epidemiologic studies have found a direct 
relationship between BMI and colon cancer in both men and women. In addition the risks 
of mortality from endometrial cancer increases with obesity and weight gain after 18 
years of age. 129- 132 
Studies have shown a complex relationship existing between obesity and the risk 
of breast cancer and its prognosis. A review on obesity and the prognosis of breast cancer 
in 2006, examined the findings from a number of systematic reviews, meta-analyses and 
individual cohort studie . The authors reported a consistent, independent and positive 
association between obesity and the development of breast cancer risk in post-
menopausal women. Literature supports the association between obe ity and the poor 
prognosis of breast cancer in both pre and post menopausal women. 132 
3.2.5 Diabetes 
A strong association between obesity and type II diabetes has been observed in a 
number of studies. 133- 136 Researchers suggest the increasing prevalence of obesity is 
related to the increasing incidence of type II diabetes that has occun-ed in both Europe, 
the USA and Canada. 133 Data from a cohort study of 51 ,529 U.S male health 
professionals 40 to 75 years of age were analyzed. These male health profes ional had 
completed biennial questionnaires ent out between 1986 and 1992. The relative risks of 
developing type II diabetes were analyzed. Compared to men with a BMI <23, men with 
a BMI >30 had a relative risk of 11 .0, which increased to a relative risk of 42. 1 with a 
BMI 235. 134 
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Authors of the longitudinal Nurses Health Study, reported that the tisk for women 
developing type II diabetes started to increase when BMI values exceeded a value of 
22.1 135 A study using nationally representative cross-sectional survey data from 
NHANES Jll , repotted on the prevalence of type II diabetes. Comparing individuals with 
a BMI (1 8.5<BM1<25), to those with a BMT value 2: 40, the prevalence ratio for type II 
diabetes for men was 18.1 [95% CI (6.7- 46.8)] and for women 12.9 [95% (CI 5. 7-
28 .1 )]. 136 The evidence presented shows a trong association between obesity as a risk 
factor the development of type II diabetes, in both men and women. 
3.2.6 Endocrine and Metabolic Disturbances 
Obesity is associated with endocrine disturbances such as elevated cho lesterol 
level and metabolic disturbances such as the metabolic syndrome. Overweight and 
obesity contribute to elevated cholesterol levels and or abnonnallipid profi les (e.g., high 
levels of LDL cholestero l, triglycerides and low levels of HDL cholesterol). Studies 
repoti higher levels of circulating cholesterol in subjects with higher BMI' s or in those 
classified as obese compared with individuals with lower BMI values (i.e., BMI < 
25).125•136 Mean values for total cholesterol, triglycerides and LD L cholestero l increased 
with each increasing BMI category from non11al, overweight to obese. 137 Using 
NHANES III ( 1988-1994) data, the authors rep01ted there was an inc rease in the 
prevalence of hypercholestero lemia (total blood cholestero l >240 mg/dl or 6.2 1 mmol/1) 
in men with increasing BMI. 138 
Obesity is associated with the ex istence of a condition described as 'the metabol ic 
syndrome' or ' synd rome X' 129 characterized by a cluster of metaboli c risk factors 
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identified in the development of CHD. In the USA, the Adult Treatment Panel (A TP III) 
on detection, evaluation and treatment of high blood cholesterol, issued guidelines for the 
clinical identification of the metabolic yndrome. 138 An individual may be diagnosed as 
having the Metabolic Syndrome if three or more ofthe following condition are present: 
abdominal obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and high 
fasting glucose. Since this classification ha been published, a number of studies have 
been conducted to estimate the prevalence of the metabolic yndrome in specific 
populations. 
ln the USA, u ing data fi·om the HA ES III and based on the above ATPlll 
criteria, the prevalence of the age-adju ted Metabolic Syndrome was estimated to be 
approximately 24%. 139 A study publi heel on 6406 men and 6475 women in Canada using 
the same guidelines reported the prevalence of the metabolic syndrome to be 14.4% in 
adults 18 to 64 years of age. In this tudy, the prevalence ofthe metabolic syndrome 
increased from 6. 7% for individuals 20 to 30 years of age to 43% for individuals 60 to 70 
years of age although there was little diffe rence in the prevalence between men and 
140 women. 
3.2. 7 Obesity and Debilitating Conditions 
Obe ity increa es the risk of developing or aggravating debilitating conditions 
such as osteoarthritis due to the excessive weight placed upon joint . A number of studie 
have reported evidence to link obesity with a va1iety ofmusculo keletal di sorders ranging 
from osteoarthritis to joint pain. The ri k of developing osteoarthriti in weight-bearing 
joints i increased in overweight and obese per ons. The knees are often involved because 
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more body weight is exerted across the knees during weight bea1ing activity than across 
other joints such as the hips. 141 There is a stronger relationship between body size and 
osteoarthritis in women as compared with men. Small increases in body weight in women 
can promote osteoarthritis. In a study of twins, symptomatic or a ymptomatic lower 
extremity osteom1hritis was found in individuals who were only 3 to 5 kilograms heavier 
than their twin sibling. For each kilogram increase in body weight, the ri sk of developing 
osteoarthriti s increased by 9 to 13%. For each kg increase in weight the increased 
likelihood of developing different osteoarth1itis traits was: tibiofemo ral osteophytes 
OR 1.14 [95% Cl (1.0 1- 1.28)] , patellofemoral osteophytes OR 1.32 [95% CI (1.09-1.59)] 
and patellofemoral nanowing OR 1.15 [95% CI ( 1.0 1-1.30)]. 142 
3.3 Obesity and Psychological Health 
Obesity experienced in chi ldhood and during adolescence has an adverse effect on 
long-tem1 social and economic outcomes in adulthood. These factors include the level of 
income and educational attainment. 143 One study followed 370 overweight subjects for 
seven years. Women who had been overweight at the beginning of the study, had 
completed 0.3 years less of schooling; [95% CI ( 0.1 to 0.60)], were 20% less likely to be 
married [95% C l( 13-27%)], had $6,7 10 household income less per year [95% Cl 
($3 ,942-9,478)] and had 10% higher rates of household povet1y [95% CI ( 4- 16%)] 
compared to women who had not been overweight. These results were independent of 
their base-line socioeconomic status and aptitude- test scores. 
Another study found men who had been overweight as adole cents were 11 % les 
likely to be married later in life [95%CI (3- 18%)). The authors concluded that being 
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overweight during adolescence had important social and economic consequences. The 
authors suggested that di crimination against overweight persons might account for this 
fi d. 144 tn tng. 
3.4 Obesity and Mortality 
Controversy ex ists over the relationship between obesity and premature mortality. 
A number of s tudies have found a ' u ' or 'j ' shaped association between BMI and 
I. h · h . h 1· h d 1 BMI 22-23 145-146 morta 1ty, s owmg a . 1g er morta 1ty rate at t e upper an ower ranges . · 
A gradual increase in mortality with increasing weight has also been demonstrated in 
d . 147-148 h"l h h d d . . 149 some stu 1es, w 1 e ot er researc oes not emonstrate any assoc1at1on. 
The relationship between BMI and mortality data was examined in a large 
prospective study of more than one million adults in the USA. Over a period of 14 years 
457,785 men and 588,369 women were followed. A j-shaped relationship between BMI 
and morta lity was ob erved. In healthy non-smokers, the lowest risk of mortality was 
seen in males with a BMI in the range of 23 .5-24.9kg/m2 and in fem ale with a BMI in 
the range of 22.0-23.4 kg/m2. A high BMI was predictive of mortality from 
cardiovascular disease in men RR 2.90 [95% C I (2 .37-3.56)]. Heavier men and women in 
all age groups had an increased mortality.22 
The expected number of years of life lost (YLL) between normal, overweight and 
obese groups in Caucasian and black Americans was compared. Years of life lo t being 
the difference in life expectancy between nonnal , overweight and obe e groups. When 
several large USA- ba ed popul ation surveys were analyzed , it was found that race and 
sex differences were observed in YLL. Among the wh ite population, a j -or u-shaped 
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association was found between overweight or obesity and YLL. The optimal BMI range 
was between 23 and 25 for the white population and between 23 and 30 for the black 
population. These BMI ranges were associated with the least YLL or greate t longevity 
for both groups. For any given degree of overweight, younger adults had greater YLL 
than did older adults. The maximum YLL for individuals between 20 and 30 years of age 
classified with severe obesity (BMI >45) was 13 years for white men and eight years for 
white women. For men, this represented a 22% reduction in the life span. Among black 
men and women older than 60 years of age, overweight and moderate obesity were 
generally not associated with increased YLL and only severe obesity resulted in YLL.23 
A more linear re lationship has been demonstrated between BMJ and mortality and 
is supported by authors who have used prospective longitudinal studies. The Nurses 
Health Study for example followed 11 6,000 women in the USA over a 17-year period. 
When biases were controlled for, a continuous positive association existed between BMI 
and mortality. This finding was supported by the largely positive relationship found 
between increasing body weight and conditi ons such as CHD, hypertension and type II 
diabetes.147 It is proposed that higher mortality rates at the underweight of the BM! scale 
or at a BMI < 18.5 are artificial. The increased mortality at this end of the BMI range, 
may result from the lack of adjustment of other factors known to increase the risk of 
mortality such as cigarette smoking or underlying comorbidities. 146 Severe obesity or 
morbid obesity is defined as a BMI ~ 35 or ~ 40kg/m2 respectively. A systematic review 
published recentl y examined the relationship between severe obesity and mortality. 
Patients with severe obesity (BMI ~35) did not have an increased risk of total all -cause 
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mot1ality RR 1.10 [95% CI (.87-1.41)]), but had the highest increased tisk for 
cardiovascular mortality RR 1.88 [95% CI (1.05-3.34)]. 150 This may be due to the specific 
chronic conditions associated with excess weight and with an increased workload of the 
heart. Another explanation for these findings is reverse causality. That is an individual 
suffering from heart disease may be more likely to lead a sedentary life thus leading to 
increased ri sk of mortality. Severe obesity has also been associated with sudden 
cardiovascular death due to its association with obstructive sleep apnea syndrome. Sleep 
apnea is a breathing disorder characterized by interruptions of breathing during sleep. 
There are two types of s leep apnea central and ob tructive. Central sleep apnea occurs 
when the brain fails to send the right signals to the breathing muscles to continue 
breathing and obstructive sleep apnea occurs when air cannot flow in or out of an 
individual 's nose and mouth. Many episodes of obstructive sleep apnea occur every night 
and, it is thought, increase the risk of hypet1ension, heart problems and death. 151 
3.5 Obesity and Disease- a Causal Relationship? 
The preceding review outlines some of the adverse health risks associated with 
overweight and obesity uggesting a causal relationship. Evidence suggests that with 
moderate weight loss, the ill-effects of excess weight can be reversed. A Cochrane 
systematic review was conducted to detennine the effects of weight loss on chronic 
diseases. 152 The Cochrane Collaboration is an international not-for-profit, independent 
organization producing information about the effects ofhealthcare interventions. This 
organization di sseminates systemati c reviews of healthcare interventions and promotes 
the search for evidence in the form of clinical tri als and other studies of interventions. 
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This review identifi ed 18 randomized controlled trials including 26 11 hypertensive 
participants with an average body weight of 84kg. This data suggested weight loss in the 
range of 4% to 8% of total body weight through weight-reduction diets, produced an 
average reduction in systolic blood pre ure of3.0 mmHg and the e fi ndings are 
consistent with earlier reviews. 153 
Another study reported weight loss resulted in a significant lowering of both 
resting and exerci e blood pressure in morbidly obese subjects. 154 In addition a meta -
analy is of intervention trials reported losing excess weight improved blood lipid profi les 
with a fall in total serum cholesterol and triglyceride level and an increase in high 
density lipoprotein (HDL) concentration .155 
Experimental evidence is emerging demonstrating a reduction in a small 
propmiion of body weight may by effecti ve in reducing adverse di sease outcomes. The e 
experimental tudies provide the strongest evidence of a causal relationship between level 
of BMJ and the development of disea e.156 
3. 6 Can Overweight or Obese Individuals be Healthy? 
Although much of the published literature focuses on the a sociation between 
obesity as a ri k factor for many advers health conditions several tudies have been 
published recently demonstrating that lower rate of cardiovascular mortality are een in 
older age groups who are overweight or obese but considered to be physically active 
h d . . I . h . d . . d I t57- t59 w en compare to tnactJve norma wetg t tn tvt ua s. 
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3. 7 Epidemiology of Obesity 
The prevalence of obesity has increased in many countries over the past 25 years. 
As well the average BMI values and the prevalence of obesity vary with age, sex, race, 
geography and socioeconomic status in these countries. Figure 3.1 illustrates the cun·ent 
prevalence of obesity in the Organization ofEconomic Development (OECD) member 
countties. 
3.7.1 Global Trends 
Of the OECD member countJies, the United States has the highest prevalence of 
adult obesity (30.6%) followed by Mexico (24.2%) and the United Kingdom (22.4%). 
Canada is ninth on the list with a prevalence of obesity of 14.9%. Korea and Japan rep011 
the lowest prevalence of obesity at 3.2% and 3.6%, respectively. 
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Global studies, Multinational Monit01ing of Trends and Determinants in 
Cardiovascular Disease (MONICA) conducted by the WHO reported that on average a 
greater proportion of women are obese compared to men, while a greater proportion of 
men are overweight compared to women. Some longitudinal data is available from 
national surveys on the prevalence and the increasing rate of obesity. The prevalence of 
obesity in the USA doubled between 1980 and 2002 and is continuing to rise. 160- 161 
During a similar time period, Canada experienced approximately a three-fold increa e in 
the prevalence of obesity. 162 
3.7.2 National Trends 
Published data on the prevalence of obesity in Canada from York University 
reporied dramatic increases in the prevalence of obesity occUlTing at both the national 
and provinciallevels.25 The data for this report was obtained from five population-level 
surveys collecting self-reported heights and weights in Canada. Obesity was defined as 
BMI 2: 30kg!n} and the sample was representative of the Canadian population for each 
year the survey was conducted. The results from the Canadian surveys showed an overall 
increase in the prevalence of obesity. The national prevalence of obesity more than 
doubled over the 14-year period from 5.6% in 1985 to 14.8% in 1998. Over the 14-year 
span considered, all provinces experienced increases in the prevalence of obesity. By 
1998, only Quebec and British Columbia demonstrated obesity prevalence below 15%. 
Data for the Northwest Tenitorie , the Yukon and Nunavut was not available. 
The preva lence of adult obesity in Canada was 16.3%, based on self reported 
heights and weights. These findings were rep011ed from data publi heel u ing the 2005 
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Canadian Community Health Survey.25•27 The comparative prevalence of adult obesity in 
NL, using this survey was approximately 27%27 (Table 3.3). The 2004 Canadian 
Community Health Survey: Nutrition, a survey conducted in between regular survey 
years collected data on direct measures of heights and weights. According to this survey 
the National prevalence of adult obesity was 24% compared to provincial prevalence of 
34% in NL. 
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Table 3.3 The Prevalence of Adult Obesity in Canada based on self reported heights 
and weights 1985 to 2005 
Canada NL 
Year of survey Prevalence% (95%CI) Prevalence0/o (95%CI) 
1985 5.6* No data available 
1990 9.2* No data available 
1994 12.7 (12.0, 13.3) 16.4 (13.5,19.4) 
1996 11.9 (11.5, 12.4) 16.2 (13.6,18.9) 
1998 14.1 (13.4, 14.9) 18.7 (16. 1 ,21.2) 
2001 15.3 (14.9, 15.6) 21.7 (19.8-23.6) 
2003 15.8 (15.5 , 16.2) 21.4 (19.4-23.5) 
2005 16.3 (16.0, 16.7) 26.7 (24.3-29.0) 
1985, 1990 Health Promotion Survey, 1994-1998 National Population Health Survey, 
2001-2005 Canadian Community Health Survey, * Confidence Intervals were not 
available for these data sets 
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Although the current study did not include children, there is an emerging childhood 
obesity epidemic being reported. 163-164 Over a 15-year time period, there has been a 
significant increase in the prevalence of overweight and obesity in Canadian children 7 to 
13 years of age. T hree national surveys were conducted between 198 1 and 1996 reporting 
the percentage of overweight boys increas d from 15% to 29% and the percentage of 
overweight girl s increased from 15% to 24%. These surveys also reported the prevalence 
of childhood obesity increased from 5% to 13% for boys and from 5% to 11 .8% for 
girls. 163 Another study in Canada, reported 33% of boys and 26% of girls were 
considered to be overweight, and I 0% of boys and 9% of girls were considered to be 
obese. These fi ndings suggest that over thi s time period, the prevalence of childhood 
overweight and obesity in boys had doubled and is increasing in girls. 164 
There is limited data on the prevalence of overweight and obesi ty in younger 
preschool children in Canada, however provincial data suggests there may be an 
emerging childhood obesity epidemic occun·ing. A study published in the CMAJ 
rep011ed 25% of NL children between the ages 3.5 and 5 participating in thei r Preschool 
Health Check were either overweight or obese. T hese results were based on direct 
measurements. 165 Another study on pre- chool children in NL found similar results .166 
These findings may have impl ications for the healthcare sy tem due to the increasing 
prevalence of higher weights seen at an earl y age in children and the potential association 
for adver e health consequences. 
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3.7.3 Provincial Trends 
Canada has experienced an increase in the prevalence of obesity, however the 
increase is not unifonn from province to province.25 The prevalence of obesity tends to 
decrease as one moves from east to west in Canada. The east coast of Canada, in 
particular the Atlantic Provinces, report a higher prevalence of obesity, whereas the 
lowest prevalence is repo1ied in western Canada. The Atlantic Province demonstrate a 
higher than average prevalence of obesity when compared to the other provinces. 
The provincial infonnation on the prevalence of adult obc ity wa obtained from 
the National Population Health Surveys and the more recent Canadian Community 
Health Surveys conducted by Statistics Canada. According to the 1995/1996 National 
Population Health Survey and the 2004/2005 Canadian Community Health Survey, the 
overall prevalence of adult obesity in NL increased from 17% to 24% of the total 
population compared to the national average increase of 13% to 16%. Although, these 
rates are comparable with other Atlantic Provinces, NL remains well above the Canadian 
average having the highest prevalence of adult obesity (Table 3.4).27 
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Table 3.4 The Prevalence of Adult Obesity in Canada by province, based on self reported 
heights and weights 1995-2005 
1995/96 2005 
Prevalence% (95%CI) Prevalence% (95%Cl) 
Canada 12.7 (12.0, 13.3) 15.5 (15.1,15.8) 
BC I 0.2 (8.5, 11.8) 13.2 ( 12.4, 14.0) 
Quebec 11.1 (9.6, 12.5) 14.2 (13.5, 14.8) 
Alberta 12.0 (9.7, 14.2) 15.8 (14.8, 16.8) 
Ontario 13.3 (12.2,14.5) 15.1 (14.5, 15.6) 
Manitoba 14.9 (12.0, 17.8) 18.1 (16.8, 19.4) 
PEl 15.4 (12.7, 18.1) 22.5 (19.9, 25.2) 
SK 16.4 (13.6, 19.2) 20.6 (19.2, 22.0) 
Nova Scotia 16.7 (14.1, 19.2) 20.7 (19.1 , 22.3) 
New Brunswick 17.2 (14.1, 20.3) 22.5 (20.8, 24 .2) 
Newfoundland and Labrador 16.5 (13.5, 19.4) 23.8 (21.9, 25.7) 
Source of data: 199511996 National Population Health Survey, 2005 Canadian 
Community Health Survey 
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3.8 Aetiology of Obesity 
Obesity is a result of an imbalance of energy intake and energy expenditure.167 
The aetiology of most human obesity is unknown. 168 There has been a marked increase in 
the prevalence of obesity over the last 25 years, suggesting alternations in va1ious 
environmental factors. Research suggests that genetics also plays a role in some fo rn1s of 
obesity. Body size depends on the complex interaction between genetic background and 
environmental factors. 
3.8.1 Environmental Factors 
The increase in the preva lence of obesity over a relatively short period of ti me 
points to the changing environment such as an increase in sedentary occupations and 
leisure activities, availability of technology, increased availabili ty of fast food and 
processed food found in supennarket as some of the factors responsible.169- 170 
The influence of environmental facto rs on body weight has been reported in a 
number of studies. However, the majority of these studies focus on aboriginal people who 
have moved from a traditional way of life to an urban lifestyle. The change in the 
lifestyle has had a dramatic influence on the health of the Pima lndi ans. These Indians 
moved from the Sierra Mountains in Mexico to A rizona. The change ofl ifcstyle to an 
urban lifestyle has led to an epidemic of obesity and diabetes. The diet of the urban Pi mas 
is much higher in fa t (50% of energy intake) than their tradi tional diet ( 15% of energy as 
fa t) and their lives are more sedentary compared to the Pimas who remained in the 
mountains and who have kept to a traditional diet. Traditionally, the Pima arc physically 
active as fa m1ers, sawmill workers and have a much lower incidence of obesity and 
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diabetes as compared to their Arizona kindred. 171 The aboriginals in northern Australia 
are another high-risk population whose weight and health status has been compromised 
by exposure to a change in the environment. Urbanized aboriginals are heavier than their 
lean hunter-gatherer kindred and have a higher prevalence of type ll diabetes. 172 
In Canada as well, a high prevalence of obesity and its as ociated chronic diseases 
are reported throughout aboriginal communities. 173- 175 Obesity and diabetes were 
undiagnosed or unknown in Abo1iginal populations in Canada before the 1950's. 
However there has been an increase in both of these conditions reported in Aboriginal 
I 173- 175 M h f h . c: . I . f h . . peop es. uc o t e tn1ormat10n on t 1e 1m pact o c angmg environments comes 
from aboriginal populations who have changed their lifestyle dramatically from a more 
traditional way of life to a more modern urban li festyle. A lthough, changing 
environment play a ro le in the recent obesity epidemic, behavioral factors such as diet, 
physical activity and socioeconomic status are also very important. 
3.8.2 Diet and Physical Activity 
A change in body weight is caused by either a change in the amount of energy 
consumed, the amount of energy being expended or by change in both. The following 
equation illustrates this relationship: 
Enet·gyin - Energy0111 = ~ Body Weight 176 
Routine surveill ance data on nutrition is limited in many countries. Health and nutrition 
surveys collecting data on eating habits have hown that over the past few decades when 
overweight and obesity were increa ing, the energy intake through diet was maintained or 
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decreased. 177 Data on the consumption of foods is reported using either surveys on 
nutrition or statistics on the disappearance of food items. The findings from these reports 
are not always consistent. 
Published data available in Canada supports the theory that there has been a 
change in Encrgy0111 which has led to the recent increase in body weight. During the last 
30 years, several surveys on nutrition have been administered to the populatio n in 
Canada. ln the early 1970's, a national nutritional survey was conducted which was 
representative of the Canadian population and this survey was repeated in L 997. During 
the 1990's many provinces conducted their own provincial nutritional surveys. These 
surveys gathered specific and very detailed information from the adult population on food 
intake. 178- 18 1 
These surveys suggest that in the late 1990' s the energy intake and total fat 
consumption of the Canadian population was lower when compared to the surveys 
conducted 30 years previously. These findings were comparable with the find ings from 
surveys on nutrition from both the UK and the USA noting a decline in overall energy 
intake since the 1960' s. 170' 182 
These findings are based primarily on nutrition surveys and selfrepot1ed intake of 
food. This empiri cal evidence suggests that using the formula for A Body Weight, it i 
more likely to be a decrease in Encrgy0111 rather than an increase Encrgyi, that accounts 
for the recent increase in body weight. 
Another way to examine trends in eating habits or Energyiu. is to analyze the 
disappearance of foods. A repot1 on the disappearance of Food Statistics reported by 
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Statistics Canada in 2002, provided evidence in contrast to the above findings based on 
nutrition surveys.183 According to this report, the total amount of energy consumed per 
capita per day increased by over 18% between 199 1 and 2002. These fi ndings highlight 
an increase in the consumption of fat, as the main cause fo r the overall increase in body 
weight. The report uggested the proporti on of energy consumed from carbohydrates and 
the proportion of protein consumed remained consistent when compared to ten years ago. 
A report on the nutlition of theN L population supp01is the findings that there has 
been an increase in Energy;11 . A diet cons isting of more energy or calorie was being 
consumed than necessary to meet the recommended dail y intake i. e. following Canada 's 
Food Guide. A larger prop01iion of an individual's Energy;11 was attributed to fa t intake, 
while less energy was attributed to carbohydrate intake.184 
There are inconsistencies in these findings. One body of evidence provides 
support for the theory that Energy;11 has decreased, whil e the second body of evidence 
provides infonnation suggesting that Energy;11 has increased and is mainly due to an 
increase in the percentage of fat consumed. It is di ffi cult to determine the extent to which 
Energy;11 has been either increasing or decreasing, due to the lack of longitudinal 
surveillance data on dietary habits. 
Different m ethodologies used to assess energy intake may be a possible 
explanation for the inconsistent findings. While health surveys are generally reli able and 
valid in their collection of some vari ables such as demographics, hea lth status and 
morbidity, they may not be as reliable when assess ing the accuracy of food intake. Thi 
may be due to recall bias and to the fact that individuals may not remember what they 
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have eaten over a specific time period. Another factor to consider is social desirability 
bias. The individual provides responses that the interviewer wants to hear. Consequently, 
it is possible when individuals respond to questions on food intake; the frequency of 
eating certain foods is inadvertentl y underestimated. 
Other researchers have suggested that the most recent increase in obesity is due to 
a decrease in Energyout. and not due to an increase in Ener·gyin through diet. A decrease 
in activity during work, leisure time and extra-cutTicula pursuits has been 
documented. 176, 182, 185- 186 
Research suggests that regular physical activity protects against overweight, 
obesity and chronic disease,2 1 however the individual-level of physical acti vi ty and or 
exercise is not the main component of Energy0 111 • 176 One graphical representation of 
energy expenditure is found in Figure 3.2. Total energy expenditure (TEE) is the sum of 
three components: resting energy expend iture (REE) and the thenn ic effect of food (TEF) 
and physical activity-related energy ex pendi ture (PAEE). 176 Figure 3.2 illustrates how 
total energy expenditure (TEE) is broken down into components and compares acti ve 
and sedentary individuals. 
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Figure 3.2 Components of Total Energy Expenditure (TEE) in Sedentary ( 1800 kcal/day) 
and Active Persons (2200 kcal/day) 
Total energy expenditure (TEE) = Resting energy expenditure (REE) + Thennic effect 
of food (TEF) + Physical activi ty energy expenditure (P AEE) 
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The majority of human energy expenditure is consumed through the body's 
metabolism at rest. Resting energy expenditure comprises on average 60-80% of the total 
energy expenditure in most people. Resting energy expenditure is the energy required by 
the body to maintain basic functions such as pumping blood, synthesizing honnones, and 
maintaining body temperature. The PAEE is the component of energy expenditure that is 
most under voluntary control, because it is influenced by the amount of physical acti vity 
perfonned. This component is the most variable component of energy expenditure and 
can range from 10% of TEE in sedentary individuals up to 40% of TEE in highly active 
individuals. Total energy expenditure includes both voluntary and non voluntary actions. 
Voluntary actions include daily activities and non voluntary actions include basic 
metabolic needs. Physical activity energy expenditure provides the greatest ource of 
flexibillty in the energy expenditure system, and it is through this component that large 
changes in energy expenditure can be achieved. The thennic effect of food refers to the 
increase in energy expenditure associated wi th digestion, absorption and storage of 
macronutrients. On average, the thennic effect of food makes up on average 8% of total 
expenditure out. 
Figure 3.2 demonstrates that an active person has control over on average 35% of 
TEE compared to a sedentary person with control over on ly 20% of TEE. The largest 
component ofEnergy0 , 1 is made up of the REE with the addition of the TEF. Increasing 
physical activity on its own is unlikely to decrease body weight. 
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According to this research, both di et or Energyin, and increased physical activity 
or Energy out are significant in their cont1ibutions to maintaining a healthy body weight, 
the normal BMI range associated with least health risk. 
3.8.3 Socioeconomic Factors 
Socioeconomic status (SES) is conceptualized as a combination of fi nancial, 
educational and occupational influences.137 Socioeconomic factors such as low education 
and loss of employment appear to be correlated with obesity. 169• 187 In an early cross-
sectional review, 144 published studies were reviewed and the relationship between SES 
and the level of obesity was examined. 188 The authors found a strong inverse relationship 
between obesity and SES among women in industrialized countries, such as the USA and 
Western Europe. In most countries, however when these studies were published, the 
generall y accepted cut-off for defining obesity was a BMI 2: 27, in contrast to the present 
day internationall y accepted cut-off of a BM I 2: 30. 
A more recent review identified 34 longitudinal studies from developed countries 
which asses ed the re lationship of various measures of SES with weight change in 
adults. 189 For non-black samples, SES was assessed using occupation onl y. There were 
consistent inverse associations between occupations and weight gain for men and women. 
When the level of SES was assessed using education, the evidence was slightly less 
consistent, but provided some supp01i fo r the inverse relationship between SES and 
weight change. However, the findings were inconsistent, when income wa included as 
an indicator of socioeconomic status. When referring to the associatio n between SES and 
obesity, onl y one component occupation was consistentl y inversely re lated to increa ing 
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weight change. The relationship between body weight and socioeconomic status was less 
consistent among men and children. 
3.9 The Genetics and Medical Causes of Obesity 
Several rare genetic causes of obesity have been described. These include 
syndromes such as Prader-Willi and Bardet Biedl syndrome where obesity is just one of 
many features. 190 
Recently, a strain of mice (i.e. , the ob/ob mouse) were identified and the aetiology 
of this obesity was found to be related to a defect in the gene known as the ob gene. The 
ob gene encodes a protein leptin which is produced in adipo e tissue. Leptin appears to 
act as a satiety factor. Mice with mutations with the ob gene become obese due to 
hyperphagic (overeating). This gene is present in humans and the leptin protein is found 
in human adipose tissue. Humans with mutations with the ob gene have been identified, 
however, to date this accounts for a very small percentage of the overall obese 
I 0 191 popu ahon. 
ln addition, endocrine disorders due to a honnonal imbalance can cause weight 
gain. 192 Cushing' syndrome with a predominance of central fat distribution is the most 
common endoc1inological cause of obesity. This syndrome is caused by an exce 
production of cortisol. Hypothyroidism, another endoc1ine condition may be a 
contributing factor of excessive weight gain.190 Drug-induced weight gain is also 
common in individuals taking antipsychotics, steroids and insulin.193 
Due to the rare nature of purely genetic and medical causes of obesity, it appears 
that for mo t people, the genetic predi position wi ll not be defined by one gene but by 
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multiple genes and their interaction with the environment. 168 Attempts are on-going to 
identify these multiple genes. In large population surveys, more than 244 genes, markers 
and chromosomal regions have been linked to human obesity. 195 Adoption stud ies 
demonstrated that genes exetied a strong effect on body weight. The weight of adults 
who were adopted as children, related more closely to that of their natural parent, and not 
to the new or adoptive parent. 196 In addition, it was shown that twins who were separated 
and raised in different environments, demonstrated a similar heritability or increased 
likelihood of passing on the trait for overweight and obesity. 197 In another study of twins, 
identical male adult twins were fed a surplus of I OOOkcal per day, six days a week for a 
period of l 00 days. Significant increases in body weight and fat mass were observed in 
these adults, following the petiod of overfeeding. The findings demonstrated that there 
were considerable differences between the pairs of twins and how they responded to 
excess calories. There was at least three times more variance in response to overfeed ing 
between pairs of twins than within pairs of twins, for the gain in body weight, fa t mass 
and fat-free mass. This study demonstrated that ome individuals were more at risk than 
others for gaining weight when energy intake surplus is the same for everyone, and when 
all subjects were restricted to a sedentary lifestyl e. The 'within ' identical twin pair 
respon e (i.e., similar weight gain) suggests that the amount of fat stored is influenced by 
genotype. 198 
In families with one or two morbidly obese parent , the risk of an offspri ng 
becoming obese is two to three times that of those having nonnal weight parents, 
suggesting that both geneti cs and the env ironment play a role in determining the 
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likelihood of an individual's weight status. 199 A better understanding of the complex 
aetiology of obesity may lead to more effective means in treating and preventing obesity 
in the population. 
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Chapter 4 Methods 
4.1 Introduction 
The purpose of this chapter is to provide a detailed discussion of the methods u ed to 
examine the relation hip between level of BMI as a reflection of obesity and health 
services utilization and associated co ts, for a representative sample of the province of 
NL, Canada using individual-level data from the 2001 CCHS. This chapter provides an 
overview of the (i) study design (ii) study population/ sample (iii) database linkage 
procedure (iv) variables analyzed in the current study (v) data analysis and (vi) ethical 
considerati ons. 
4.2 Study Design 
This is a population-based study of adults aged between 20 and 64 years of age 
living in NL. The population was stratified by BMI category for the purpose of the 
analysis. The study included: (i) a secondary analysis of a sub sample of data from a 
National cross-sectional health survey and (ii ) an analysis of actual health services 
utilization and direct costs over a five-year period. lnfonnation on factors associated 
wi th obesity/morbid obesity and subjective health services utilization were obtained from 
the CCHS. Objective health services utilization was obtained through linkage of the 
CCHS to two administrative databases; the Clinical Database Management System 
(CDMS), the provincial hospital separations database and the Medical Care Program 
(MCP) database which processes claims for fee-for-service (FFS) physician in the 
province. 
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The data on subjective health services utilization referred to the 12 months p1ior 
to the survey date, while the objective health services utilization data was examined over 
a five-year period from January 1998 to December 2002 for physician utilization and 
from September 1999 to August 2003 for hospita lization utilization. This included 
utilization data on the period 30 months before and 30 months after an individual ' s 
survey date. The timeframe for the study (i.e., five years) was limited by the availabi lity 
of the data. A time lag existed between collection of the data, analysis by CTH I, 
standardization by the Provincial Department of Health and Community Services and the 
distribution of data to the provincial health agencies. 
4.3 Study Population/Sample 
The 2000/2001 CCHS was conducted over a 12 month period. This survey was 
administered to 131 ,535 Canadians tlu·ough personal interviews either by telephone or in-
person. The response rate was 84.7%. The survey used a multi-stage cluster sampling 
design to collect information related to the health of non-institutionalized individuals and 
included household residents aged 12 years of age and over in all provinces and 
teiTitories. Indian Reservations, Canadian Forces Bases, and some remote areas were not 
included. The total sample size was suffici ent to provide reliable cross-sectional estimates 
at the provincial and sub-provincial or health region level for some variables. 
The cuiTent study included analysis of survey responses exclusively on the NL 
portion of Statistics Canada ' s 2000/200 1 CCHS. Key inclusion criteria for the current 
study included: agreement to share survey responses with Health Canada and other health 
information agencies and permission to link individual survey responses with other 
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provincial health infotmation databases. Individuals had to be between 20 and 64 years of 
age and have a calculated BMI available. The age range was limited. Research suggests 
BMI may not be an accurate predictor of exce s body fat or associated health tisk in o lder 
age groups a both men and women naturally lose lean body mass thr ugh the life cycle. 
For example, although the percentage of body fat increases with age, BMI can remain 
constant?0 As a result; researchers limit the use of BMI to this middle age-group. 
Pregnant women were also excluded from this study. 
In this study, BMI, defined as weight in kilograms divided by height in metres 
squared (kg/m2) wa classified using the y tem endorsed by both the World Health 
Organization and Health Canada. This class ification system was presented in Table 3. 1. 
Underweight, overweight and all obese BMI categories are associated with increa ed 
health risk .17•21 As de cribed earlier in this tudy, a BMI 2: 30 and < 35 kg/m2 will be 
considered obe e. Obese class II (BMJ 2:35) and obese class III (BMI 2:40) wi ll be 
combined and described as morbid obesity (BMI 2: 35 kg/m2). 
The total eligible study population was 3734 survey respondent in NL. All 
survey respondent consented to share their non-identifiable survey rc ponses with 
Health Canada and other health informati on agencies and 94% (n=3497) consented to 
the linkage of their individual health urvey responses with other provincial health 
information. In total, one thousand and seventy-five (n= l 075) individual were excluded 
from the study. Individuals excluded were those under 20 or over 64 years of age and 3 1 
pregnant women. In addition 25 individual had invalid or mis ing inf01mation on 
heights and/or weight . The study sample wa reduced to 2366 individual . Categorizing 
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the study population into BMI groupings resulted in the following: 881 nonnal weight; 
916 overweight; 407 obese, 141 morbidly obese and 21 underweight individuals. The 
underweight population of 21 individuals was excluded from further analysis due to the 
focus of the research hypothesis, that increasing levels ofBMI are associated with an 
increased use of health services. The sample size for the secondary analysis of the health 
survey data was 2345 individuals, before the linkage. Figure 4.1 illustrates the calculation 
of the final sample size before linkage. 
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3734 I· Eligible population 100% agreement to share 
j 
Less: 
n=297 who did not give 
permission to link 
3497 I· 93% permission to link 
j Less: 1 075 outside 20-64 years 31 pregnant females 
25 with missing information 
2366 
(N=1131) 
1 
I 
881 141 21 916 407 
normal Morbid 
underweight overweight Obese Obesity 
2345 
Figure 4. 1 Flowchart of the Selection of Study Sample 
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4.4 Sources of Data 
The following section describes the data sources utilized for the research study, 
the linkage process and the vmiables of interest under study. The research study used 
three data sources: (i) the NL component of Statistics Canada's 2000/200 l CCI-IS; (ii) the 
MCP database and (iii) the CDMS. The 2000/2001 CCHS provided a sample 
representative of the population ofNL with information on demographics, health status 
and lifestyle, chronic disease and subjective health services utilization while the health 
administrative databases provided an objective measure of health services utilization. 
4.4.1 The 2000/2001 Canadian Community Health Survey 
The Canadian Community Health Surveys were developed by Statistics Canada to 
address gaps in health information at the regional or sub-provincial level and to explore 
the health issues and the healthcare concerns of Canadians. The survey commenced in 
2000 and is repeated every two years. The primary objective of the CCHS i to provide 
timely cross-sectional estimates across provinces on health detenninants, health status 
and health system utilization. Survey results provide a "snap-shot" of the health status of 
the residents in a province or territory. The CCHS provides health information for 
governments, health boards, health agencies researchers and communities contributing to 
health policy, research and the development of programs. 
The CCI-IS takes approximately 45 minutes to complete: thirty minute of 
"common content" questions being asked to all sample units in all province in order to 
meet the basic health data requirements on an on-going basis. As well , ten minutes of 
questions on "optional content" are offered to the provinces. These optional c ntent 
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questions are in modules and offered to the provinces at an additional cost. Individual 
provinces can decide if they want to purchase the "optional content" questions depending 
on their individual needs for information. An example of a topic for optional content 
questions is smoking cessation. Standard questions on socio-economic and demographic 
characteristics complete the interview. The survey questionnaire and comprehensive 
information is available on the Statistics Canada website,200-202 The relevant survey 
questions used in the current study on health services utilization, health status and 
lifestyle included: 
• Do you have a regular medical doctor? 
• In the past 12 months, have you been an overnight patient in a hospital, 
nursing home or convalescent home? 
o For how many nights? 
• Not counting when you were an overnight patient, in the past 12 months, 
how many times have you seen or talked on the telephone about your 
physical, emotional or mental health with a family doctor or general 
practitioner, a mental health provider or another type of doctor (e.g., a 
specialist such as a surgeon)? 
• In the past 12 months have you received any hospital services at a hospital 
either as an inpatient an outpati ent or an emergency room patient? 
• In the past 12 months, not counting hospital visits, have you received any 
health care servi ces from a family doctor or other physician? 
• How tall are you without shoes on? 
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• How much do you weigh? 
• In general would you say your health is excellent? Very good? Good? Fair 
or Poor? 
• Now I' d like to ask you about certain chronic health conditions which you 
may have. We are interested in long-term conditions that have lasted or 
are expected to last 6 months o r more and that have been diagnosed by a 
health professional. 
o Questions included: Do you have food allergies? Other allergies? 
Asthma? At1hritis? Back problems? High blood pre ure? 
Diabetes? Cancer (what type?) Interviewer lists 25 chronic 
conditions. 
• For certain groups of question , derived vatiables were calculated us ing 
validated formul as. Deri ved variables combine an wers to everal 
questions to fom1 one compo ite vatiable with an as ociated value. 
Questions on level of income, education, phy ical activ ity, fruit and 
vegetable consumption, alcohol intake and smoking behavior were 
combined into derived variables. 
4.4.1.1 Access to Survey Data 
Stati stics Canada stores and maintains its survey data on several fi le two of 
which include: a " master fil e" and a "share" fi le. In addition a ' link file ' can be acces ed 
in order to link individual survey respon e from either the ' master' or the ' share ' fi le 
with o ther individual health infonnation. 
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The "master fil e" includes survey responses and identifying information uch as 
names, addresses and telephone numbers for all respondents. The master file is not 
available to be taken off-site for research purposes. The master fil e w ill include survey 
responses fo r individuals who have not agreed to share responses. lf a researcher(s) can 
show that access to the ' master fi le' is required for research purposes and the other fi les 
do not provide the needed infonnation, access can be provided through a remote access 
service or through the Research Data Centres Program. Researcher are provided with 
' dummy data' on a CD rom and are able to submit research questions and requi red 
analysis by email to Statistics Canada. Analysis on the master fi le is perfonned by an 
employee of Stati stics Canada and the results returned to the researcher. 
Stati stics Canada provides a national "share fil e" to each provincial ministry of health 
and other 'share' prutners. The "share fi le" is stripped of all personal identifiers and is 
available for research purposes. This fi le contains survey responses and information on 
any respondent who has agreed to share their responses with other j uri d ictions. Jn 
addition, for those survey respondents who agree to allow the linkage of their survey 
responses to other health info rmation agencies through the provision of their health 
insurance number a " link fil e" is produced and provided to provincial ministries of 
health. 
The link fil e contains a unique identifier, the age, sex, date of birth and the health 
insurance number for each survey respondent. The ' link' fi le is housed at the provi ncial 
Depattment of Health and Community Services. The NL Centre for Health lnfonnation 
has an agreement with both the Provincial Department of Health and ommunity 
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Services and Statistics Canada to access this fil e. The present study uti lizes both the 
"share" and " link" files. 
4.4.2 Medical Care Plan Database 
The Medical Care Plan (MCP) is a comprehensive system of public medical care 
insurance covering the cost of fee-for-service (FFS) physician services for eligible 
residents of the province ofNL. The MCP database is housed within the Provincial 
Depm1ment of Health and Community Services. The MCP database captures infonnation 
on sex and age of patient, diagnosis, provider's specialty (e.g., general practitioner or 
other specialty), service date (including year) , fee code and province of beneficiary. The 
MCP fee code describes all potential fee grouping categories: office consu ltations, home 
consultati ons, in-patient consultations, outpatient and emergency visits, diagnostic and 
therapeutic procedures, in-hospital diagnostic procedures, radiology and surgical 
procedures. In all cases, only visits were included where the physician was coded as the 
primary provider (excluding code for surgical assistant and anesthetist). Fee codes range 
from 001 (general practitioner) to 082 (medical officer of health), although there are 
some codes not presently used (e.g., NC or no code). Codes are set by the Medica l Care 
Plan Board (Table 4. I). The completeness of the physicians' claims database has not 
been vetified, however as the infonnation collected is an integral part of the claims for 
payment it is considered to be complete in terms of numbers of visits and type of 
physician visited (e.g., family doctor versus specialist). Access to this database was 
provided to the researcher through the NL Centre for Health Infonnation. 
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Table 4.1 FFS Specialty codes and Specialty description 
001 GENERAL PRACTICE 048 PAEDIATRIC ONCOLOGIST 
002 ANAESTHETIST 049 PAEDIATRIC NEPHROLOGIST 
003 NC- code not currently used 050 PAEDIATRIC IMMUNOLOGIST 
004 EMERGENCY MEDICINE SPECIALIST 051 PAEDIATRIC HAEMATOLOGIST 
005 NC - code not currently used 052 NEONATOLOGIST/PERINATOLOGIST 
006 DERMATOLOGIST 053 PHYSICAL MEDICINE SPECIALIST 
007 NC- code not currently used 054 NC- code not currently used 
008 GENERAL SURGEON 055 PLASTIC SURGEON 
009 NC- code not cunently used 056 NC- code not currently used 
010 CARDIAC SURGEON 057 PSYCHIATRIST 
011 VASCULAR SURGEON 058 NC- code not currently used 
012 THORACIC SURGEON 059 UROLOGIST 
013 INTERNIST 060 NC- code not currently used 
014 NC- code not currently used 061 DENTIST 
015 CARDIOLOGIST 062 ORAL SURGEON 
016 ENDOCRINOLOGIST 063 ORTHODONTIST 
017 RESPIROLOGIST 064 PERIODONTIST 
018 RHEUMATOLOGIST 065 PEDODONTIST 
019 GASTROENTEROLOGIST 066 DENTURIST 
020 MEDICAL ONCOLOGIST 067 PATHOLOGIST 
021 NEPHROLOGIST 068 NC- code not currentl y used 
022 CLINICAL IMMUNOLOGIST 069 DIAGNOSTIC RADIOLOGIST 
023 HAEMATOLOGIST 070 NC- code not cunently used 
024 GERIATRIC MEDICINE SPECIALIST 071 OPTOMETRIST 
025 MEDICAL GENETICS SPECIALIST 072 NON-CERTIFIED ORAL SURGEON 
026 NUCLEAR MEDICINE SPECIALIST 073 PUBLIC HEALTH DENTAL 
027 INFECTIOUS DISEASE SPECIALIST 074 DEVELOPMENTAL NEUROLOGY 
028 NEUROLOGIST 075 DEVELOPMENTAL PEDIATRICIANS 
029 NC- code not currently used 076 ENDODONTIST 
030 NEUROSURGEON 077 RADIATION ONCOLOGIST 
031 NC- code not cunently used 078 NC- code not currentl y used 
032 OBSTETRICIAN/GYNECOLOG 1ST 080 PEDIATRIC SURGEON 
033 NC- code not curTently used 081 PAEDIATRIC INTENSIVIST 
034 GYNECOLOGY ONCOLOGIST 082 MEDICAL OFFICER OF HEALTH 
035 OPHTHALMOLOGIST 
036 NC- code not currently used 
037 ORTHOPAEDIC SURGEON 
038 NC- code not cunentl y used 
039 OTOLARYNGOLOGIST 
040 NC- code not currently used 
041 PAEDIATRICIAN 
042 NC- code not cunently used 
043 PAEDIATRIC CARDIOLOGIST 
044 PAEDIATRIC ENDOCRINOLOGIST 
045 PAEDIATRIC RESPIROLOGIST 
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4.4.3 Clinical Database Management System 
All provincially administered healthcare faci lities in NL submit hospital discharge 
data to the Canadian Institute for Health Information or CIHI, which describes inpatient 
and surgical day care services. The data are reviewed for data quality and specific values 
are calculated (e.g., resource-intensity-weight, case mix groupings and level of 
complexity index) and added to the database by CIHI before the discharge abstract 
database (DAD) is provided to the provincial Department of Health and Community 
Services where it is housed. Subsequently data is provided to the NL Centre for Health 
Information where the quality of the infom1ation is verified. In addition, the NL Centre 
for Health Infonnation ensures standardization of the data prior to integrating the data 
into the provincial database, the CDMS. This database includes all discharge diagnostic 
codes based on the lntemational Classification of Diseases (I CD). 
The lCD provides the rules for coding and classifying cause-of-death data. 
Diseases listed on death certificates are assigned specific codes according to this system. 
The JCD was developed collaboratively between the WHO and ten intemational centers. 
The system allows mortality data to be collected and compared among different 
populations and countries. For example, the list of lCD covering endocrine, nutrition and 
metabolic diseases as well as immunity disorders includes diseases coded from 240 to 
279. 
The CDMS contains demographic, clinical and procedural data on all in-patient 
and surgical day care patients. This database includes infonnation on residents of N L 
receiving care in all provincial hospitals as well as infonnation on NL residents receiving 
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care outside the province. Access to this database was provided through the NL Centre 
for Health Information. 
4.5 Database Linkage Procedure 
As part of the health survey, respondents indicated their willingness to share 
and/or link their individual survey responses with other jurisdictions and/or to other 
provincial health administrative data. Respondents who agreed to share and link their 
survey responses provided their health insurance MCP numbers. MCP numbers were 
used to link the health survey sample to the MCP claims file and the CDMS in order to 
obtain physician and hospital health services utilization. A detailed descripti on of the 
linkage process can be found in Appendix B. 
4.6 Measures in the Current Study 
The following section describes the dependent and independent vari ables of 
interest. 
4.6.1 Dependent Variables 
The primary dependent variables of interest were I) self reported presence of 
chronic disease 2) measures of objective hea lth services utilization and 3) associated 
direct costs over a five-year period from 1998-2003. Using Andersen's Model , the 
measures of health services utilization are described as Health Behaviors (see Table 4.2). 
The specific measures of health services utilization included visits to a physician as well 
as measures of hospitalization. Direct costs included total costs of physician services and 
total inpatient costs. 
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To examine the relationship between level of BMI and self reported chronic 
diseases, the dependent variable was the presence of a chronic disease as diagnosed by a 
health professional (1 = yes, 2 = no). The variables describing self reported health 
services utilization are listed in Appendix C Table 1 a and the variables describing the 
presence of chronic diseases were extracted from questions asked in the 2000/2001 
CCHS and are listed in Appendix C Table 1 b. 
The objective data on health services utilization was obtained through individual 
record linkage to the MCP and CDMS databases. The data extracted from the MCP 
physician claims database of particular relevance to the current study included: provider' s 
specialty (e.g., general practitioner or other specialty), fee code (i.e., O=GP, all else = 
specialist). Service date and service year were also collected. To examine the relationship 
between level of BMI and the measures of objective health services utilization, five 
regression models were developed where the measures of uti I ization were designated as 
the outcome variables and the level of BMI along with the other covariates were 
designated the independent variables. 
In the first model the dependent variable was the sum of the number of visits to a 
GP. In the second model the dependent vatiable was sum of the number of visits to a 
specialist doctor. For each of these dependent variables all visits were summed over the 
study period to obtain the total number of visits per individual. In the third, fourth and 
fifth models, the dependent variables were measures of hospital use. Hospital data was 
abstracted from the CDMS and included information on: episode type (e.g., 0= acute and 
I =surgical day care); length of stay or LOS; Resource Intensity Weight (RIW) and Day 
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Procedure Group weight (DPG_ W). These two quantitative variables (i.e., RIW, 
DPG_ W) measure resources used by in-patients or surgical daycare patients and are 
calculated using a methodology developed by the Canadian Institute for Health 
Information (CIHI).203 The rationale for developing this methodology is that patients 
have varying levels of illness severity and require different levels ofhealthcare resources. 
The Canadian Institute for Health Infonnation has developed a methodology for costing 
hospital services based on an individual ' s u e of hospital resources. These variables 
combine resources used with published patient-specific cost data in order to detennine a 
specific value. These resource-intensity-values provide a key element in developing the 
approach of combining clinical and financial data in utilization management. This 
approach is based on a relative resource allocation methodology for estimating a 
hospital's inpatient-specific costs for both acute and day care. Resource-intensi ty-weights 
are used to standardize hospital in-patient case volumes across the country. T he RIW and 
DPG_ W values can be used to estimate patient-specific resource use and these variables 
can then be combined with cost data and used to estimate hospital co ts. Both these 
values are used to estimate the cost of a hospital tay ei ther as an inpatient or day surgery 
patient as an outcome variable by multipl ying the patient specifi c RIW' by the 
provincial cost per weighted case (CPWC) estimated and supplied by CIH I. A simple 
equation would be: Cost of hospital stay/procedure = RIW/per patient X CPWC. The 
CPWC measures the average cost of treating inpatient acute care cases and is published 
annually in the CJHI Financial Perfonnance Indicators report for all provinces. T he 
CPWC for 200 I suppli ed by C IH I for the province ofNL was $45 12.00.204 
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Specifically in the third model the dependent variable was the number of inpatient 
admissions and was obtained by summing the number of individual admissions. In the 
fourth model the dependent variable total length of stay (LOS). Length of stay was 
calculated by summing the total number of days per individual spent in hospital and in 
the fifth model, the dependent variable was the total number of day surgeries per 
individual. 
As well to examine the relationship between level ofBMl and direct costs, two more 
regression models were developed. In the first model the dependent vmiable was total 
physician costs associated with the services provided and the fee claimed as per the MCP 
database. In the second model the dependent variable was total costs fo r inpatient 
hospital services. Costs for day surgeries were not included in thi s analysis as there was 
not enough data to estimate day surgery costs. The coding of the DPG _Win the CDMS 
database commenced in February 2002 providing only 6 months of data on this variable 
for calculation purposes. 
4.6.2 Independent Variables 
4.6.2.1 The Primary Relationship under Study 
The main independent variable of interest for the current study was level ofBMl 
described as a categorical predisposing variable (I = nonnal, 2 = overweight, 3 = obese, 4 
= morbidl y obese). Confidence in using an individual's self reported BMI during the 
2000/200 I CCHS as an estimate over the five-year period is supported by several 
published at1icles?05-209 T hese m1icles suggested adults who become overweight or obese 
are likely to remain in that weight category during their adult li fe and if any new change 
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occurs in BMI, it tends to be in the direction of a higher weight category. Therefore based 
on these reports, the majority of individuals in the current study classified as obese at the 
time of the survey would probably have been classified as obese over the full five-year 
study period. However to provide evidence to this argument, a separate analysis was 
conducted using the longitudinal components of the National Population Health Survey 
(Appendix D). 
4.6.2.2 Selection of Independent Va.-iables from the Survey 
The following independent variables were extracted from the CCHS to represent 
those described in Andersen ' s model as Population Characteristics. Variable described 
as Predisposing in the model included age, sex, education level and marital status. The 
Enabling variables included access to a regular doctor, income level, rural/urban location 
and health region of residence. The Need variables included a measure of chronic disease 
(e.g., the presence and the number of chronic conditions) and the health status variables: 
phys ical activity, con umption offruits and vegetables, alcohol consumption and 
smoking behavior as they reflect the health status or need of health services of an 
individual. There were no variables selected to represent the Environment or Outcomes 
and therefore were not included in Table 4.2. A detail ed description of these variables can 
be found in Appendix C : Table 1 b. 
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Table 4.2 Independent and Dependent va1iables used in the primary analysis 
Predisposing 
age 
sex 
education level 
marital status 
Population Characteristics 
Enabling 
regular doctor 
income level 
urban/rural location 
health region of 
residence 
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Need 
chronic disease 
health status 
level of physical 
activity 
consumption of 
fruits & 
vegetables 
alcohol/smoking 
behavior 
Health 
Behavior 
Physician 
visits 
-GP 
-specialist 
Hospital use 
-inpatient 
admissions 
-LOS 
-day surgeries 
Direct costs 
-total 
physician 
costs 
-total inpatient 
costs 
4.7 Comparison of Subjective and Objective Visits to a Physician 
ln the current study, both self reported and actual data on physician utilization 
was obtained. The self reported data was collected through the 2001 CCHS for a period 
of 12 months prior to the survey and actual data was obtai ned through the I inkage of the 
survey respondents to the physician claims database (MCP) over a 5-year period. Self 
reported data on physician utilization was collected though the use of two questions that 
asked survey respondents whether in the previous 12 months they had seen their regu lar 
or fam ily doctor or 'another doctor'. These questions were able to pick up physician 
utilization, irregardless of whether the doctor was salaried or paid fee-for-service (FFS). 
The data on actual physician visits was limited to visits or services provided by 
physicians paid FFS, as this is the only information coll ected at a provincial level and is 
done so for payment purposes. In NL doctors on salary do not submit shadow or dummy 
invoices and therefore it is not possible to get infonnation on visits made to salaried 
doctors. 
The actual data provided many more data points per survey respondent. It was felt 
that for the purposes of the current thesis, in order to run the regression models developed 
to answer the research questions more data rather than less data would be beneficial (i.e., 
5 years versus 12 months) as these extra data points would increase the ability to control 
for confounding variables. 
According to the most recent report on the Distribution of phy icians in NL 
(Annual Report 1999/2000 Medical Care Plan), on average acros the province, 66% o f 
all physician are paid FFS. This percentage varies from a high of77% in the Eastern 
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Health Region to a low of22% in the Northern Health Region. The proportion also varie 
within health regions. For example within the Eastern Health Region the proportion 
ranges from a high of84% in St. John 's, the capital city to a low of42% in Clarenville 
while in the Northern Region the proportion ranges from a high of77% in the Labrador 
C ity/ Wabush area to a low of22% in St. Anthony Goose Bay area (Appendix E: Table 
1 ). 
Under the FFS coding scheme resources used or visi ts made can be categorized a 
office or home, in-patient, out-patient and emergency, diagnostic and therapeutic 
procedures, in-hospital diagnostic procedures, radio logy and surgical procedure . 
Analysis ofFFS physician visits over the 5-year period by code (e.g., office, home, 
radiology) demonstrated that 89% of GP visits were categorized as either office or home. 
Over the same time period only 15% of speciali st services were classified as office or 
home visits while the majority (43%) were cia sifi ed as radiology services fol lowed by 
12% and 9% categorized as in-hospital diagnostic procedures and out-patient and 
emergency visits respectively (Appendix E: Table 2). 
Analyses to compare self reported and actual physician visits were stratified by 
BM l category and conducted on; the province as a whole, the four regional health board 
and the urban and rural geographical regions. Using student t-tests, the average number 
of self repo1ied visi ts to a GP and a specialist doctor were compared with actua l FFS 
physician visits over a 12 month period. As the actual data included five years of data, for 
comparison purposes the total sum of FFS visit was divided by five for an annual sum 
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and these numbers were compared with 12 months of su rvey data. These results are 
presented in A ppendix E: Tables 3-4. 
4.8 Data Analysis 
Data analyses were conducted using the Statistical Package for Socia l Sciences 
(SPSS 13.5 fo r Windows) and the' R' software program in the Department of Statistics, 
M emo ria l University. Regression analyses using Statistics Canada health survey data 
were weighted due to the non-random sampling design of the survey. Statistics Canada 
uses a complex multi-stage design , with over-sampl ing fo r some s ub-populations (i.e. , 
health boards). Consequently, sampl ing weigh ts are developed to account fo r survey 
design and to provide an adjustment for survey non-response. To account fo r sam pli ng 
design the CCHS conta ins a ' weight variable' which represents the number of ind ividuals 
that each survey respondent represents. Statistics Canada suggests that all predictive 
analyses should be run incorporating the weight variable.213 Weighted analyses were not 
used fo r descripti ve statistics; however fo r both the Poisson and multiple linear regression 
m odels, a sample weighting variable was employed. 
4.8.1 Descriptive Statistics 
Descriptive statistics were conduc ted to describe the characteristics of the sample 
studied stratified by level of BMI. As there were fou r groups of BMI (e.g. , no1mal, 
overweight, obese and morbidly obese), the statistical test ch i-squared was conducted on 
all categorical vari ables to detennine the level of significance. Continuous variab les such 
as the Health Utility Index and the number of disability day were analyzed using the 
Analysis of Variance (A NOVA). A pre liminary analysis of the measures of health 
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services utilization through histograms illustrated data that was positively skewed to the 
1ight and therefore not normally distributed (see Figure 4.2 for Total FFS visits). 
Therefore reporting averages with standard deviations does not always clearly illustrate 
the variability of the data. The outliers (data points that are greater or Jess than 3 standard 
deviations from the mean) can influence the average. The median as a descriptive 
measure of health service use can be more accurate than the mean to describe the central 
tendency of the data and to compare the variability of the data.2 10 
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In order to detennine whether differences existed across level of BM I and the 
measures of HSU (e.g., number of visits to doctors, to hospitals and of nights spent in 
hospital) median tests were performed. To demonstrate the variability of the data, the 
inter quartile range (i.e. , 251h - 75111 percentiles) was reported. For categorical data, cross 
tabulations and chi-squared tests were conducted for gender, health region and smoking 
status. An alpha of .05 wa selected as the significance level forte ts of association and 
difference and all tests were two-tailed. 
4.8.2 Model Development 
The next section presents the inferential statistical model employed to estimate: 
i) the association between level ofBMI and the presence of chronic di sease, ii) the 
predictive relationship between level ofBMl and health services utilization and iii ) the 
predictive relationship between level of BMl and the direct costs associated with health 
services utilization. 
Most statistical tests are based on a model whereby the response/dependent 
variable is a functi on of an independent variable(s). The cia sic quation fo rmat is 
Y = f( xl, x2, x3, x4 . ... ) where Y is the outcome variable and the x's arc independent 
variables. This equation can take many fom1s and is dependent on the innate relation hip 
with the variables. The most appropriate statistical model to fi t any data et depends on 
the type of re ponse variable. The association between Y ' and x ' s determines the shape 
of the relationship of interest. For example to use a stati stical test based on a linear model 
there must be a linear relationship (i .e., a straight line) between the dependent and 
independent variable (i.e. , as x increases, Y increases at a constant slope). 
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In the current study, several types of regression analyses were u ed to estimate the 
relationships under study. For variables where a linear relationship existed, the Ordinary 
Least Squares method (OLS) which minimizes the observed values of the response Y and 
their mean per each unit ofx was used. Where the response variable was a continuous 
numerical measure, as in the case of direct health system costs, multiple linear regression 
was employed. Logistic and Poisson regression models were developed where non-linear 
relationships existed. In contrast to the OLS methods, both these models used the 
Maximum Likelihood Estimation method (MLE), as the distribution of the response 
variables was binomial or Pois on? 11 
4.8.2.1 Logistic Regression Models 
Logistic regression was used to detennine whether the level of BMJ was a 
predictor of the presence of chronic di sease in this population controlling for age and 
gender. Given the binary nature of the dependent variable (e.g., presence of chronic 
disease 1 = yes, 2= no), the choice of statistical test included both logit and probit 
techniques. Both technique require the dependent variable to be dichotomou that is 
having only two outcomes, and therefore to be interpreted as probabilities. Under most 
circumstances, the conclusions will be similar for both logit and probit methods. T he 
choice of test is primari ly that of famili arity and one of preference and ease of 
interpretation? 12 The advantage of using logistic regression is that the estimates of the 
coefficients in the equations can be interv reted easil y as they are presented a odds ratios. 
Logistic regression was employed in this study. 
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Logistic regression is part of a category of statistical models called generalized 
linear models or GLM and allows one to predict a discrete outcome, such as group 
membership from a set of independent variables that may be continuous, discrete or 
dichotomous such as presence/absence of a disease. The dependent variable is most often 
dichotomous, and can take the value of l with a probability of success or the value 0 wi th 
the probability of failure. This type of variable is called a Bernoulli or binary vatiable. 
The relationship between the predictor and the dependent variable is not a linear one, it is 
a logit transfom1ation. An advantage of us ing logistic regression is that no as umptions 
about the distribution of the dependent variable need to be met. 
One form of the logistic regression equation is: 
( Pi ) 1 - Pi 
A particular element of Xi can be set to I for all I to yield an intercept for the model. The 
unknown parameters B1 are usually estimated by maximum likelihood. Interpretation of 
the Bj estimates is the additive effect on the log odds ratio, a unit change in thejth 
explanatory variable. In the case of a dichotomous explanatory variable, gender, e1l is the 
estimate or odds of having the outcome for examples males compared with females . The 
odds are a measure of effect size and are defined as the ratio of the probab ility of an event 
occurring in one group to the probably of it occurring in another group. These groups 
might be men and women, or an experimental group and control group. If the 
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probabilities ofthe event in each group arep (first group) and q (the second group), then 
the odds ratio i : 
p/(1 - p 
q/(1 - q) 
p(1 - q) 
q(1 - p) 
These results of the logistic regression are ea y to interpret, as they are reported using 
odds ratios. An odds ratio of I indicates that the odds of expo ure i the same in both 
groups. An odd ratio greater than one indicates that the condition or event is more likely 
to have occurred in the exposed group when compared to the non expo ed group. In 
contrast an odds ratio less than one indicate that the condition or event is less likely to 
have occurred in the exposed group. 
In the model analyzing the as ociation wi th chron ic disease, the level ofBMI wa 
the independent variables or x while the ex istence of chronic disease was the dependent 
variable or y (e.g. , the ex istence of hypertension yes/no). In the equations, age and gender 
were controlled for because of their well-evidenced relationship with health. Age was 
entered a a continuous variable and gender was included as a dummy variable. A 
dummy variable a llows for the add ition of nominal or ordina l variable in a regression 
equation. T he standard approach is to include the categorical variables in the regression 
equation by cod ing each level of each categorical vari able as 0 or I. onventionall y I 
means the attribute of interest is pre ent. A binary nominal variable uch as gender may 
be coded 0 for male and I for fema le. 
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4.8.2.2 Poisson Regression Models 
Poisson regre ion models were developed to examine the predictive relationship 
between level of BMI and health services utilization. Thi s regress ion technique was 
util ized as the dependent variables of interest; the num ber of phy ician and ho pi ta! visit , 
LOS and day surgeries per pa tient were measured as whole discrete numbers or counts . 
Health services utilization data does not generally follow a nonnal dis tribution and is 
often positively skewed to the right w ith many individuals havi ng zero or li ttle health 
services utilization and very few individuals having a large number of visit . 
A Pois on distribution can be used to describe the di screte di tribution of a 
number of occurrences o r counts over time such as the number of visit to a physician in 
one year. There is no assumption that the dependent o r independent vari ables are re lated 
linearly. There is no assumption of homogeneity of variance; that i variances are equal. 
The predictors or independent variable may be either continuou or categorical. A key 
characteristic of the Poisson distribution is that its mean is equal to it variance? 13 
T he fo llowing section describes Pois on regression providing the relevant 
equations for clarification. lf the respon e variable of interest ha a Pois on di stribution 
as in this case the probability of observing Y occunences is calculated as: where e = 2.7 1 
(approx imately) and f.l is the mean. 
Probability (Y) = e-uuy, fo r any Y = 0, l ,2 .... . . . 
Y ! 
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If Y is a Poisson variable that has a mean of ~ which depends on explanatory 
variables X1 and X2, then a Poisson log-linear regression model states the natural log(ln) 
of the mean can be written as a linear function of the regression coefficients. 
Ln(~t) = ~o + ~ ,x , + ~zXz 
This can be ex tended to include any number of regression coeffi cients. For 
example if : Y = number of physician visit in a year; X 1 = age, X2 = BMllevel 
The interpretation of Bi depends on w hether X 1 is quantitative (age, heart ra te) or 
categ01ical (level of BMI). If X 1 is quantitati ve the B I tells us, assuming X2 remain 
fixed a I - unit increase in X 1 is associated with K-fo ld increase in the mean ofy (i . e., ~) , 
where K = eP, . IfX 1 is age and B 1 = 0.069, then increasing age by I year is estimated to 
be associated wi th e0·069 = 1.07-fo ld change o r a 7% increase in the mean (average) 
number of phy ician visits (Y). lfX 1 is categori cal the 8 1 tells us that X2 remains fixed , 
that~ (mean ofY) is eP , times higher for the group represented by X 1 than for baseline 
group. For example suppose B 1 = 0.03 then keeping X2 fi xed, the average number of 
physician vi its (Y) for a per on with an obese level of BMJ i eP, = e0·03 = 1.03 times 
higher (3%) than a person with a normal BMI. 
There are two common problems with Pois on regre sion. Fir t, in certain 
circum tance the observed vari ance can be greater than the mean and thi is known as 
overdi spcrsion. Dispersion is the spread of a set of observations. Ovcrdi persion occur 111 
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Poisson regression when the variance is greater than the mean. lf the overdispersion is 
large, it may signal a problem with the model. If the overdispersion i 
moderate it can be coJTected by using an adjusted standard error = SE * qrt (0/df), 
where Dis scaled deviance, which for loglinear equals G2 and elf = the number oftenn n 
. h d I . h 2 14 111 t e mo e not countmg t e constant. 
The second problem with Poisson regression is excess zeros. If there are two 
processes at work, one determining whether there are zero events or any events, and a 
Poisson process detennining how many event there are, there will be more zeros than a 
Poisson regres ion would predict. An example would be the disttibution of cigarettes 
smoked in an hour by members of a group where some individuals arc non-smokers. 
Both challenges were encountered in the study. There wa moderate 
overdispersion that was corrected by the inclu ion of a cotTection factor. The inclusion 
of a correction factor does not change thee timates of the equation, but does change the 
standard errors attached to the estimate a the correction fonnula demon trates. In 
addition, as the HSU data had many zeros, the Poisson regressions were run with and 
without the zeros and no difference were found. In the Poisson regrcs ion models u mg 
Andersen's model as a guide, all the predi posing variables were included. Under 
enabling all the variables were included with the exception of 'regular doctor' as a high 
proportion of all BMI groups had access to a regular doctor. Under the category ofNeed, 
the number of chronic conditions and the health status variables were included; the 
inclusion in the model ofthe other 'need ' variables did not impact there ul ts . 
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4.8.2.3 Multiple Linear Regression Models 
Two multiple linear regression models were conducted to estimate the predictive 
relationship between level of BMI and the dependent variable of direct costs associated 
with physician and inpatient services considered to be continuou variables. As 
presented earlier, linear regression is a param etJic statistic based on calculating averages 
and standard deviations using the parameters of a nom1al distribution. Linear regression 
uses the correlation between variabl es in order to find the best mathematical model for 
predicting one variable from another. As well , linear regression describes the straight line 
relationship between a predictor variable(s), plotted on the x-ax is, and a re pon e 
/outcome variable, plotted on they-ax is. 
A simple linear regression equation is as follows: 
Y = bo + b 1x 1 + e where: 
bo is the Y -intercept, and b 1 is the regression coeffi cient which defines the slope of the 
I ine for x 1 the independent or explanatory variable. The dependent/ response variable is 
' Y ' and e is a random variable called the error term. A multiple linear regression 
equation is similar to a simple linear regression equation other than that it include mor 
than one independent variable (i .e., x2, x3 etc.), for example: 
Y = bo + b 1 X 1 + b2X2 + b3X3 + b4X4 + e 
Multiple linear regression is a parametric statistic and is based on the parameters 
of the normal di stribution. Therefore, several assumptions app ly to the analy is. 
The sample size must be relatively large, and there should be between five and fifteen 
cases per independent variable. Independent variables should not be highl y cotTelated or 
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demonstrate multi collinearity. The residuals should have a linear relationship with the 
predicted scores. Only one response per dependent variable is allowed, therefore there 
should be no repeated measures. The va1iance for residuals about the predicted score 
should be the same for a ll scores. 
Initial exploration via a histogram of the cost data, illustrated a di stribution that 
was not quite nonnal as well as many values that were zero. However non-l inearity of a 
continuous response variable can be corrected by a mathematical transfonnation in order 
that the data can be used in a linear model. In this scenario the dependent variable was 
log transformed to ensure the data met the criteria ofnonnality. Modeling using multiple 
regression analysi was run on the natural log (In) of the response variable. One needs to 
be aware that any data transfonnation changes the meaning of the model parameters and 
their interpretation. Therefore caution should be made when interpreting the beta 
coefficients in the equation. A positive increase in a beta increases the natural log of the 
dependent vari able. 
Due to the number of zeros encountered in the dataset (i.e., those urvey 
respondents who had not utilized either physician or hospital services), 0.1 was added to 
each individual cost so the natural log could be computed. The log of zero produces a 
value of' infinity' which cannot be u ed in any statistical analysis, therefore in order to 
use the information from these data points an arbitrary value ofO. I was added to each 
zero value. This retains the data while keeping the value close to zero. A lthough this 
produces a negati ve value, it a llows the data to be used in the stati stical analysis. In the 
ca e of physician co ts, the analysis (running the natural log of the costs with the above 
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procedure) reported approximately 200 individua ls with negative costs. In terms of the 
hospital costs, running the natural log produced well over 1500 individuals w ith negative 
costs. A decision was made to include the individuals with the 200 negative cost values in 
the analysis of physician costs.218 As a check the multiple regression models were run 
with and without the 200 negative values and the results were similar. In terms of the 
hospital costs, a decision was made to include only those individuals who had an in-
patient stay and an associated cost. 
Standard multiple regression was used to detennine if level of BMI was an 
independent predi ctor of direct healthcare costs. The chosen variables were entered into 
the model at the same time as it was not the focus of the current thesis to test Andersen's 
empirical model but rather to use the model to guide the choice of independent variables 
for the regression models. Variables contro lled fo r in this regression model were similar 
to those variables contro lled for by other researchers in this fi eld when analyzing the 
relationship level of BMI and health services util ization. However, only those variables 
showing a significant relationship were included in the cost analysis as to determine more 
accurately the ex plained variance (i.e., the R2 ofthe model). These variables included ; 
level of BMI, age, gender, education level, region of residence and smoking behavior. 
Due to the limited data avail able on the cost of surgical clay care the cost analysis was not 
tested. This was due to the limited coding of the variable used to code fo r resource use of 
clay surgeries - the DPG _ W . The coding of surgical day care commenced in February 
2002. Earl y descriptive analysis of this data demonstrated mai nly zeros for th is variable. 
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4.9 Chronic Disease as a Mediator Variable 
In the cunent thesis, regression equations were developed to examine the 
relationship between level ofBMI and an individual's use of health services. However as 
other variables can affect the u e of health ervices, these variable were taken into 
consideration both in the Poisson and multiple regression models. For the Poisson and 
multiple linear regression models it was hypothesized that the number of chron ic 
conditions may act as a mediator variable? 15 A mediator variable is a type of third 
variable s ituated between the independent and dependent vmiablc . Mediating vmiables 
account for a perc ntage of the relationship between the predictive variable and the 
outcome variable. To determine if a variable may be classified as a mediator variable, 
statistical analysis is run between, (1) the predictor and the dependent variable (2) the 
mediator and the dependent variable, and (3) the predictor, mediating variable and the 
dependent variable. If a variable(s) is to be described as a mediator, the stati tical analysis 
should demonstrate a decrease in the effect of the predictor variable, once the mediator 
variable is included.2 15 The relationship between the independent and dep ndent 
variables can be decomposed into two causal paths. For example in Figure 4 .3, a BM I ~ 
30 may have a direct relationship with increa ed health services utilization, however thi 
relationship may be mediated or attenuated with the addition of chronic disea e into the 
model. In thi s relationship one of the paths links the independent variable to the 
dependent variable directly and the other path links the independent variable to the 
dependent vari able indirectl y. An indirect or mediated effect implies that the independent 
variab le causes the mediator variable which in turn cause the dependent variable. If a 
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variable is to be de cribed as a mediator variable, the statistical analy is hould 
demonstrate a decrease in the effect of the independent variable when the mediator is 
added to the model.215 
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Independent Variable 
BMI ~ 30 
Indirect effect = ap 
Mediator 
Chronic disease 
T 
B 
Dependent variable 
Health services utilization 
Direct effect = T 
Total effect = a~ + 1: 
Figure 4.3 Illustration of a Mediator 
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This is in contrast to a confounding variable, another type of third variable. A 
confounder is a type of third variable a sociated with both the independent variable and 
outcome variable. It i an extraneou factor that i in itself ad tem1inant of the outcome 
of interest. 2 13 onfounding occurs when the effects of two variables have not been 
separated and it is concluded that the effl ct observed is due to one variable rather than the 
combination of variables. A simple example would be the relationship between coffee 
drinking as an independent variable and its association with coronary heart disease as on 
outcome. Coffee drinking is associated with c igarette smoking and, cigarette smoking i 
in tum associated with heart disease. lf one were to look only at the relationship between 
coffee drinking and heati disease, the strength of the relation hip would be overestimated, 
as it may be the relationship with smoking that causes the increased incidence of heart 
disease (Figure 4.4). If known confounding variables are not controlled for in an analy i 
the strength of the relationship under tudy may be overestimated and there ulting 
interpretation may be incorrect. 
126 
EXJ>O S RE 
offee drinking 
DISEASE/OUTCO ME 
Heart disea e 
/ 
CONFOUNDNG VARIABLE 
Cigarette sm king 
F igure 4.4 Illustration of a Confounder 
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Confounders in the current study include those variables that have demonstrated a 
relationship with both the use of health services as well as BMI such as age, gender, 
. d . k. b h . d I h I . 213 215 mcome, e ucat10n, mo mg e av10r an a co o consumption. ' onfounding 
variables may distort the true relationship of the variables under tudy by being 
independently related to the outcom of interest. These variables are extraneous to the 
relationship under study and are often unequally disttibuted among the groups being 
compared such as age and gender. If the e confounding variables are not controlled for in 
analysis, the strength of the relationship may be overestimated. Stati tical analysis for 
observational tudies can only control for known confounders, and there i always the 
possibility that an unknown or unmeasured confounder exists. In randomized control 
trials, where participants are randomly allocated to two groups (e.g., treatment or 
placebo), unknown confounder can be control led. 
Both type of variables are treated identically for statistical purpo es and can only 
be distingui heel on conceptual grounds. When a mediator or confounder is added to the 
analysis, each is quantified my measuring a change in the relationship between the 
independent variable and the dependent variable. It i hypothesized that the existence of 
chronic disease is a mediator variable within this relationship. 
4.10 Ethical Con iderations 
This study wa approved by the Human Investigation Committee at Memorial 
University ofNcwfoundlancl (Appendix F). Permission to use the anadian Community 
Health Survey 1.1 ''link fi le" wa received from the Depm1ment of Health and 
Community Services, L (Appendix G). Penn is ion to access and u e the 2000/200 I 
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CCHS 1.1 "share file", the Clinical Database Management System (CDMS) was received 
from the NL Centre for Health Infonnation (Appendix H). Pem1ission to use the fee-for-
service physician claims database was received from the Medical Care Plan (Appendix I). 
All personal identifiers (name, address, telephone and health insurance number) were 
removed from the research database after linkages were conducted . An anonymous 
unique identifier number replaced the MCP number. The researcher wa required to sign 
a standard oath of confidentiality. Access to the identities associated with the personal 
health infom1ation was limited to a co-investigator employed by NLCHI who also 
conducted the database linkages. All paper forms and printouts of electronic fi les were 
kept in a secure place and computer files related to the study were password protected 
and kept in a locked office. 
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Chapter 5 Results 
5.1 Introduction 
This chapter presents the findings of the research study. Data analyses were 
perfom1ed using statistical software packages SPSS (Version 13.5) and ' R' . SPSS was 
used fo r the descriptive analysis, logistic regression equations and multiple regression 
equations whil e ' R ' was used to run the Poisson regression analysis (i .e. , the count data 
models for prediction of health services utili zation). The study findings are presented in 
the following fo ur sections. Section 5.2 reports the secondary analysis of the 2000/200 I 
CCHS (Tables 5. 1 to 5.6). Section 5.3 reports the analyses of the measures of actual 
health services utilization (Tables 5.7, 5.8, Figure 5. 1 ). Section 5.4 reports the results of 
the analysis comparing self reported and actual visits to a physician (Table 5.9). Table 5.5 
reports the predi ction models desctibing the relationship between the ' actual' level of 
health services utilization and the level ofBMI (Tables 5. 10 - to 5. 14). Section 5.6 
describes the direct costs of obesity (Table 5. 15, Figures 5.2, 5.3) and the multiple 
regression prediction estimates which desctibed the re lati onship between level of BMl 
and the direct hea lthcare cost (Tables 5. 16, 5. 17). 
5.2 The 2000/2001 CCHS 
A total of2366 survey respondents between 20 and 64 years of age met the ini ti al 
criteria and were included in the study analys is: 47.2% were males and 52.8% were 
females with an average age of 4 1 years (SO= 11 .67). The average BMl was found to be 
27.0 kg/m2 with a range between 18.0 - 60.4 kg/m2. The sample was divided into the 
appropriate BMI categories using the WHO classifica tion system. A total of548 (23%) 
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survey respondents were classified as obe e with BMI scores~ 30kg/m2. The obese 
group was further broken down into 407 obese (BMI ~ 30kg/m2 and < 35kg/m2) and 141 
morbidly obese (BMT ~ 35kg/m2). A total of 9 16 (39%) survey resp ndents were 
classified as overweight with BMI score between 25.0 and 29.9kg/m2 and 88 I (37%) 
survey respondents were classified as nonnal weight with BMI score between 18.5kg/m2 
and 24.9kg/m2. Less than 1% (n=2 1) of the study population was clas ificd a 
underweight (BMI < I 8.5 kg/m2). 
Table 5.1 summarizes the difference in selected characteri tic tratified by BMI 
category. Due to the nature of the data (e.g., categorical and nominal), chi-squared te ts 
were conducted to determine whether there were significant differences between the 
independent variables such as gender, age etc. and level of BM I. The p-values (the 
probability of obtain ing the study result by chance) were reported according to the level 
of significance from high, to moderate to low significance p<.OO I, p<.O I and p<.05. 
Significant differences were found in the sample population between all categorical 
variables and BMI category with the exception of education. Morbidly obese individuals 
were more likely to be female, to be between 40 and 49 years of age, live in the area 
described as the Eastern Health Region to be middle income earner and to be either 
married or in a common-law relationship. Obese individuals were similar to the morbidly 
obese group in relation to demographic variable with a few exceptions. The obese 
population were divided equally between men and women and were more li kely to be 
slightly older than the morbidly obese group that i between 50 and 64 years of age. 
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Table 5. 1 CCHS Demographics by Level of BMI 
Characteristic Morbid -value 
n=141 
n 
Gender 
male 48 (34) 204 (50) 505 (55) 353 (40) <.00 1 
Female 93 (66) 203 (50) 41 1 (45) 528 (60) 
Age in years 
20-29 25 (1 8) 53 ( 13) 103 ( I I) 17 1 (20) <.00 1 
30-39 33 (23) 100 (25) 234 (26) 237 (27) 
40-49 43 (3 1) 120 (30) 252 (28) 2 11 (24) 
50-64 40 (28) 134 (33) 327 (36) 262 (30) 
Health Region 
Urban (~5000) 96 (68) 241 (60) 567 (62) 599 (68) <.0 1 
Rural( <5000) 45 (32) 166 (4 1) 349 (38) 282 (32) 
Eastern I 52 (37) 155 (38) 392 (43) 428 (49) <.0 1 
Central 32 (23) 78 (19) 158 ( 17) 126 ( 14) 
Western 23 ( 16) 62 ( 15) 148 ( 16) 160 ( 18) 
N011hern 34 (24) 11 2 (28) 2 18 (24) 167 (19) 
Education 
< Secondary 25 ( 18) 72 ( 18) 148 ( 16) 145 ( 17) s 
Secondar/ 33 (24) 87 (22) 174 ( 19) 168 ( 19) 
Trade school3 69 (50) 200 (50) 437 (4 ) 4 15 (47) 
University graduate 12 (9) 43 ( II ) 149 (16) 148 ( 17) 
4 Income 
Low 7 (5) 28 (7) 42 (5) 75 (9) <.001 
Middle 120 (88) 30 1 (77) 666 (75) 6 17 (75) 
High 9 (7) 64 ( 16) 175 (20) 128 ( 16) 
Marital Status 
manied/common- law 94 (67) 304 (75) 708 (77) 562 (63) <.001 
U npartnercd5 47 (33) 103 (25) 208 (23) 3 17 (36) 
1 Includes St. John 's, 2includes some po t secondary 3 includes some uni versi ty 4a derived 
variable that combine total household income with number of hou eho ld members,5 
includes widowed/separated/divorced/single 
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Table 5.2 summmizes the differences in lifestyle and health status characteri stics 
stratified by BMI. Lifestyl e vaJiables include: smoking, drinking behavior, level of 
physical activity and daily consumption of fruits and vegetables. Health Status 
variables may include subjective and objective measures of health. Self-perceived 
health, subjectively measures how an individual perceives his or her own health. 
Objective measures of health include questions on the number of disability days taken 
in the previous two weeks, and the presence of chronic condi tions. In addition, the 
Health Utility Index (HUI), a derived vari able that combines questions on activities of 
daily living objectively measures fu nctional health . The HUI, a continuous variable is 
reported in the range 0 to I and is not normall y distributed. T he Kruskai-Wallis 
nonparam etri c test fork-independent groups was conducted to detennine if there were 
signifi cant differences between the HUI and BM I category. 
Morbidly obese individuals were more likely to have reported being inactive, 
occasional/never drinkers of alcohol and to consume < 5 servings of fruits and 
vegetables per day. A high percentage of morbidly obese individuals reported being in 
excellent, very good or good health, although the percentage was signi fica ntly lower 
than the other BMI categoties. T he average HUI for the morbidly obe e was high but 
again it was significantl y lower than the other BMJ groups. A larger percentage of 
morbidl y obese ind ividuals reported having been diagnosed with a t lea t one chronic 
condition. 
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Table 5.2 Lifestyle Characteristics and Health Status Variables by Level of BMI 
Morbid Obese Overweight Normal p-value 
Characteristic n=141 n=407 n=916 n=881 
n o; o n o; o n % n o; o 
Smoking 
Daily/fo1mer 80 (57) 240 (59) 556 (6 1) 506 (57) NS 
Occasional± 28 (20) 68 ( 17) 148 (16) 162 (18) 
Never smoked 33 (23) 99 (24) 2 12 (23) 2 13 (38) 
Physical activity 
level 
Active/moderate 38 (27) 14 1 (36) 355 (40) 366 (43) <.0 1 
Inactive 95 (72) 254 (64) 532 (60) 492 (57) 
Type of drinker 
Regular/fo rmer 85 (60) 263 (65) 662 (65) 632 (72) <.0 1 
Occasional/never 56 (40) 144 (35) 254 (35) 249 (28) 
Consumption of 
fruits/vegetables 
<5 servings/day 11 5 (83) 300 (74) 684 (75) 597 (68) <.00 1 
2.5 servings/day 24 (1 7) 105 (26) 226 (25) 278 (32) 
Self-rated health 
excellent/very Ill (79) 355 (87) 816 (89) 769 (87) <.01 
good/good 
fa ir/poor 30 (2 1) 52 (13) 100 ( 11 ) 11 2 (13) 
Health Utility Index 139 .84(.23) 404 .89(. 19) 908 .90(.1 7) 873 .89( 19) <.0 1 
n, mean (SO) 
# of disability days 14 1 1.5(3.8) 407 1.0(3. 1) 916 .77(2.6) 88 1 .93(2.9) NS 
n, mean (SO) 
Presence of a 107 (76) 260 (64) 545 (60) 530 (60) <.0 1 
chronic condition 
# chronic 
conditions 
0 34 (24) 147 (36) 37 1 (4 1) 349 (40) <.00 1 
1-3 93 (66) 208 (5 1) 480 (53) 465 (53) 
> 4 14 (1 0) 52 ( 13) 64 (7) 67 (7) 
Morbidly obese (BMI 2:35), obese (BMI>30), overweight (25 :::; BM I < 30), normal (BM I 18.5-
24.9), ± includes occasional, always occasional and fonnerl y occasional smokers 
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5.2.1 Chronic Conditions 
Table 5.3 summarizes the self reported prevalence of chronic conditions 
compa1ing morbidly obese, obese, overweight and normal weight groups. Morbidly 
obese and obese groups were significantly more likely to have repor1cd being diagnosed 
with cerebrova cular and cardiovascular disea es, hypertension, endocrine diseases 
including diabetes and a gastrointestinal or neurological disease. The self reported 
prevalence of cerebrova cular and cardiova cular diseases was 27.7% in the morbid ly 
obese, 26.3% in the obese, 17.8% in the overweight and 9.2% in the normal weight The 
self rep011ed prevalence of hypertension increa ed from 6.7% in the normal weight to 
26.2% in the morbidly obese group. The elf reported prevalence of endocrine diseases 
was 7.5% in the nom1al weight group, 9. 1% in the overweight group, 12.3% in the obese 
group and 17.0% in the morbidly obe e group. As well an increase in the prevalence of 
self reported diabete was rep011ed from 2. 7% in the normal weight group to I 1.3% in the 
morbidly obese group. There were significant differences in the self reported prevalence 
of the gastrointestinal and neurological disease across levels of BM I. There were no 
differences seen across the levels of BMI with the prevalence of di ea e for 
rheumatology, pulmonary, asthma or allergies. 
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Table 5.3 Self-Reported Prevalence of Chronic Conditions by Level ofBMI 
Chronic 
Condition1 
Cerebrovascular and 
CVD2 
morbid 
n= 141 
n (%) 
39 (27.7) 
obese 
n =407 
n (%) 
107 (26.3) 
overweight normal 
n =916 n = 881 
n (%) 11 (%) 
163 (17.8) 82 (9.2) 
p-
value 
<.001 
High blood 
pressure 
37 (26.2) 97 (23.8) 133 (14.5) 60 (6.7) <.00 I 
Endocrine diseases3 
Diabetes 
mell itus 
Gastrointestinal 
diseases4 
Rheumatologic 
diseases5 
Pulmonary disea es6 
Asthma 
Neurolo~ical 
diseases 
Allergies8 
24 ( 17.0) 50 
16 (11.3) 32 
9 (6.4) 23 
(12.3) 83 
(7.8) 41 
(9.1) 
(4.5) 
(5 .6) 24 (2.6) 
66 
24 
39 
(7.5) 
(2.7) 
(4.4) 
42 (29.8) 134 (32.9) 259 (28.3) 251 (28.5) 
15 
12 
24 
(10.6) 
(8.5) 
(17.0) 
33 
24 
46 
(8.1) 
(5.9) 
( 11.3) 
33 (23.4) 79 (19.4) 
56 
44 
79 
(6.1) 
(4.8) 
(8.6) 
70 
54 
117 
(7.9) 
(6.2) 
( 13.3) 
201 (22.8) 
<.01 
<.001 
<.05 
NS 
NS 
NS 
<.01 
NS 
In the Canadian Community Hea lth Survey 1. 1, survey respondents were asked if they had ever been 
diagnosed by a doctor with a list of 25 chronic conditions. This list was collapsed into a sma ller list of 
chronic conditions based on the disease (as per a medical doctor). 
2 includes high blood pressure, heart disease (including heart attack, angina and congesti ve heart failure) 
and effects of stroke 
3 includes diabetes mellitus and thyro id condition, 4 includes bowe l disorder (Crohn's or colitis) and 
stomach or intestinal ulcers 5 includes fibromyalgia, arthriti or rheumatism and back problems, 6 inc ludes 
chronic bronchitis, emphysema or chronic obstructi ve pulmonary disease, 7 includes migraine headaches, 
epilepsy, Alzheimer's disease or dementia, Parkinson's disease multiple sclero is and chronic fa tigue 
syndrome 8including food , other allergies and multiple chemical sensiti vities 
S, not significant for p < .05 
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5.2.2 Self Reported Health Services Utilization 
Respondents were asked several questions pertaining to their health care 
utilization patterns in the 2000/2001 CCHS. Table 5.4 summarize and compares the 
respondents' healthcare utilization patterns. Interviewers asked que tions requiring either 
a 'yes or no ' response (e.g., have you received physician service in the pervious 12 
months or do you have a regular famil y docto r?). As well , questions were asked about the 
level ofhealthcare utilization (e.g., the number of visi ts to a hea lth professional or the 
number of nights spent in a hospital, in titution or convalescence home). T here were 
significant di fferences identified in the number of visits to a G P in the previous 12 
months. T he morbidl y obese and the obe e group reported having seen a GP a median of 
four and three times, respectively, compared to the normal and overweight groups who 
reported a median of two visits for a GP. However, there were no ignificant difference 
seen in any other utilization of healthcare ervices across the weight categories. 
More than 75% of individuals in all levels of BMI reported having a regular 
doctor and having received physician serv ices in the previous 12 months. Approximately 
50% of the normal, overweight, obe e groups and 40% of the morbidly obese group 
reported having received hospital services in the previous 12 month . PI rox imately 
I 0% of the morbid ly obese, obese and normal weight groups and 7% of the overweight 
group reported having been in hospital overnight. As well , I 0% of the morbid ly obese 
group reported having consulted a mental health professional. 
137 
Table 5.4 Subjective Healthcare Resource Use Indicators in Previous 12 months by Level ofBMI 
Measure of Morbid Obese Overweight Normal p-
Utilization n= 141 n=407 n=916 n=881 value 
n % n % n % 
Have a regular I 1 3 80.1 317 77.9 726 79.3 710 80.6 NS 
doctor' 
No. of consults 4.0 [2.0,6.0] 3.0 [1.0,5.0] 2.0 [1.0,4.0] 2.0 [ 1.0,4.0] 0.001 
with GP** 
[median] 2 
No. of consults 0.0 [0,0] 0.0 [0,0] 0.0 [0.0] 0.0 [0, 1.0] NS 
with other medical 
doctor [median] 2 
Consulted mental 15 10.7 27 6.7 50 5.5 70 8.0 NS 
health provider' 
Received hospital 
services 1 •3 
12 41.4 51 52.6 93 49.7 97 50.5 NS 
Hospitalized 14 9.9 39 9.6 65 7.1 81 9.2 NS 
. hI overmg t 
No. of nights spent 4 [2.0, 14.0] 4.0 [ 1.0,7.0] 4.0 [2.0,7.0] 4.0 [2.0,7.5] NS 
in hospital 
[median] 2 
Received 27 93.1 79 81.4 156 83.4 161 83.9 NS 
physician services 
,3 
yes or no response, median shown with [25t \ 75t 1 percentiles] , 
3 questions asked of a sub-sample of the total survey population n = 602 categorized into 
obese= 126 and normal weight = 195 
** p < .001 
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5.2.3 Logistic Estimates: Associations with Obesity 
This section explores the predictive relationship between demographic, health 
status and lifi style variables and categories of obesity, as well as the predictive 
relationship between level ofBMI and self reported chronic disease in the L population 
(Tables 5.5, 5.6). These relationships were examined using logi tic regression models. 
Table 5.5 examines the demographic/ lifestyle and health status associations with 
being morbidly obe e and obese in NL. Two logistic regression model were run for each 
set of independent variables. The outcome variable was dichotomou fo r each model ( 1 = 
morbid obesity; 0= nonnal weight) and (I = obese; 0= nonnal weight). Each logistic 
model was adj usted for age and gender by including in each equation, age as a continuous 
variable and gender as a dummy variable (male = 1, female = 0). Non significant findings 
were demon tratcd by the inclusion of one in the 95% confidence interval and are 
reported in Table 5.5. The morbidly obese group was more likely to live in the Central 
and orthern health regions, to be inacti ve to consume < 5 servings of fruits/vegetables, 
to report poor or fair health, difficulty with activities and to be diagnosed with ~ 4 
chronic conditions compared with the normal weight group. The morbidly obese group 
was less likely to be in a high income bracket, smoke and drink regularl y. T he obese 
group were more likely to live outside St. John ' have secondary or < ccondary 
education, to be married, to be inacti ve, consume < 5 serving of fruit /vegetables per 
day, to report being in poor or fair health, to have difficulty with activ ities and to have 
been diagno ed with ~ 4 chronic conditions. The obese group was less likely to drink or 
smoke regularly compared to the nonnal weight group. 
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Table 5.5 Logistic Regression: Associations with Morbid obesity and Obesity adjusting fo r 
age and gender 
Variable Morbid Obesity Obese 
Adjusted OR 95% CI 
Health Region1 
Ad,ju ted OR 95% Cl 
Ea tern 1.11 .62 1 - 1.99 1.54 1.1 0 - 2.1 6 
Central 2.1 5 1.25 - 3.73 1.54 1.1 0 - 2.16 
Western 1.24 .689 - 2.22 2.2 1 1.56 - 3.1 4 
Northern 1.74 1.02 - 2.96 2.27 1.64 - 3. 15 
Education2 
Sec,< Secondary 1.27 .87 - 1.88 1.26 1.24 - 1.29 
Income3 
Low .70 .42 - 1.1 7 .69 .45 - 1.05 
High .55 .36 - .85 .82 .60 - 1.1 2 
Matital tatus4 
Married/common- 1.11 .76 - 1.62 1.66 1.62- 1.69 
law 
Smoking5 
Daily .5 1 .33-.78 .64 .63 - .67 
Physical acti vity level6 
Inactive 1.82 1.22 - 2.73 1.56 1.53 - 1.59 
Type of drinker7 
Regular .49 .34 - .71 .59 .57 - .60 
Consumption o f 
fruits/vegetables8 
<5 servings/day 2.39 1.50 - 3.8 1 1.5 1.55 - 1.62 
Self-perceived healthy 
poor/fa ir 1.99 1.20 - 3.01 1.33 1.29 - I. 7 
Difficulty with 2. 11 1.22 - 3.66 1.90 1.86 - 1.95 
activities (yes) 
> 4 chronic conditions 1.67 1.63 - 1.7 1 1.67 1.63 - 1.7 1 
OR: odds rati , Relative to: St. John's; - post-secondary, trade/college and some post secondary education; 
1 middle income earner; 4 unpartnered; 5 occasional/never; 6 active/moderate; 7 ccasional/ former/never; 8 ~ 
5 servings o f fruits/vegetables per day; 9 excellent/very good/good. 
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5.2.4 Obesity as a Predictor of Chronic Disease 
This section examines the level of BMI as a predictor of self reported chronic 
disease in the NL population. Logisti c regression models, adjusting for age and sex were 
developed. The independent variable in the model were level of BM I, age and sex. The 
dependent or outcome variable was di chotomou : the presence or absence of chronic 
disease wher yes = 1 and no = 0 (Table 5.6). 
The likelihood of having reported being di agnosed with the fo llowing chronic 
condition ; cerebro/cardiovascular, hyperten ion, endocrine conditions and diabetes 
increased a the level of BMI increased. The strength of this relationship was 
demonstrated by the increasing odds ratio . As the cotTesponding confi dence intervals did 
not include one, these findings were significant. For example, the overweight, obese and 
morbidl y obese groups reported odds ratios (OR) of 2.9 1 [95% I (2.82, 3.0)], OR 5.39 
[95% C l (5 .2, 5.5 )] and an OR 8.24 [95%CI (7.86, 8.63)] time more li kely to have 
reported been diagno eel with hypertension compared to the normal weight group. 
Analysis of the remaining chronic diseases (e .g., gastrointestinal, rheumatologic, 
pulmonary, a thma, neurological and allergies) did not demon trate a clear dos -response 
relatio nshi p with increasing levels of BM I. 
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Table 5.6 Logistic Regres ion: Level of BMI as a Predictor of Self-Reported Chronic 
Disease, adjusting for age and sex 
Chronic comorbidity1 Level of BMI2 Odds Ratio 95% CI 
Cerebro/cardiovascular overweight 2.63 2.56 - 2.71 
diseases2 obese 4.24 4.10 - 4.38 
morbid 6.10 5.84 - 6.38 
High blood pressure overweight 2.91 2.82 - 3.00 
obese 5.39 5.20 - 5.58 
morbid 8.24 7.86 - 8.63 
Endoctine diseases3 overweight 1.11 1.07 - 1.14 
obese 1.44 1.39 - 1.50 
morbid 2.45 2.39 - 2.51 
Diabetes mellitus overweight 1.44 1.37 - 1.50 
obese 2.44 2.32 - 2.56 
morbid 5.41 5.09 - 5.76 
Gastrointestina l overweight .549 .326 - .926 
diseases4 obese 1.25 .732 - 2.1 2 
morbid 1.47 .696 - 3.1 2 
Rheumatologic overweight .948 .930- .966 
diseases5 obese 1.27 1.24 - 1.30 
morbid .969 .934 - 1.01 
Pulmonary diseases6 overweight .924 .894- .955 
obese 1.23 1.18 - 1.28 
morbid 1.72 1.64 - 1.81 
Asthma overweight .879 .580 - 1.33 
obese 1.05 .635 - 1.17 
morbid 1.36 .708 - 2.63 
Neurological diseases7 overweight .710 .52 1 - .966 
obese .916 .633 - 1.33 
morbid 1.28 .784 - 2.08 
Allergies8 overweight .991 .97 1 - 1.01 
obese .937 .9 12-.962 
morbid 1.2 1 1.08 - 1.16 
1 In the Canadian Community Hea lth Survey 1. 1, respondents were asked if they had been di agnosed by a 
doctor with a lis t of 25 cllfoni c conditions. This list has been collapsed into cllfonic conditions based on the 
disease (as per a medical expert RA), 2 has hig h blood pressure, hea11 disease (including heart attack, 
ang ina and congestive heart fa ilure) and effects of stro ke 3 includes thyro id conditio n, 4 inc ludes bowel 
disorder (Crohn 's or colitis) and sto mach or intestinal ulcers 5 includes Fibro myalgia, a rthriti s or 
rheumatism and back prob lems, 6 includes chronic bronchitis, emphysema or clu·onic obstruc tive 
pulmonary disease, 7 includes migraine headaches, epilepsy, Alz heimer' s disease o r dementia, Parkinson's 
disease, Multiple sclerosis and chro nic fa tigue syndrome 
8including food , o ther alle rgies and mu ltiple chemical sensiti vities 2 referent category nom1al weight 
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5.3. Measures of Actual Health Services Utilization 
The linkage of the health survey to the MCP and the CDMS databases were 
successful for 2 177 survey respondents who provided valid health insurance numbers. 
These individual health insurance numbers were linked to the MCP and CDMS databases 
to obtain physician and hospital utilization. 
5.3.1 Medical Care Plan 
The descriptive results of this analysis are presented in Table 5.7. Thi s table is 
categorized into physician consults, consults w ith a GP and consults w ith a special ist A 
total of94% of the survey respondents (2036) with a valid MCP had at lea t one visit 
with either a GP or specialist doctor, including a radio logy a ses ment over the fi ve-year 
study period 1998-2003. Of the total survey respondents with a valid MCP number, 84% 
(1 838) had at least one visit with a GP and 85% ( 1858) had at least one visit with a 
specialist doctor. A significant difference was identified in tenns of total utili zation of 
physician services across the BMI categori es. The morbidly obese gro up reported a much 
higher median number of visits (median 3 1) compared to the other BM I categori es. 
When physician consults were separated into GP or specialist visits, a sign ificant 
relatio nship remained only with the morbidl y obese group fo r consul ts wi th a GP. A 
significant difference was seen between the morbidly obese group and all other BMI 
groups in terms ofGP consults. The morbidl y obese group reported a median of22 v isits 
to a GP compared to obese (median 17), overweight (median 16) and normal weight 
(median I 7). A lthough, there were no significa nt di fferences across BM I categories and 
visits to a specialist doctor, the morbid ly obese group did report a higher median than the 
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other three BMI categories (median 9). In all cases, the relationship among BMI 
categories appear to be non-linear (i.e., the number of physician con ults does not 
increase linearly with increasing BMI category). The relationship appears to be j or u-
shaped. The nonnal weight group reported a higher median number of visits to a 
physician compared to the overweight group. The overweight group reported a fewer 
median number of visits compared to the obe e group. The obese group also reported a 
fewer number of median visits compared to the morbidly obese group (Figure 5.1 ). 
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Table 5.7 Actual Physician Health Services Utilization by Level of BMI 
BMI category Morbidly Obese Overweight Nor·mal 
Obese 
Total physician consults 13 1 388 4 1 817 
(n=2036) 
n (%) 127(97) 360(93) 783(93) 766(94) 
median [25th' 75th %]* 3 1 [ 14,52] 24[ 1 0,45] 2 1 [8,45] 24[1 0,48] 
GP consults 
n (%) 11 4(87) 3 I 2(80) 695(83) 7 17 (88) 
median [25th' 75th%]* 22 [ I 0,37] 17[7,29] 16[6 28] 17[7,2] 
Specialist con ults 
n (%) 12 1 (92) 33 1 (85) 7 13(85) 693(85) 
median [25th' 751h %] 9[5,2 1] 7[4,22] 6[4, 19] 7[4,20] 
Sample size varie based on number of valid M P numbers in each BMl category 
1BMI categorie : nonnal (18.5-24.9); overweight (25-29.9); obe e (30-34.9); morbid ly 
obese (2:.35.0) *p < .05 
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Figure 5. 1 Physician Uti lization (GP and speciali st) by Level of BM1 
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5.3.2 Descriptive Statistics: Hospital Separations 
Table 5.8 presents the descriptive statistics for hospital separations (e.g., in-
patient visits length of stay and surgical day care cases). A total of 547 (25%) 
re pondents with a valid MCP number had at least one overnight tay in ho pita! and a 
total of 551 (25%) had at least one surgical day care procedure over the five-year study 
period. For acute ho pitalizations, there were no difference between levels of BMI for 
length of stay per episode, median number of visits per patient or average RIW (resource-
intensity-weight for inpatient stay). For urgical day care there were no differences 
between levels of BMI for either the median number of day surgerie per patient or the 
average DPG _ W (i.e. the day procedure group re ource-inten ity-weight) per patient. 
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Table 5.8 Hospital Health Services Utilization by Level of BMI 
BMI category 1 Morbidly Obese Oven veight Normal 
Obese 
Acute hospitalizations 
n=547 53 102 191 201 
mean (SO) 2(2) 2(1) 2( I) 2(2) 
episode/patient 
median [251h,751h %] 1.0[1 ,2] 1.0 [1,2) 1.0[1 ,2] 1.0 [ 1,2] 
episode/patient 
median LOS2 
[25th' 75th%] 
per episode 4[ I, I 0] 3[ 1 ,7] 3[ l ,7] 3 [ 1 '7] 
mean RIW3 ±SD 1.60( 1.62) 1.43( 1.61) 1.93(3.26) 2.44(5.08) 
Surgical day care cases 
n=55 1 38 98 2 14 20 1 
median [251h, 75th%] 1 [I ,2] I [ l ,2] I [ I ,2] I [ 1 ,2] 
mean DPG w4 ± SD .26(.30) .78(1.52) .61 ( 1.29) .55(.930) 
Sample s ize varies based on number of valid MCP numbers in each BMI category 
1BMJ categories: nonnal (18.5-24.9); overweight (25-29.9); obe e (30-34.9); morbidly 
obese (2:35 .0); 2 LOS, length of stay; 3 RIW, resource intensity weight; 4 surgical day 
care cases (weight DPG_ W - available from February 2002) 
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5.4 Comparison of Self Reported and Actual Visits to a Physician 
Using student t-tests, the means were compared for self reported visits made to a 
' regular family doctor' and to 'another doctor' in the previous 12 months to the actual 
FFS physician visits made to both a GP and pecialist over a 12 month pe1iod. (A 
comparison of medians provided similar results). As the actual FFS data included five 
years of data, for comparison purposes the total sum ofFFS visit was divided by five for 
an annual average and these numbers were compared to the self reported data cove1ing a 
12 month period. A t-test comparing the means of self reported and actual GP visits was 
conducted eparately on each level of BMI (morbidly obese, obe e, overweight, normal 
weight) and within different geographical health regions. The results are presented for: I) 
the province as a whole, 2) the urban and rural geographical regions and 3) the four 
regional health board . These results are presented in Table 5.9 and Appendix E: Table 
3-4. 
At a provincial level , there were no ignificant differences found comparing self 
reported and actual visits to a GP across levels of BMI (Table 5.9). In addition similar 
results were found when comparing self reported and actual GP visits between the rural 
and urban region as well as within the pecific health board with th exception ofthe 
orthem Health Board. A significant difference was found betwe n the number of actual 
FFS GP visit and those self reported by the morbidly obese in the Northern Health 
Board. (Appendix E: Table 4d). Due to limited sample size the regression analysis 
conducted wa at a provincial level. 
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In contrast to the GP visits there were significant differences found between self 
reported and actual FFS visits when comparing visits made to a specialist. An evaluation 
of the types of data collected through both sources: self reported and actual demonstrated 
that the data were not directly comparable. For example the FFS actual data provides 
infom1ation on various types of speciali st services (e.g., office/home visits, in-patient 
consultation, out-patient and emergency consultation, diagnostic and therapeutic 
procedures, in-hospital diagnostic procedures, radiology and surgical procedures) and 
was not limited to visits per se. Office and home visits contributed only 15% of specialist 
visits. (Appendix E : Table 2). In comparison the type of specialist visit collected in the 
survey, the question is aimed at collecting infonnation on number of visits made to 
'another docto r' (other than the respondent's fami ly doctor) . This survey question would 
be unlikely to pick up infonnation on surgica l, diagnostic or therapeutic procedures. The 
linked database allows a greater capture of services provided by specialists although it 
must be noted that the data on salaried specia lists is missing. In general the average 
number of office visits to a specia li twas quite low across all BM I groups and within a ll 
geographies and the desc1iptive statistics demonstrated that there were no s ignificant 
di fferences across levels ofBMl (Tables 5.4, 5.7). This pattern observed was simi lar 
whether using the self reported data or the linked dataset. Therefore for analysis purpose 
it wa decided to stick with the larger dataset of actual data as it provided five years of 
data versus only one year of data coll ected in the s urvey. At this point there is no reason 
to believe that the pattern of service displayed would be any different fo r a laried 
physicians. 
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Table 5. 9 Comparison of Self Report (SR) and Actual Visits to a Physician by Level of BMI for GP 's and Specialist (SP) 
doctors within the province of L 
Morbidly Obese 
SR Actual 
n=114 
X (SD) X (SD) 
GP 5.29(4.92) 5.75(5.31) 
n= 121 
SP * .93(2.62) 3.42(3.81) 
*p<.05 for specialist only 
Obese 
SR Actual 
n=312 
X (SD) 
4.64(5.68) 
X (SD) 
4.14(3.84) 
n=330 
.99(2.75) 3.33(4.21) 
Overweight Normal 
SR Actual SR Actual 
n=693 n=717 
X (SD) X (SD X (SD) X (SD) 
4.09(5.58) 3.97(3.95) 4.05(6.11) 4.34(6.95) 
n=72 1 n=696 
.73(2.10) 3.22(5 .08) .74(1.86) 3.31 (5.03) 
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5.5 Poisson Prediction Models 
Five Poisson models were developed to detem1ine the predictive relationship 
between level of BMI as an independent variable and the various measures of health 
services utilization as dependent variables. The measures of health ervices utilization 
included : (i) the expected (mean) number of actual visits to a GP and/or specialist (ii) the 
expected (mean) number of visits as an in-patient (iii) the total number of nights spent in 
hospital and (iv) the number of surgical day care procedures. 
5.5.1 Poisson Estimates for Actual Measures of Health Sea·vices Utilization 
A summary of the Poisson models are presented in table 5.1 0 - 5.14 (complete 
models are pre ented in Appendix J, Models I a-1 c for GP utilization and Models 2a-2c 
for utilization of specialist services). For each dependent variable, three separate Poisson 
models were run to predict health services utilization. The model have been labeled (I), 
(2) and (3). Model (I) includes control variables and BMJ as a categorical variable· 
Model (2) includes control va1iables and the number of chronic conditions (CC) only; 
and Model (3) includes the control variables, the number of chronic conditions and BMI 
as a categ01ical variable. 
For each model, the parameter estimates, beta (~), standard errors (SE) and 
relevant level of significance were reported. The three model were run to detennine 
whether the number of chronic conditions acted as a mediator variable in the relationship 
between level of BMI and HSU. By ob erving the change in the~ value in the models (I) 
and (3), one is able to detennine if level of BM l for example is working through chronic 
comorbidity to affect HSU. If the~ values obtained in Model (I) for any ignificant 
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findings decreases in size when the mediating variable (i.e. , number of chronic 
conditions) is included, the mediating variable may be affecting the relationship. The 
number of chronic conditions was representative of general morbidity in this sample, or 
eed as de cribed in Anderson 's model of Health Services Utilization. -9 
5.5.1.1 Dependent Variable: Actual Number of Visits to a GP 
Poisson estimates for the relationship with the expected number of mean visit to 
a GP are presented in Table 5 .1 0. Model (I) shows that being morbidly obese was 
predictive of the expected number ofvisits to a GP (p<.OOI). Model (2) indicates the 
increasing number of chronic conditions was predictive of the expected number ofGP 
services and was highly significant (p<.OO I). These findings did not vary in Model (3). 
Being morbid ly obe e and the number of chronic conditions were both predictive of the 
expected mean number of GP visits (p<.OO I). The number of chronic condi tions partly 
mediates the relation hip between BMI and GP vi its as seen by the decrease in the p 
value from .4269 to .2935. 
5.5.1.2 Dependent Variable: Actual Number of Visits to a specialist 
Poisson estimates are presented for the predictive relationship between BM I and 
the expected mean numbers of actual visit to a specialist (Table 5. 11 ). In Model ( I), no 
significant relationship was found among BMI categories and the number of visits to a 
specialist. Model (2) indicates a po itive signifi cant relationship with number of chronic 
conditions and the expected mean number of visits to see a speciali t (p<.OO I). In Model 
(3) the findings remain unchanged. 
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5.5.1.3 Dependent Variable: Actual Number of Visits as an In-Patient 
Table 5.12 presents the Poisson estimates for the predictive relationship between 
BMI and the actual number of inpatient visits. The results of the full Poi son model are 
presented in Appendix K 3a-3c. Model ( I) demonstrates no significant relationship 
between BMI category and expected mean numbers of visits as an in-patient. However, 
the relationship illustrated by the model is a negative one for the overweight and obese 
variables. Being in the overweight and obe e groups compared to the nonnal weight 
group was predictive of fewer in-patient vi its. Being in the morbidl y obese group 
demonstrated a positive relationship with in-patient visits although it was not significant. 
Model (2) indicates a highly significant relationship between the number of chronic 
conditions predictive of the expected mean number of in-patient v isits. As the number of 
chronic conditions increase, the number of visits to hospital also increa es. In Model (3), 
the findings remain unchanged. 
154 
Table 5.1 0 Poisson Regression Estimates (P) and Standard Errors (SE); Dependent 
Variable Actual Number of Visits to a GP 1998-2003 
Model Levels of BMI Chronic Conditions Levels of BMI and 
BMI 
variables 
25-29.9 
30-34.9 
2: 35 
Risk 
variable 
#of 
chronic 
condition 
DF 
f3 
(1) 
SE 
.0623 .0569 
-.0036 .0691 
.4269*** .087 1 
1644 
f3 
(2) 
SE 
.2103*** .0124 
1644 
Chronic Conditions 
(3) 
f3 
.04674 
-.0580 
.2935*** 
.2065*** 
1644 
SE 
.053 1 
.0648 
.0820 
.0 125 
IO!Model I BMI only (2) Model 2- #of chronic condi tions only (3) Model3- Both 
BMI and# of chronic conditions, ***p<.OO l , **p<.O I, *p<.05 
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Table 5.1 1 Poisson Regression Estimate W) and Standard Errors (SE); Dependent 
Variable Actual Number of Visits to a specialist Doctor 1998-2003 
Model Levels of BMI Chronic Conditions BMI and Chronic 
Conditions 
(1) (2) (3) 
n SE n SE n SE 
BMI 
variables 
25-29.9 .0942 .0685 .0 39 .0643 
30-34.9 -.02 11 .0835 -.0975 .0788 
2: 35 .1857 .1 J 61 .0059 .1107 
Risk 
variable 
# of .22 7*** .0142 .23 13 *** .0144 
chronic 
condition 
D F 1644 1644 I 644 
I 0 1 Model I BMJ only (2) Model 2 - # of chronic conditions only (3) Model 3- Both 
BMI and # of chronic conditions, ***p<.OO I, **p<.Ol , *p<.05 
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Table 5. 12 Poi on Regression Estimates (p) and Standard Error (SE); Dependent 
Variable Actual Number ofVisits a an in-Patient 1998-2003 
Model Levels of BMI Chronic Conditions BMI and Chronic 
BMI 
variables 
25-29.9 
30-34.9 
2': 35 
Risk 
variable 
# of 
chronic 
condition 
DF 
-.0258 
-.1916 
.2573 
1644 
(1) 
SE 
.1020 
. 1272 
.1542 
(2) 
SE 
.2383*** .0226 
1644 
Conditions 
(3) 
6 SE 
-.044 1 
-.2353 
.1535 
.2379*** 
1644 
.0992 
. 1241 
.1509 
.0227 
(1) Model l BMI only (2) Model 2 -#of chronic conditions only (3) Model 3- Both BM I 
and # of chronic conditions, ***p<.OO I , **p<.O I , *p<.05 
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5.5.1.4 Dependent variable: Total Length of Stay in Hospital 
Poi son e timates are presented for the predictive relationship between BMI 
category and the sum of the total numbers of days spent in hospital (Table 5.13). The 
output from the full model is presented in Appendix K 4a- 4c. Model (I) indicates a 
significant negative relationship observed only between the obese group and the expected 
total length of stay spent in hospital (p<.OO I). Model (2) indicate a po itivc significant 
relationship between the number of chronic conditions and expected total length of stay 
spent in hospital (p<.OO 1 ). In Model (3) these findings remain unchanged; the number of 
chronic condition but not BMI wa a ignificant predictor of total LO . 
5.5.1.5 Dependent Variable: Number of Surgical Day Care Visits 
Poi one timates are presented for the predictive relation hip between BMI 
category and the number of surgical day visits (Table 5.14). The detail of the full output 
are presented in Appendix K 5a-5c. Model (I) indicates a po itivc ignificant relation hip 
between the overweight category and the number of surgical day care vi its. In Model (2) 
the number of chronic conditions was significantly associated with the expected number 
of day surgeries (p<.OO I). In Model (3), the c findings do not change; the o crweight 
category and the number of chronic condition were significant predictor of the number 
of surgical day care visit . 
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Table 5.13 Poisson Regression Estimates W) and Standard Errors (SE); Dependent 
Variable Total Length of Stay (LOS) in Hospital 1998-2003 
Model 
BMI 
variables 
25-29.9 
30-34.9 
2: 35 
Risk 
variable 
#of 
chronic 
conditions 
Levels of BMI 
(1) 
-.0203 
-.6299*** 
-.2053 
SE 
.11 24 
. 1546 
.1900 
Chronic Conditions 
(2) 
SE 
.30 18*** .0240 
BMI and Chronic 
Conditions 
(3) 
B 
-.1830 
-.6499*** 
-.2803 
.3059*** 
SE 
. 1090 
.1 496 
. 185 1 
.0243 
DF 1644 1644 1644 
I 0 1 Model 1 BMI only (2) Model 2- #of chronic condi tions only (3) Model 3- Both 
BMI and # of chronic conditions, ***p<.OO I , **p<.O I , *p<.05 
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Table 5.1 4 Pois on Regression Estimates (B) and Standard Error (SE) Dependent 
Variable: Actual Surgical Day Care Visits 1998-2003 
Model Levels of BMI Chronic Conditions BMI and Chronic 
Conditions 
(1) (2) (3) 
SE SE f3 SE 
BMI 
variables 
25-29.9 .2603* .1 054 .26 11 * .1036 
30-34.9 .2286 .1238 . 1800 .1 22 1 
2 35 .00 19 .2016 -.1508 .1991 
Risk 
variable 
# of .1935*** .0235 .1 977*** .0238 
chronic 
conditions 
DF 1644 1644 1644 
(I) Model 1 BMI on ly (2) Model 2 - # of chronic conditions only (3) Model 3- Both BM I 
and # of chronic conditions, ***p<.OO I, **p<.Ol, *p<.05 
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5.6 Direct Costs of Obesity 
The direct costs associated with health ervices utilization were estimated for both 
physician and ho pita) usage over a five-year period across BMI categories. To estimate 
FFS physician cost , the cost per individual visit was obtained through the linkage of the 
200012001 CCHS to the MCP physician claims database. SPSS wa used for the 
calculations. Inflation was not adjusted for in these analyses. 
Individual patient costs were summed over the five-year tudy period ( 1998-
2003). Average cost per BMI category wa calculated for each category of physician 
costs: (i) total physician costs, (ii) GP co ts and (iii) specialist costs. The equation is a 
follows for each category: 
Average Physician Cost1 = Total Cost BMII I n1 
where Average Physician Cost for each category of BMI (I = normal, 2= overweight, 3= 
obese 4 morbidly obe e) was calculated. The Total Cost for each category of BMI was 
divided by the number of individuals in each category in order to determine the Average 
Cost for an individual in a particular category of BMI. For example, to calculate the 
Average Cost over the five years per individual in the obese category, the sum ofTotal 
Costs associated with visits to both GP and pecialist physician for all individuals in the 
obese category wa calculated (i .e., 30 I ,6 0). The total was then divided by the number 
of individuals in the obese category (n = 360) to obtain an Average o t of physician 
service per obese individual of$360.00. For example 
Average Physician osl]= Total Cost ~BMI 3 I n 
Average Physician Co t3= 30 I ,680 I 360 = $838.00 
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To estimate hospital costs, the RIW's obtained through the linkage of the 2000/2001 
CCHS with the CDMS were summed over the five-year study period (1998-2003) for 
each individual. The total sum of individual RJW's were multiplied by the 2001 co t per 
weighted case or CPWC ($4512) obtained from the CII-II. The total costs were summed 
for each BMI category. Average Cost per in-patient hospitalization for each category of 
BMI (I = nonnal, 2= overweight, 3= obese, 4 morbidly obese) was then calculated by 
dividing the Total cost per BMI category by the number of individuals in each category. 
The equation is as follows for the estimating the hospital inpatient costs for the normal 
weight group: 
Average Hospital Cost 1 = Total Cost BM 1 1 I n 1 
where Total Cost1 = L RIW 1 X CPWC 
5.6.1 Descriptive Cost Analysis 
The top portion of Table 5.15 reports the summary of phy ician and hospital costs 
by BMl category. Differences were found across all BMI categories for total FFS 
physician costs (p < .05), costs ofGP services (p < .001) and cost of specialist services 
(p < .05). Aj or u-shaped relationship was observed across the BMI categories for all 
physician costs. The nom1al and morbidly obese groups demonstrated the highest 
average physician costs compared to the overweight and obe e f,JTO ups (Figure 5.2). 
Significant differences were seen aero s BMI categories and total hospital costs 
and hospital inpatient stays (Table 5.15). There were no differences aero s BMI 
categories for day care surgical co t . For total and in-patient hospital co ts, au-shaped 
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relationship was demonstrated. The cost data for surgical day care across BMI levels 
demonstrated an inverse j-shaped curve. The morbidly obese group and the normal 
weight group demonstrated the lowest average surgical day care costs (Figure 5.3). 
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Table 5.15 Summary of Average Five-Year (1 998-2003) Physician and Hospital Costs by 
BMI 
Physician costs in 
dollars2, mean (SD) 
Total* 
GP*** 
Specialist* 
Hospital cost in 
Dollar·s,3 mean (SD) 
Morbid 
(n=127) 
1105 ( 124 1) 
484 (502) 
621 (903) 
BMI category 
Obese Overweight 
(n=360) (n=783) 
838 ( 1145) 869 ( 1411) 
304 (344) 303 (362) 
533 (947) 566 ( 1248) 
Normal 
(n=766) 
940 ( 1512) 
355 (730) 
584 ( 1213) 
Total* 2747(5687) 18 14(50 11 ) 2247(8423) 2923( 12648) 
In-patient* 2702 (5666) 1615 ( 4576) 2096 (8 1 02) 2777 (12 455) 
Surgical day care 155 (620) 474 (2768) 310 (2 133) 242 ( 1503) 
1BMI categories: nom1al (1 8.5-24.0); overweight (25 .0-29.9); obese (30-34.9); morbidly 
obese (~35.0). 
2 Includes Fee-for-Service physicians only: all office, home, in-patient, out-patient, 
emergency con ultations and all diagnostic, therapeutic procedures, in-hospital radiology 
and surgical procedures. Costs based on the provincial government Medical Care Plan. 
3 Hospital costing based on RIW costing methodology developed by the Canadian 
Institute for Health Information (CIHI). 
4 Overall sample size was n=2177 which was divided based on BMI classification into the 
fol lowing categories: normal n=817; ove1weight n=84 1; obese n=388; morbid obese 
n= 13 1. 
*** p< .001 , ** p< .01 , * p< .05 
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Figure 5.3 Hospital in-patient o ts by Level of BMI 1998-2003 
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5.6.2 Multiple Regression Cost Estimates 
Multiple regre sion models were developed in order to detennine whether the 
level ofBM I was predictive of physician and or hospital costs. The cost data was not 
normally di ttibuted; therefore a natural log transformation wa performed producing a 
more nonnally distributed dataset.210 
Two co t models were developed. In th fir t model, the dependent variable was 
total physician co t . In the second model, the dependent variable wa total inpatient 
costs. The independent variables u d in these models were the level of BMI and the 
control variable found to be significant having run the Poisson regression model on 
HSU. These control vatiables included: age, gender, education, region of residence and 
smoking behavior. T he cost of day surgerie was not calculated due to the limited data 
on there ource-inten ity-weight variabl (DPG_ W) associated with urgical day care 
use. The DPG_ W variable had been coded less than a year at the time of the study. 
For each dependent variable, three separate Poisson model were run to predict 
the costs of health services utilization. The models were labeled (I), (2) and (3). Model 
(I) included control variables and BMI as a categorical variable. Model (2) included 
control va1iable and the number of chronic conditions and Mod I ( ) included the 
control variable , the number of chronic conditions and BMI a a categorical va1iable. 
Table 5.1 6 pre ents a summary of the resu lts for the dependent variable: total costs of 
FFS physician services (see Appendix L - Models 6a-6c for complete output). Adjusting 
for covariate , Model ( I) indicated a significant relationship between morbidly obese and 
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total cost of physician services (p< .05). The total variance in cost explained in this model 
was approximately 17% indicated by the adjusted R2 value of .1732. 
Model (2) indicated a highly significant relationship between the number of 
chronic conditions in the population and tota l physician costs (p<.OO I) . T he number of 
chronic conditions and the control va1iables ex pla ined 26% of the vari ance in to ta l 
physician co t (adju ted R2= .259). In Model (3), a lthough the morbidly obese category 
remained a significant predictor of tota l physician costs, its significance decrea eel 
(p<.O I) , shown by the change in the P from .4329 to .2827. The number of chronic 
conditions in the po pulation remained a highly ignificant predi cto r of to tal physician 
costs (p<.OO I). Model (3) suggests it is the number of chronic conditions that is 
predictive of total physician costs as the adju ted R2 value did not vary in this mode l 
Overall , the complete set of variables in the model demonstrated low predi ctability of 
total physician co ts. 
A summary of the multipl e regression estimates for total in-patient hospital co ts 
are presented in T able 5. 17 (Appendix L Model 7a-7c). Model ( I) indicated there was no 
predicti ve re lationship between BMI and to ta l in-patient costs. fn Model (2), although 
there was a s igni ficant relationship between the number of chronic conditions and 
inpatient cost (p<.OO I) , the explained vari ance was onl y 6% (adj usted R2 .0648). In 
Model (3), BM I was not a significant predictor of tota l in-patient cost but the number of 
chro ni c conditi ons remained significant (p<.OO I). The expla ined vari ance of Model (3) 
increased s lightl y to 7% (adj usted R2= .07 1 0). T he complete et of vari ables in this model 
demon trated very low predictability fo r to ta l in-patient costs. 
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Table 5.16 Multiple Regression Estimates (p) and Standard Errors (SE) Dependent 
Variable: Total Costs ofPhysician Service 1998-2003 
Model Levels of BMI Chronic BMI and Chronic 
(1) 
f3 
BMI 
variables 
25-29.9 .0437 
30-34.9 .0666 
2: 35 .4392** 
Risk 
variable 
# of 
CC's 
OF 1507 
R2 
.1 808 
Adjusted 
R2 
.1 732 
F- 23.76 
statistic 
SE t 
.0775 .564 
.0932 .7 15 
. 1397 3. 145 
Conditions 
(2) 
f3 SE t 
Conditions 
(3) 
f3 SE t 
.04 13 
-.00 15 
.2827* 
.0734 .563 
.0883 -.0 17 
.1327 2. 13 1 
.3029*** .0223 13.549 .2993*** .0225 13.323 
1509 
.2648 
.2590 
45.3 
1506 
.2672 
.2599 
36.6 1 
10 I Model I BMI only (2) Model 2- #of chronic conditions only (3) Model 3- Both 
BM! and # of chronic conditions, ***p<.OO l , **p<.O I, *p<.05 
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Table 5.17 Multiple Regression Estimates (p) and Standard Errors (SE) Dependent 
Variable: Total Costs for in-Patient Hospital Services 1998-2003 
Model Levels of BMI Chronic 
BMI 
variable 
s 
25-29.9 
30-34.9 
2: 35 
Risk 
variable 
(1) Conditions 
n 
.0114 
-.1989 
.1784 
SE t 
.0968 .117 
.1203 -.16.53 
.1505 1.185 
(2) 
SE t 
BMI and Chr·onic 
Conditions 
(3) 
.0001 
-.2270 
SE t 
.0945 .002 
.1176 -
1.93 
. 11 76 .1475 .797 
#of .1130*** .0241 4.698 .1 13 1 *** .0240 4.70 
CC's 
DF 429 431 428 
R2 
.0563 .0902 .1025 
Adjuste 
d R2 .0255 .0648 .07 10 
F- 1.826 3.559 3.258 
statistic 
I 01 Model 1 BMI only (2) Model 2- # of chronic conditions only (3) Model 3- both 
BM I and # of chronic conditions, ***p<.OOl , **p<.O I *p<.05 
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Chapter 6 Discussion and Conclusions 
This chapter discusses the key findings of the study and draws conclusions from 
the analysis and the findings. As well the strengths and limitation of the tudy design 
and recommendation for future research are presented. Policy implications and 
recommendation for the treatment and prevention of obesity are discu sed b1ief1 y. 
6.1 Summary of Key Findings 
In the health survey, 6% and 17% of the study sample were class ified as morbidl y 
obese and obese and 39% and 37% were cia ified as overweight and normal weight, 
respectively. Analy e of the prevalence of chronic disease reported by indi viduals 
suggest that a monotonic relationship ex i ts between increa ing level of BM I and the 
likelihood of having been diagnosed with some form of chronic eli ease. Of the 2 177 
linked survey re pondents, 94% had one or more visits with a physician, and 25% had 
either one ho pita! in-patient stay or one urgical day care visit o er the study period. T he 
morbidly obese group had a significantly higher median number of GP visits compared to 
other BMI categories. This fi nding was repeated in the estimation of the crude utilization 
rate of total phy ician visits across I vels of BMI, where the morbidly obese group 
demonstrated a igniftcantly higher projected utilization rate of total physician visits. The 
data on physician util ization and co ts illu trated a j - shaped cur across levels of BM I. 
The Poisson regression models demonstrated the morbid ly obc e group to be the only 
independent BM I category predi cting the expected mean number of vi it to a GP, having 
contro lled for the number of chronic conditions and other variabl . The predictive value 
of being morbidly obese decreased when the number of chronic condi tion wa added to 
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the model, however it did remain an independent significant predictor. The number of 
chronic conditions was a highly significant predictor of GP utilization in all three models, 
suggesting that level of morbidity defined as a Need variable in Anderson's Model of 
Health Services Utilization was the main predictor of physician utilization in th is 
analysis. 
Body mass index was not a predictor of any measure of hospital ization. However, 
the number of chronic conditions reported by individuals was a significant predictor of all 
measures of hospitalization. The obese category showed a significant negative 
relationship with LOS, demonstrating a j - shaped curve. Being overweight was a 
significant predictor of increased surgical day care visits. Interestingly, the relationship 
between the level of BMI and surgical day care visits was an inverse j or u-shaped 
relationship. One interpretation of this finding may be that surgical day care is uti lized 
more often by individuals considered to be at low risk for complications compared to 
those individuals at high risk. 
There were significant differences in the costs of physician ervices. The cost of 
treating morbidly obese individuals compared with nonnal weight individuals was 36% 
and 6% higher for GP and specialist healthcare services, respectively. Being morbidly 
obese was a significant predictor of total physician costs when the number of chron ic 
conditions and other variables were contro ll ed fo r in the multiple regre sion models. 
There were significant di fferences in the cost of in-patient hospital service , however the 
relationship was surprising. The cost of treating the normal weight category was 
significantl y higher than the other BMI categorie. The level ofBM I was not predictive 
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of in-patient costs when the number of chronic conditions and other variables were 
controlled for in the multiple regression models. 
6.1.1 The 2000/2001 Canadian Community Health Survey 
Compared to the nom1al weight group, analyzing a sociat ion between the 
categories of obesity, lifestyle and health status variables demonstrated individuals with a 
BMJ ::=:: 30 and BMT ::=:: 35 were more likely to be inactive and cons ume < 5 servings of 
fruits/vegetables per day (Table 5.2). These findings are cross-sectional in nature, and 
therefore it is difficult to ascertain whether it is the decrease in activity that has caused 
the current increa e in obesity or whether the increase in obesity has caused a decrea e in 
physical activity due to its association with comorbid conditions s uch as hypertension and 
type II diabetes. Some researchers support the theory a decrease in Energyour has caused 
the recent increase in body weight, 176•182•185-186 while others support the theory that the 
. . b . h b db . . E 178- 181 .M b"dl b mcrease 111 o esrty as een cause y an mcrease m nergyin. or 1 yo ese 
individuals were less likely to report incomes in the high income bracket. The obese 
group was more likely to report having secondary or < secondary education. Although 
not always consistent, some researchers have reported an inver e relationship between 
obesity and socioeconomic status which includes level of ed ucation, income and 
occupation.137•169•188 Morbid obesity, obesity and overweight individuals compared to 
normal weight individuals reported a higher prevalence of chronic disea es such as 
cerebro/cardiovascular di seases, hyperten ion, and endocrine disea es. The logistic 
regression models, controlling for age and ex, demonstrated a positive relationsh ip 
across increa ing levels ofBMI and the increasing likelihood of having been diagnosed 
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with several chronic diseases (Tables 5.3, 5.6). Other studies have indicated s imilar dose-
response relationships between obesity and coronary heart di sease, cardiovascular 
disease, hypertension and diabetes? ' ·94• 130 
6.1.2 Generalizability of Findings 
The analysi comparing self reported and actual GP visits at a provincial elvel 
reported no significant differences with the exception of the northem region where the 
self reported number of GP visits were significantly higher than the actual vis its obtained 
for the morbidly obese group only. However as the regression results hawed a 
significant predictive relationship between the morbidly obese and GP vi its, it was 
agreed that the potenti al missing data of some visits in this region did not pose a problem. 
There were ignificant differences between e lf reported and actual vi sits to a speciali t, 
however due to the small number of visits provided in the self reported data and that the 
utilization pattern were similar acros level of BMI and both datasets, the decision was 
made to use the actual data on speciali t visits in order to provide an increased number of 
outcomes. Approximately 62% of the pecialists in L were paid FFS in 2000 there is no 
known reason to believe the patterns reported in the current analysis aero s levels of BMI 
would be any different if data for visits to alaried specialists were included . It is 
uggested that the hape of the relation hip would be similar w ithout oth r evidence. 
6.1.3 Obesity and Actual Visits to a Primary Care Provider 
When compared to the normal weight, the overweight and obese groups, the 
morbidl y obese group demonstrated a significantly higher median number of both self 
reported and actual vi its to a GP (Table 5.4 and 5.7). Several tudies have uggested a 
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link between obesity defined as BMI 2: 30 and increased utilization of physician 
· 
38 72
-
73 M d. I d b . . I . . h I . services. · ost stu Ies ana yze o esity as an me us1ve category, Wit out ana yzmg 
the obese sub-groups. The number of GP visits stratified by BMI iII ustrated a j-shaped 
relationship. It has been suggested that overweight and obese individuals e pecially 
women are less likely to avail of preventive health services such as cervical sm ear and 
mammography. It may be that the nonnal weight groups avai I of these and other 
preventive health services such as a medical check-up more often than other BM I 
groups.72 The present study found morbid obesity controlling fo r known confounders 
such as age, gender, region of residence, smoking, level of education and physical 
activity was a significant predictor of objective GP services (Table 5. 1 0). Similar 
findings have been reported in other studi es; even tho ugh variable defini tions of obesi ty 
have been used. Given the well known associati on between excessive body weight and 
the increased likelihood of chronic diseases, it would seem logical that obese individuals 
with a high level of morbidity would demonstrate higher utilization of orne health care 
services. Most tudies identified in the li terature review used the current defi ni tion of 
obesity (BMI 2: 30 kg/m2) encompassing all sub-categories of obesity and do not for 
examp le separate out the other categori es of excessive overweight such as obesity clas 
(BMI 2: 30 kg/m2) , obesity class II(BMI 2: 35 kg/m2) and obesity class Ill (8M l 2: 40 
kg/m2).32-33·72-73 In contrast to the current study, another study controll ing for sex, 
smoking status, alcohol intake, household income, ethni c group, and education found no 
significant relationship between BMI and increased GP utilization.35 A potential 
explanation fo r thi s null fi nding may have been the small number of HSU outcome 
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measures available as questions on GP utilization were limited to a two week recall 
period compared with other studies that often u eel 12 month recall period . As well the 
age-range ofthe tudy sample was limit d from 50 to 69 years of age. In a study 
conducted in Germany including 2301 women between 25 and 74 years of age, the 
authors found no significant relationship between obese women (BMI 2: 30kg/m2) and 
total physician visits or hospitalizations.72 
Regres ion anal ysis demonstrated being morbidly obe e remained an independent 
predictor of GP utilization controlling for the presence of chroni c eli ease, a lthough it 
impact on the outcome was attenuated by the inclusion of the number of chronic disea e 
(Table 5.1 0). orne tucli es using regre ion analysis to study the relation hip between 
BMI and HSU choose not to control for obe ity associated comorbidite on the basis that 
these conditions lie on a causal pathway with HS U and thus controlling for them 
constitutes over adju tment.33.38•72 
6.1.4 Obesity and Hospitalization 
There w re no significant relation hips found between level of obesity and any of 
the mea ure of hospital utilization (Table 5. 1 I - 5. 14). Several tudi have reported 
s imilar finding 3 1-32.35·38 however other tudi reported fi nding in contrast to the 
present one.33-34•36•41 •45•73-74 In a large tudy (n=8762) author found the number of in-
patient days increased with each increasing BM I category.45 Controlling fo r age, race, 
insurance statu , marital status, education, family income, region, smoking behavior and 
drinking behavio r, ignificant relationship were al o found between obesity and the 
number of inpatient day .33 A large tudy (n=8754) found mi ld obesity defined as a BM I 
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2': 30 and moderate to severe obesity defined as a BMI 2': 35 to be related to a higher risk 
of hospitalization in individuals 65 to 75 years of age.34 A significant relationship was 
found between obe ity and increased in-patient days. Potential contributing factors were 
the large ample size (n= 17, 118) and the extended age range of 20 years of age and 
over.41 A tudy examined the likelihood of an overnight stay in ho pita! in the previou 
12 months and its associated LOS and it relationship with BMJ in a large national survey 
(n= 11 3 603) and was published in Canada in 2006. The authors reported that obesity 
d fined a BM1 2': 30, was associated with the increased likelihood of being an in-patient 
and was a significant predictor for mo t categories of LOS.46 Gi en the extensive 
literature published on obesity and its a ociated adverse health con cquences, it is 
urp1ising that this study as well as others did not find obesity to be a predictor of 
hospitalization. There are several possible explanations for thi tudy' null finding. 
Although the survey ample size for the current study was 2345 individuals, the sub 
group analy is based on the WHO BMI categories reduced th ample for the obese and 
morbidly obe e group to 407 and 141 , respectively. These smaller sample sizes combined 
with an outcome that wa relatively rare (i .e. , only 25% of the sample had expe1ienced 
any type of hospitalization visit) may have reduced the power of the study the chance of 
finding a ignifi cant result. The common methodological d ifference aero many of the e 
positive studies appears to be the large ample size allowing for an increased number of 
outcomes of interest such as hospitalizat ion to occur. As well many of the chronic 
condition that obe e people suffer from may not become acute or require ho pi tal care 
until the individuals are well into their 60' or older. This study analyzed health survey 
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data from individuals between the ages of20 and 64 years of age. Studying an older age 
group might allow for ascertainment of more outcome measures of interest. Also self 
reported BMI on its own may not be a valid measure of morbidity. Although BMI 
correlates highly with excess body fat, this measure provided no indication of the location 
of excess adiposity (e.g. , abdominal obesity) which researchers uggest is an important 
indicator of increased health risk and should be measured in conjunction with height and 
weights.70• 94 It may be that the null findings demonstrated by th analysis ofBMI and 
the use of hospital ervices were correct and obese individuals compared to other BMI 
categorie were no more likely to be user or be predictors ofho pita! ervices.212 
6.1.5 Obesity and Andersen's Model of Health Services Utilization 
There were no studies reviewed that used Andersen's model to guide, analyze or 
interpret the r lation hip between BMJ and health ervices utilization. The use of this 
model in the current thesis highlights an important finding that may have policy 
implications. Although the logistic regre ion analysis demon trated that increasing 
levels of BM I predisposed an individual to the increased likelihood of chronic illness, the 
Poisson regression analysis suggested that it was mainly the presence of chronic disea e 
on its own that increa ed the need for healthcare services as a Health Behavior, and with 
the exception of being morbidly obe e, the other levels of BMI did not in rease 
healthcare utilization directly. As are ult if the pertinent dtiver of use of health service 
is primarily the pre ence of chronic disease, it may be that health policy need to be 
directed firstly to the management, treatment and prevention of chr nic conditions in the 
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population and secondly to risk factors for the development of chronic disease such as 
excessive overweight, smoking and sedentary behaviors. 
6.1.6 Obesity and Direct Healthcare Costs 
Due to the increasing prevalence of obesity world-wide, numerous studies have 
been undertaken in order to capture obesity associated heal thcare costs. Most of these 
studies have used a COl methodology. As previously discussed in detail in Chapter 2, the 
COl prevalence-ba ed approach is the most common method for estimating costs or 
burden of illness. This approach uses the top-down method by calculating the Population 
Attributable Risk Fraction (P AF %). Most empirical studies have used this approach and 
reported the direct health care costs attributable to obesity representing approximately 
between 2% and 7% oftotal healthcare expenditures.33•36.4°-48•142 
Although COl estimates assist in determining medical research priorities, there 
are some key limitations associated with this approach: di fferent BMI cut-offs have been 
used to define obesity in different countries and the inclusion of different obesity-related 
medical conditions will impact on the calculated costs. 
Few studies using individual-level data linked to healthcare databases have 
estimated the impact of obesity on HSU.40-42•45 This type of analysis however, can 
provide useful information for healthcare providers. T he current study utilized individual-
level data to examine the relationship between BMI and d irect healthcare co ts for both 
physician and inpatient hospital costs. An advantage of using thi s approach is that 
specific factors known to have an impact on HSU such as age, gender and education can 
be controll ed for in the statistical analy i . 
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Health care costs are an extension of the utilization patterns and can serve as a 
proxy for HSU. The findings from the cost analy is in the current study are imilar to 
those on HSU. For example, utilization ofGP services and the a ociated costs for the 
morbidly obese group were much higher compared with the no rmal weight group, as co t 
is estimated by these two factors: utilization and the ervice cost. 
Overall the morbidly obese group had total physician costs that were 17% higher 
than tho e of the normal weight group. The morbidly obese group was associated with 
36% and 6% higher costs of GP and peciali t ervices, respectively (Table 5. 15). These 
finding ar similar to those in other studies reporting average increases in healthcare 
expenditure between 3 1% and 37% when comparing obese with normal weight groups, 
even though different data sets were examined and varying methodological approaches 
were utilized.41 •45•73 One author reported a large increase of 61 % in total healthcare 
expenditure when comparing obese and non obese patients. A potential explanation for 
the high cost of phy ician utilization may be due to the study ample. As compared to 
many studie using population health surveys to obtain information on healthcare 
utilization and costs, this author examined primary care co t associated with newly 
registered adult patients randoml y allocated to physicians. 8 One interesting finding wa 
that there were no di fferences in specialist vis it across BM I categories but there were 
s ignifi cant difference in costs. Being morbidly obese had ignificantly higher costs for 
specialist services (e.g., $62 1 ver us $583 for obese, $566 for overwe ight and $584 for 
normal weight). lt may be that morbidly obese individuals have a high r number of 
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chronic conditions and that their health needs are more complex and require more costly 
treatment? 1 
Morbid obesity remained a significant predictor of total physician costs adjusting 
for other contro l variables which is upported in the literature (Table 5. 16).72-73 Physician 
costs are directly linked to utilization of physicians, and therefore thi finding was 
expected. Consistent with the earlier findings on uti lization, morbid obesity remained an 
independent significant predictor for total physician costs controlling for known 
confounders and the number of chronic conditions (Table 5.16, Model 3). A imilar 
finding in another study reported that obe ity was significantly a ociated with increased 
primary care costs controlling for physical health as a proxy for comorbidity, age, 
education income, sex, smoking, drinking and mental health tatu .38 
There were no significant associations found between morbid obesity and total 
hospital costs, consistent with the findings on hospital utilization supported by other 
studies.40•42 A study on a large representative sample of the US population (n= 16,2 17) 
was conducted. The high BMI category defined as BMI >36 was not a ociated with 
increased total healthcare expenditures such as inpatient, outpatient and prescriptions 
costs.34 In contra t, two larger studie (n = 16,262, n= 33, 196), found significant 
relationship between obesity and increa ed overall healthcare expenditures contro lling 
for covmiates.2 17-2 18 
The results from this study were fairly consistent with previous studies and 
reinforce the credibility of the result , as many of the studies di cu sed were conduct din 
different healthcare ystems, with different conditions of acces and ervice. Many of the 
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prediction tudie suggest that the relationship between obesity and health services 
utilization and or associated costs are a function of treating obesity re lated medical 
condition and that BMI on its own is not an independent risk factor fo r measures of 
utilization. However, in the present study, morbid obesity remained an independent 
significant predictor of GP vis its and total physician costs, contro lling fo r known 
confounders and the number of chroni c conditions. It may be that morbidl y obese 
individual , even without having been diagnosed with chronic condition see themselves 
as unhealthy individuals and frequent the phy ician more frequently. It ha been 
suggested that the relationship observed between obesity and G P utilization i associated 
with di vergent patient health beli efs and help-seeking behavior or supplier induced 
demand. Either obe e patients believe they are at increased risk for health problems that 
may be prevented or attenuated by more frequent v isits to their primary care providers,38 
or physicians may be cognizant of the increased risk associated with obe ity and may 
request more fo llow-up appointments with di agno tic testing and monitoring. The 
increased utilization of GP services may occur in the absence of actua l health status 
differences between obese and non obe e gro ups. Thi s behavior may be motivated by 
perceived ri k for potential health problems by either the individual o r the physician. 
6.2 Conclusions 
T he main purpose of thi s study was to explore the relation hi p between BMI and 
its association with HS U and direct hcalthcare costs by examining the relationship 
between obe ity and the presence of chronic di sea es. Based on the data analysis and 
tudy fi ndings, the fo llowing conclusion have been reached. 
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The morbidly obe e and obese groups were significantly more likely to report 
having been diagnosed with a number of chronic diseases, prima1i ly those related to 
cerebra/cardiovascular diseases, hypertension and diabetes. Morbid obesity was an 
independent predictor of increased vi its to a GP, and with the addition of the number of 
chronic conditions attenuating the relationship, morbid obesity rem ained a ignificant 
independent predictor of this service. lncrea ing level of BMl was not found to be 
associated with any measure of hospital utilizat ion, although the relationship remained j-
shaped. Controlling for covariates and the number of chronic diseases, morbid obesity 
remained a ignificant independent predi ctor of total physician costs. Morbid obesity was 
not found to be a predi ctor of hospital costs. Overall it was interesting and surprising that 
the j-shaped relationship between BMI and HSU found in this s tudy was similar to the 
published j-shaped relationship found between BMI and increased ri sk of morbidi ty and 
mortality that has been extensively documented? ' The relation hip between BMI and 
morbidity and health ervices utilization appears to be non-linear in nature and does not 
fo llow the straight line dose-response relation hip that might be expected. Thi infers a 
more complex relationship between excess body fa t, health and utilization of health 
services. 
6.3 Strengths and Limitations 
T here are a number of strengths associated with this study design. The study 
sample is representative of the N L population at a provincial level. T he hea lth survey and 
admini trati ve databases provided a rich data et of variables that were u cd in the 
analysis of the relationships between obesity and health services utilization and 
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associated direct health care costs. As a result, variables known to have an impact on 
health services utilization such as age, gender and smoking were controlled for in 
statistical analysis and the impact ofBMI on health services utilization was explored 
independently. Due to the use of individual-level data, this study represents a more 
conect relationship between BMI and hea lth services utilization. The linkage of several 
datasets was conducted and objective health services utilization data were obtai ned. This 
allowed for more complex analyses of data over time and the ability to look at level of 
BMJ as a predictor of health services utilization. 
The study used individual-level data to estimate the direct costs of obesity. This 
approach allowed for the calculation of direct costs per patient and per individual level of 
BMI. This is in comparison to many of the published studies utili z ing the prevalence-
based COl approach. The utilization and costs of FFS physicians were assumed to be 
complete and accurate as this information is in a claims database and is used in the 
payment ofFFS physicians. In addition hospital costs were based on CII-Il ' s costing 
methodology using both resource-intensity-weights (i.e. , proxies statistically derived, 
using empirical data based on patient diagnosis or procedure, illness severity, co-
morbidity and age) and the cost per weighted case as per the CIH I published cost data 
and not an average cost per hospital day. 
There are several limitations associated with this study. The sample popul at ion 
was limited to those individuals between the ages of 20 to 64 years of age with a self 
reported BMI. As many of the chronic conditions associated with obesity are not 
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diagnosed until later in life, extending the age of the sample may have produced a 
different set of results. 
In addition, the power of the study may have been low for the study of hospital 
admissions as an outcome variable. While the eligible study sample size was 2345, the 
research design required the sample be categorized into levels of BMI. The numbers in 
the obese categ01ies were relative ly small. Using small numbers as ociat d with rare 
events (i.e. , hospital visits) may have resulted in low power. Although, the numbers in 
this study were large enough to run the re levant statistical tests, a larger sample may have 
increased the power of the study. There was a large survey of the adult NL population (n 
> I 0,000) conducted in 1995 examining HSU. These survey respondents provided 
consent for the use of their individual health insurance numbers in order to examine 
individual health utilization patterns until 1999. Obtaining pennission from these urvey 
respondents to examine HSU was not considered feasib le for the current research.2 12 
The use of cross-sectional survey data limits the ability to draw causal inferences 
about relationships. Analysis of the survey data is limited to a discussion of associations 
with obesity. In addition, the self reported health survey responses should be interpreted 
with caution, even though the response rate for the survey was approximately 84% . 
Selfrep01ied infom1ation often suffers from infonnation bias in tenns of recal l, social 
desirability and misclassification bias. Issues of recall bias may impact on survey 
responses, as many survey respondents do not always remember pa t behaviours or 
experiences accurately. Social desirability bias is providing responses the interviewer 
would like to hear. This bias relates to questions ptimarily on li festyle such as level of 
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physical activity, smoking, drinking habits, food intake and health status. Survey 
respondents often provide answers to these types of questions considered to be acceptable 
to society. In this study, BMI was calculated using self reported heights which may be 
overestimated and weights which are often underestimated, impacting on an individual' 
weight classification and may result in misclass ification of the BMI. It is generally agreed 
that this systematic bias may result in conservative study fi ndings. 
6.4 Future Research 
This was o ne of few studi es in Canada using individual-level data linked to 
longitudinal datasets to model the relationship between the level ofB MI, health services 
utilization and direct healthcare costs . It would be interesting to examine whether the 
findings in this study are similar to findings in alternative datasets in other provinces, or 
in healthcare systems such as in the UK and Australia. This population sample may serve 
as a baseline for a longitudinal study on future health serv ices utilization patterns and 
costs, as well as on mortality rates and causes of death . 
In this study 95% of individuals visited a physician annually, however onl y 25% 
of individuals had any type of hospitalizati on. To study ho pital utilization as an 
outcome, either a larger population sample or a longer time period are needed to ensure 
adequate power of the study. 
There is a high level of morbidity associated with obesity in the NL population. 
As indicated by the published COl li terature, the indirect health care costs associated with 
obesity are considerable. It would be beneficial in a future study to include indirect costs 
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for example loss of productivity, work days lost and intangible costs to the individual 
such as the impact on social status, self-esteem, income and educational attainment. 
The current study did not include drug utilization or cost of medications 
associated with obesity. Many of the studies have reviewed thi s relationship. These 
studies analyzed levels ofBMI and drug utilization patterns often concluding that obese 
individuals when compared to nonnal weight groups were more likely to be presc1ibed 
medications such as anti-hypertensive and cholesterol lowering drugs. With the 
development of the Phannacy Network in NL, a future study exploring this relationship 
will soon be possible. Finally as the results of the present study demonstrated, a non-
linear relationship existed between level of BMI and many measures of health services 
utilization illustrated by the j or u-shaped curve. More research is needed to better 
understand the complex relationship between excess body fat, increased health risk and 
its association with health services utili zation. 
6.5 Policy Implications 
In thi s section, the policy implications will be briefly discussed from the 
perspectives of the obese individual using the healthcare system and from a public health 
prevention approach. In the cun·ent study increasing BMI was associated with increasing 
prevalence of chronic disease. Interventio ns focu ed on the treatment, management and 
prevention of chronic disease or obesity as a risk factor are very similar in nature with 
interventions aimed at targeting high risk individuals and implementing population health 
approaches.2 The prevalence of chronic diseases in particular tho c related to 
cardiovascular illness, diabetes, cancers and respiratory disea es are increasing in both 
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developed and under developed countries and are being described by some as the 
' world ' s next tidal wave' or ' tsunami ' due to the numbers being affected and the 
devastating impact on quality of life, morbidity and mortality? 19 As discussed in Chapter 
I, the main risk factors for the development of chronic diseases include high blood 
pressure, high cholesterol, excessive overweight or obesity, low fruit and vegetable 
intake, physical inactivity and tobacco use.2 The focus of the current study has been on 
excessive overweight as a risk factor for chronic disea e and increased health services 
utilization and therefore the policy interventions will focus on the cuiTent study findings. 
In the cuiTent study, the morbidl y obese group represented 6% of the population 
studied and when compared to other BMI categori es were more likely to utili ze G P 
services. The morbidly obese group demonstrated significantly higher total physic ian 
costs when compared to the other BMI categories and remained a s ignificant predictor of 
both GP visits and total physician costs in multivariate models controlling for covariates 
including the number of chronic diseases. Although the morbidl y obese were more likely 
to utilize certain servi ces, this group represented only 6% of the population studied. 
Therefore, it might appear to be a minimal threat to the current healthcare ystem in tenns 
of overall use and cost. Interpretation of these findings should be exercised with caution 
due to the short follow-up time for the ex ploration of some study outcomes and the 
emerging epidemic of childhood obesity. Although the long-tenn effects of excess body 
weight have not been examined in the current study, this population may serve as a 
baseline for future longitudinal studies on health services utilization and associated costs. 
One challenge to this approach may be that health services utilizati on of high risk 
188 
populations may change over time if diagnosed and targeted with more intensive 
treatment due to increased awareness by physicians and or other health professionals or if 
public efforts are successful in promoting healthy body weights. 
6.5.1 Individual-Based Approach 
Based on the current study's finding concerted therapeutic efforts may be focused 
on the morbidly obese group, the BMI category found to be associated with increased 
utilization and costs in the healthcare system. Traditionally, efforts have been made by 
health professionals to reduce a patient's excess body weight associated comorbidities. 
Efforts have included: phannacologic, reduced calorie diets, surgery for the xcessivcly 
obese and psychotherapy, as well a behavioral therapy in an attempt to change lifestyle 
habits. The management of obesity from a health professional ' s point ofview has been to 
manage the associated chronic diseases such as hypertension, diabetes or high 
cholesterol. Very recently, in Canada clinical practice guidelines were published on the 
management and prevention of obesity in adults and children. These guidelines are based 
on the most up-to-date evidence of treating and managing obesity.::!~o Using these 
guidelines, an example of an individual strategy to address the treatment and 
management of obesity is discussed. 
6.5.1.1 Individual-Based Intervention 
In 2007, the Canadian Medical Association Journal published a supplement on 
Canadian clinical practice guidelines related to the management and prevention of 
obesity in adults and children.220The supplement is the summary of a detailed report 
written by a panel of experts convened by Obesity Canada, a non-for-profit organization 
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founded in 1999 to improve the health of Canadians by decreasing the occurrence of 
obesity. This rep01i highlights the management and treatment options available for 
overweight and or obese adults ba ed on the most recent peer-reviewed evidence fo r 
lifestyle modifications, available pharmacotherapy and surgery options. This rep01i 
identifies an algorithm for the assessment and stepwise management of an overweight or 
obese adult. The treatment options for an individual with a BMI 2: 35kglm 2 recommended 
for application by a health professional are presented below. If the health professional 
(often the primary care physician) is concerned that a patient is obese or at risk for 
obesity-related diseases, the following should be conducted. The BMI and waist 
circumference should be measured and if either is greater than the recommended cut-
points, clinical and laboratory investigations should be conducted in order to assess 
comorbidities (e.g., blood pressure, heati rate, fasting glucose, lipid profile). Following 
the clinical assessment the patient should be screened for depression, eating and or mood 
disorders. While comorbidties, should be treated according to normal standards of care, 
the patient should be assessed for readiness to change li festyle behaviors.:!20 
According to the algotithm, the next step for the ptimary healthcare provider is to 
help establish goals and a lifestyle modification program for weight loss with the advice 
and consultation of several health professionals. In order to achieve thi s, the clinical 
practi ce guidelines suggest it is valuable to have a ' Health Team ' develop and advi se the 
patient on a lifestyl e modification program to include components on nutrition intake, 
physical activity and participating in cogni tive-behavior therapy. Thi approach requi res 
input from a multidisciplinary team of health professionals including a GP and or 
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specialist, nutrition health professional , exercise health professional, clinical 
psychologist, and long-term monitoring as is the case for many chronic diseases such as 
type II diabetes. During follow-up period, an on-going evaluation hould take place to 
detennine progress. If satisfactory progress is being accomplished then monitoring 
continues, and if progress is not successful then other options such as the introduction of 
phannacotherapy and or bariattic surgery may be discussed. 
6.5.1.2 Challenges and Opportunities to the Individual-Based Approach 
One challenge to the individual-based approach is that it is labour intensive 
requiring input from many healthcare professionals. According to the new clinical 
practice guidelines a second challenge to this approach is the requirement of increased 
collaboration between disciplines and the need to establish a Health Team of 
multidisciplinary professionals in order to deliver the services recommended. Although 
the province ofNL does not have a multidisciplinary approach to the treatment and 
management of adult obesity, the pediatric hospital in St.John's,NL has established an 
Obesity Lifestyle multidisciplinary clinic. The recommended management and treatment 
options may be as ociated with increased costs in the short-tenn due to the resources 
required (e.g., human, physical , financial). The hope is however, that in the long-tenn 
this approach will be more cost-effective and the health of the individuals will improve a 
the health effects of comorbidities are treated, managed and potentially minimized. 
Geography may present another challenge as many rural areas have a high prevalence of 
obesity and a limited number of health professionals providing continuity of care. In 
areas where the service density is low it may be difficult to deliver the multidisciplinary 
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approach. In the case of the Northern region of this province where there is an increased 
likelihood of being obese for example the availability and access to a range of health 
professionals is limited. The strength of these new guidelines and the individual-based 
approach is that they provide health professionals with a long-awaited management plan 
for obese patients that are evidence-based. In addition, the establishment of the new 
primary healthcare renewal satellite practices in certain areas of the province may help to 
supp011 this approach. These satellite sites offer a new and exciting approach to 
healthcare delivery in thi s province. The mix ofhealth professionals working in these 
sites aim to strengthen the balance of services promoting health, preventing illness and 
injury, and diagnosing and treat episodic and chronic illness. This advance emphasizes a 
team-based, interdisciplinary approach providing health services where physicians work 
closely with other physicians and health care professionals both locally and provincially. 
This fairly recent development is one that would complement the individual-based 
approach to obesity treatment and management using the new practice guidel ines. 
6.5.2 Evolution of the Problem 
Data suggests that adult obesity rates in NL are increasing and according to the 
cuJTent study a large ' pre-disease population ' exists (i.e., 39% of adults are overweight). 
Based on the tracking of obesity over the life cycle, this pre-disease popu lat ion is more 
likely to gain weight over time. ln addition, in children of very young ages obesity is an 
emerging health problem as 25% of preschool children were classified either as being 
overweight or obese in this province. 165 Individuals will be exposed to the negative heal th 
effects of obesity over a longer portion of their li fetime compared with those adults who 
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are now obese. As a result, the adverse health consequ ences such as adult onset diabetes 
may appear earl ier, for example in obese children. 
6.5.2.1 Population Health Approach 
Due to the large percentage of individuals classified as obese (i.e., 23%), and the 
large percentage classified as overweight (i.e., 39%), it is important to strengthen the 
focus of policy and resource allocation decisions on population disease prevention and 
health promotion. This approach is appropriate not only because of the large number of 
individuals affected by excessive weight in the population, but because there is a general 
consensus among researchers that increasing body weight has been largely influenced by 
environmental change. Changing environments (social, behavioral, cultural, community) 
have resulted in an imbalance of energy intake and energy expenditure. Findings from the 
current study found individuals across all levels of BMl reported what behaviors that my 
considered ' unhealthy' . For example, 55% of total survey respondents reported being 
inactive and over 66% reported infrequent consumption of fruits and vegetables. The 
obese groups reported these behaviors more often. 
A synthesis paper published by the Cll-11 concluded that obe ity was a multi-
factorial problem. Many factors are a ociated with and predict obesity including 
individual li festyle choices, community structure, societal values and public policy.221 
The authors of the report suggested that policy makers in collaboration with stakeholders 
must identify and implement programs and policies that target different levels of 
environmental influence (e.g., local , community, global) in order to have an effective 
impact on the population prevalence of obesity. Examples of intervention eff01is 
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designed to have an impact on these levels of influence include; introducing mandatory 
physical education classes and healthy food choices in schools, providing infrastructure 
for bike lanes, safe places to walk, recreation areas and partnering with food 
manufacturers to ensure food products low in fat, sugar and salt are avail able at 
affordable ptices. 
This holistic environmental approach to obesity prevention has been suggested in 
various reports.222-224 One report published in 2001 provided a strategic plan on how to 
decrease obesity in the population. This report included a diagram illustrating the 
different factors influencing the prevalence of obesity by acting on the individual and the 
population as well as the interactions between the two. There factors can be classified as: 
International (e.g., globalization of markets, development), National (e.g. , urbanization, 
transpOii, education), Community (public safety, healthcare), Work/Home (leisure 
activities, family and home). These factors impact the individual at the most basic level, 
that of energy expenditure and energy intake. This comprehensive diagram is referred to 
as the Causal Web of social influences on obesity prevalence and may provide guidance 
to policy makers in the development of a population public health approach to obesity 
. 222 prevention. 
6.5.2.2 Population Health Intervention 
To provide an evidence-base for the public health approach, the Canadian 
Population Health Initi ative recently published a review of the literature on overweight 
and obesity in Canada from a population health perspecti ve focus ing on successful 
population health interventions.221 The authors concluded that interventions at the 
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population level can be successful ifthere is an integrated, multi-level coordinated 
approach to policy by stakeholders and policy actors (e.g., government, health 
professionals, national organizatio ns, community groups and the public). A range of 
complementary actions such as healthy school policies, work-site exercise facili ties and 
buy-in by food manufacturers are recommended for individuals, group , communities, 
institutions and public policy. The rep01t suggested that for obesity prevention effotts to 
be both successful and sustainable it is mandatory to have political buy-in or politi cal will 
as this will ensure the commitment of dedicated resources (e.g. , time, money and staff) 
and aid in the implementation of populati on-based interventions. As well new policies 
and programs must be integrated into ex isting structures and frameworks to ensure long-
term sustainability. 
In NL in 2001 , the government initiated a population health approach to 
improving the health status ofNewfoundlanders and it was conveyed in its Strategic 
Health Plan. Included in the plan was a focus on obesity prevention. The strategic health 
plan identified three main goals fo r NL's health and community services system, as well 
as objectives and targets within each goal. The directions set out under each of the three 
goals addresses the challenges NL is facing and ai ms to work toward the best possible 
solutions. Goals number one and two are aimed at increasing the health status of the 
population. Goal number one is to : improve the Health Status of the Population 
ofNL and includes specifi c objectives to; increase healthy behav iors, improve health 
outcomes and reduce negative impacts of selected diseases and improve hea lthy growth 
and development for children and youth. Goal num ber two is to improve the capacity of 
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communities to support health and well-being. its objectives include: develop and 
enhance community patinerships and resources that focus on health and well-being; 
enhance individual and family participation in community groups and organizations 
which enable them to make healthy decisions. 
Other policy options include sin taxes on energy dense foods, fast foods high in 
fat or foods considered to have low nutrient value. These taxes have been used in an 
effort to decrease smoking and were relatively easy to implement. In addition the health 
effects of smoking on both individuals and those exposed to smoke are well evidenced. 
The causes of obesity are complex and not well understood. It is felt these types of 
policies arc unlikely to be feasible for obesity prevention. 
6.5.2.3 Challenges and Opportunities to the Public Health Approach 
Challenges associated with a public health approach include: obtai ning buy-in from 
stakeholders in both the public and private industries and developing a long-tenn vision 
for better health that may include altering social s tructures such as neighborhood design, 
changing school policies, and targeting individual behaviors especiall y those around 
energy intake and expenditure. 
There are many oppotiunities emerging supporting the public heal th approach to 
obesity prevention. There is evidence that other coll aborati ve public heal th interventions 
may have been successful in educating the public on the risks of these behaviors, 
changing individual and societal behaviors and decreasing negative health effects. Two 
public health efforts incl ude interventions directed towards: decreasing smoking behavior 
and educating the public on HIV/AJDS. These successes demonstrate that popula tion 
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health interventions work, but may take time and will require the commitment of many. 
It is recognized that these health issues differ in many ways from the obesity epidemic 
being experienced by most western countries today, however there may be similarities 
and lessons to be learned from these initiatives. 
197 
-----------------------------------------------
References 
1. OECD data 2005, copyright. Canadian Institute for Health Infonnation. 
Available at http://secure.cihi.ca/cihiweb/en/media 13nov2007 tab2 ehtml 
(accessed 22 April 2008) 
2. World Health Organization Global Report (2005). Preventing Chronic Di eases: 
a vital investment. Geneva, World Health Organization 
3. National Health Expenditure Database (NHEX) (database online). Health 
Expenditure by use of Funds, by Source of Finance, by Province/Territory and 
Canada: Canadian Institute for Health Information. A vai I able at 
http://secure.cihi.ca/cihiweb/en/media_13nov2007 _ tab2 _ e.html. (Accessed 22 
April 2008) 
4. Health Canada, Economic Burden ofl llness 1998 Available at htt ://www. hac-
aspc.gc.ca/publicat/ebic-femc98/pdf/ebic 1998.pdf (Accessed on 22 April 2008) 
5. Jefferson T. Elementary Economic Evaluation in Health Care. BMJ Publishing 
Group, BMA House, 1996 London 
6. The Public Health Agency of Canada, Available at http: //www.phac-
aspc.gc.ca/publicat/cdic-mcc/27-4/pdf/cdic274-l e.pdf (Accessed on 28 April 
2008) 
7. Andersen J. Health Services Utilization: Framework and Review. Health Serv 
Res 1973;184 - 99 
8. Andersen R, Newman J. Societal and Individual Determinants of Medical Care 
Uti lization in the United States. Milbank Mem Fund Q Health Soc 
1973 ;51 ( I ):95-124 
9. Andersen R. Revisiting the behavioral model and access to medical care does it 
matter? J Health Soc Behav 1995;36 (1 ): 1-10 
I 0. Andersen R, Harada N , Chiu Vet al. Application of the Behavioral Model to 
Health Studies of Asian and Pacific Islander Americans. Asian Am Pac lsi J 
Health 1995;3(2): 129-41 
II. Gel berg L, Gallagher T, Andersen Ret al. Competing Priorities as a Banier to 
Medical Care Among Homeless Adults in Los Angeles Am J Public flealth, 
1997;87(2):2 I 7-20 
198 
12. Andersen R, Davidson P (eds.) Ethnicity, Aging and Oral Heal th Outcomes: 
Findings from the JCS-ll USA Research Locations, Adv Dent es 1997;11(2): 199-
303 
13. Chen M , Andersen R, Barnes D et al. Comparing Oral Health are System 
1997 Geneva: World Health Organization 
14. Gelberg L, Andersen R, Leake B Applying the Behavioral Model to Vulnerable 
Populations. Health Serv Res, 2000;34(6): 1273-302 
15. Andersen R, Bozzette S, Shapiro Metal. Access of Vulnerab le Groups to 
Antiretroviral Therapy Among Per ons in Care for - HIV Disease in the U.S. 
Health Serv Res 2000;35(2):389-4 16 
16. WHO, Global Strategy on Diet, Phy ical Activity and Health, 
(http://www.who.int/dietphysicalactivity/media/en/gsfs chronic di case.pdf) 
17. World Health Organization ( 1998). Obe ity. Preventing and managing the global 
epidemic. International Obesity Task Force. Geneva, World Health Organization 
18. Oxford Engli sh Dictionary 2 11d ed. Oxford: Oxford University Press; 2007 
19. Online Medical dictionary. Available from http://www.on li nc-medical-
dictionary.org/omd.asp?q=Obc ity 
20. Garrow J. Quetelet' index as a measure of fatness. fnt J Obe 1985;9 : 147-53 
21. World Health Organization (2000). WHO Technical Report eric no.894. 
Obesity: Preventing and managing the global epidemic. Geneva: World Health 
Organi zation 
22. Calle E, Thun M, Petrelli J et al. Body mass index and mortality in a prospective 
cohort of U.S. adults. N Eng! J Med 1999;341( 15): 1097- 105 
23. Fontaine K, Redden D, Wang C ct al. Years of life lost due to obc ity. lAMA 
2003;289(2): 187-93 
24. Sturm R. The effects of obe ity, smoking and drinking on medical problems and 
costs. Health Aj( 2002;21 :245-54 
25. Katzmarzyk P. The Canad ian obesity epidemic 1985- 1998. CMAJ 
2002; 166(8): I 039-40 
199 
--------------- ---
26. Health Statistics Division, Health Reports, Statistics Canada, 1994/1995 
National Population Health Survey [Ottawa] , Statistics Canada 
27. Health Statistics Division, Health Reports, Statistics Canada, 2005. Health 
Indicators: The Canadian Community Health Survey 2005 [Ottawa], Health 
Statistics Division, Health Reports, Statistics Canada 
28. Canadian Institute for Health Information, National Health Expenditure Trends. 
1975-2006 (Ottawa: CIHI, 2006) 
29. Seidell J , Deerenberg I. Obesity in Europe-prevalence and consequences for the 
use of medical care. Pharmacoeconomics 1994;5(Suppl. I ):38-44 
30. Sansone R, Sansone L, Wiedem1an M. The relationship between obesity and 
medical utilization among women in a primary care setti ng. Jnt J Eat Disord 
1998;23:161-67 
31. Trakas K, Lawrence K, ShearN. Utilization of health care resources by obese 
Canadians. CMAJ 1999;160(1 0): 1457-62 
32. Reidpath D, Crawford D, Tilgner Let al. Relationship between body mass index 
and the use of healthcare services in Australia. Obes Res 2002; l 0:526-31 
33. Guayar-Castillon P, Lopez G, Palacios Let al. The relationship of overweight 
and obesity with subjective health and use of health-care services among 
Spanish Women. Jnt JObes 2002;26:247-52 
34. Luchsinger J, Lee W, Can·asquillo 0 et al. Body mass index and hospitalization 
in the elderly. JAm Geriatr Soc 2003;51: 1615-20 
35. Popoola F, Increase in obesity and health-care use, from the Health Survey for 
England, Ages 50-69,1998 Obes Surg 2004;14: 1258-62 
36. Zizza C, Herring A, Stevens J et al. Length of hospital stay among obese 
individuals. Am J Public Health 2004;94(9): 1587-91 
37. Centre for Health Infonnation. Obese are three times as likely to need a hip or 
knee replacement. In: 2005 CJRR Report: Total Hip and total Knee 
Replacements in Canada 
Http://secure.cihi.calcihiweb/di spPage,j sp?cw page=mcdia 17aug2005 e 
Accessed on October 18111,2005 
200 
38. Bertakis K, Azari R. Obesity and the use of health care services. Obes Res 
2005; 13(2):3 72-79 
39. Levy E, Levy P, Le Pen C et al. The economic cost of obesity: the French 
situation. Jnt JObes Relat Metab Disord 1995;19:788-92 
40. HeithoffK, Cuffe) B, Kennedy Setal. The association betw en body mass 
index and health care expenditures. Clinical Therapy 1997;19:8 11-20 
41. Quesenbury C Jr, Caan B, Jacobson A. Obesity, health services use, and health 
care costs among members of a health maintenance organization. Arch Intern 
Med 1998;158:466-72 
42. Thompson 0 , Brown J, Nichol G, Elmer P, Oster G. Body mas index and 
future healthcare costs: A retrospective cohort study. Obes Res 200 I ;9:2 1 0-18 
43. Finkel tein E, Fiebelkorn I, Wang G. National medical spending attributable to 
overweight and obesity: how much and who's paying? Health Ajf2003;(Suppl 
W3):2 19-26 
44. Raebel M, Malone D, Conner D et al. Health services use and health care cost 
of obe e and non obese individuals. Arch Inter Med 2004; 164:2 135-40 
45. Andreyeva T, turm R, Ringel J . Moderate and severe obe ity have large 
difference in health care costs. Obes Res 2004;12(12): 1936-43 
46. Birmingham C, Muller J. Palepu A et al. The cost of obesity in anada. CMAJ 
1999;164(4):483-88 
47. Katzmarzyk P, Janssen I. The economic costs associated with physical inactivity 
and obe ity in Canada: an update. Can J Appl Physio/2004;29( I ):90-115 
48. Colditz G. Economic Costs of obesity. Am J Clin Nutr 1992;55(2 Supp 1):503S-
507S 
49. Wolf A, Colditz G.The cost of obe ity: the US perspective. Pharmacoeconomics 
1994;5 :34-7 
50. Wolf A, Colditz G. Cunent estimates ofthe economic costs of obesity in the 
United States. Obes Res 1998;6:97- 1 06 
51. Colditz G. Economic Costs of obesity and inactivity. Med Sci Sport Exerc 
1999;31 : 663-S667 
20 1 
52. Siedell J . The impact of obesity on health status: some implications for health 
care costs.lnt JObes 1996;19(Suppl 6):S 13-S 16 
53. Allison D, Zannolli R, Narayan K. The direct health care costs of obesity in the 
United States. Am J Public Health 1999;89: 1194-99 
54. Hakkinen U. The production of health and the demand for health care in 
Finland. Soc Sci Med 1991 ;33:225-37 
55 . Hodgon T, Meiners M. Cost-of-illness methodology: a guide to cuJTent practices 
and procedures. Milbank Mem Fund Q 1 982:60;429-62 
56. Segal L, Carter R, Zimmet P. The cost of obesity. The Australian perspective. 
Pharmacoeconomics 1994;5(suppl I ):45-52 
57. Swinbum B, Ashton T. Gillespie J et a!. Health care costs of obesi ty in New 
Zealand. Jnt JObes Rela Metab Disord 1997:21:89 1-96 
58. Burnette D, Mui A. Physician utilization by Hispan ic elderly persons, National 
perspective. Med Care 1 999;37(4):362-74 
59. Epstein A, Cumella E. Capitation payment using predictors of medical 
utilization to adjust rates. Health Care Finane Rev 1988;1 0( I ):51-69 
60. Hulka B, Wheat J. Patterns of utilization, the patient per pective. Med Care 
1985; 23(5):43 8-60 
61. Starrett R, Rogers D, Walters G. Home health care utilization: a causal model. 
Home Health Care Serv Q 1988;9(4): 125-40 
62. Ward R. Services for older people: an integrated framework for research. J 
Health Soc Behav 1977;18:6 1-70 
63. Finlayson M . DalMonte J. Predi cting the use of occupational therapy services 
among people with multiple sclerosis in Atlantic Canada. Can J Occup Ther 
2002;69( 4):239-48 
64. Parboosing E, Larsen D. Factors influencing freq uency and appropriateness of 
utilization of the emergency room by the elderly. Med Care 1987;25( 12): 11 39-
47 
202 
65. Aday LA, Andersen R. A framework for the study of access to medical care. 
Hlth Serv Res 1974;9(3):208-20 
66. Bradley E, McGraw S, Cury Let al. Expanding the Andersen model: the role of 
psychosocial factors in long-tenn care use. Hlth Serv Res 2002;37(5): 1221-42 
67. McWhinney I. Beyond diagnosis - an approach to the integration of behavioral 
science and clinical medicine. NEJM 1972;287:384-87 
68. Fontaine K, Faith M, Allison D et al. Body weight and health care among 
women in the general population. Arch Fam Med 1998; 7:381-84 
69. Ostbye T , Taylor D, Jung S. A Longitudinal study of the effects of tobacco, 
smoking and other modifiable risk factors on ill-health in middle-aged and old 
Ame1icans:Results from the Health and Retirement Study and Asset and Health 
Dynamics among the Oldest Old Survey. Prev Med 2002;34:334- 45 
70. Leon-Munoz L,Garcia E, Ranegas J et al. Relationship of BMI, waist 
circumference,and weight change with use of health services by older adults. 
Obes Res 2005;13(8): 1398-1404 
7 1. von Lengerke T, Happich M, Reitmeir Petal. Utilization of out and inpatient 
health services by obese adults : a population based study in the Augsburg 
region, Germany. Gesun.dheitswesen 2005;67( 1 ):S 150-S 157 
72. Meisinger C, Heier M, Lowe] H. The relationship between body weight and 
health care among German women. Obes Res 2004;12(9): 1473-80 
73. van Dijk L, otters H, Schuit A. Moderately overweight and obese patients in 
general practice:a population based survey. BMC Fam Pract 2006;7(43) 
74. Peytremann-Bridevaux l,Santos-Eggimann B. Healthcare utilization of 
overweight and obese Europeans aged 50-79 years. J Public Heal/ h 
2007;15:377-84 
75. Hart C, Hole J, Lawlor D et al. Obesity and use of acute hospital services in 
participants of the Renfrew/Paisley study. J Public Health 2006;29( I ):53-66 
76. Counterweight Project Team. Obesity impacts on general practice appointments. 
Obes Res 2005;13(8): 1442-49 
77. Chen Y, Jiang Y, Mao Y. Hospital admissions associated with body mass index 
in Canadian adults. lnt Journal of Obesity 2006;31(6):962-7 
203 
78. Payne J, Coy J, Patterson S etal. Is use of hospital service a proxy for 
morbidity? A small area compa1ison of the prevalence of arthritis, depression, 
dyspepsia, obesity and respiratory disease with inpatient admission rates for 
these disorders in England. J Epidemiolo Community Health 1994;48:74-8 
79. Thompson D, Wolf A. The medical-care cost burden of obe ity. Obes Rev 
2001·2(3): 189-97 
80. Joung I, van der Meer J, Mackenbach J. Marital Status and health care 
utilization. fnt J Epiemiol 1995;24(3):569-75 
81 . Daviglus M, Liu K, Greenland P et al. Benefit of a favorable cardiovascular risk-
factor profile in middle age with respect to Medicare co t NEJM 
1998;339( 16): 11 22-9 
82. Simp on L, Owens P, Zodet M. Health care for children and youth in the United 
State :annual report on patterns of coverage, utilization, quality, and 
expenditures by income. Ambul Pediatr 2005;5(1):6-44 
83 . Green C, Pope C. Gender, psychosocial factors and the use of medical services: 
a longitudinal analysis. Soc Sci Med 1999;48(1 0): 1363-72 
84. Finkel t in M. Do factors other than need detern1ine utilization of physicians 
service in Ontario? CMAJ 200 I ;165(5):565-70 
85. Bertakis K, Azari R, Helms L ct al. Gender differences in the utilization of 
health care ervices J FAM Pract 2000·49(2) 147-52 
86. Kopelman P. Obesity as medical problem. Nature 2000;404:635-43 
87. Brodie D, Moscrip V, Hutcheon R. Body Composition Measurement: a review 
of hydrodensitometry, anthropometry and impedance. Nutrition 1998; 14(3):296-
340 
88. Willett W , Dietz W, Colditz G. Guidelines for healthy weight. NEJM 
1999;341(6):427-34 
89. Ross R, Leger L, Mon·is D et al. Quantification of adipose ti sue by MRI: 
relationship with anthropometric variables. J Appl Physiol 1992;72(2):787-95 
90. Han T, Fe ken E, Lean M et al. Waist c ircumference reduction and 
cardiovascular benefits during weight lo in women. Int JObes 1997;21 : 127-34 
204 
91. Lean M, Han T , Deurenberg P. Predicting body composition by densitometry 
from simple anthropometric measurements. Am J Clin Nutr 1996;63( I ):4-1 4 
92. Zimmet P , Collins V, de Courten M et al. Is their a relationship between leptin 
and insulin sensitivity independent of obesity? A population based study in the 
Indian Ocean of Mauritius. Mauritius NCO Study Group. lnt J Obes Relat 
Metab Disord 1998;22(2): 171-77 
93. Despres J, Lemieux I, Prud ' homme D . Treatment of obesity: need to focus on 
high risk abdominally obese patients. BMJ 200 I ;322:7 16-20 
94. Janssen I, Katzmarzyk P, Ross R. Waist circumference and not BMI explains 
obesity related health risk. Am J Clin Nutr 2004;79(3):379-84 
95. ChanD, Watts G, Barrett P et al. Waist circumference, waist-to-hip ratio and 
body mass index as predictors of adipose tissue compartments in men. QJM 
2003;96:441 -47 
96. Seidell J, Kahn H, Williamson D et al. Report from the Centers for Disease 
Control and Prevention: Workshop on u e of adult anthropometry for public 
health and primary health care. Am J Clin Nutr 200 I ;73: 123-26 
97. Lemieux S, Prud ' homme D, Bouchard C et al. A single-threshold val ue of waist 
girth identifies normal-weight and overweight subjects with excess visceral 
adipose tissue. Am J Clin Nutr 1996:64(5):685-93 
98. Health Canada. (2003). Canadian guidelines fo r body weight classificat ion in 
adults. Retrieved July 2 1, 2004 
99. Intemational Diabetes Federatio n. The lDF consensus worldwide defini tion of 
metabolic syndrome. Brussels, Belgium. Available at ww.idf.o rg/webdata!doc/ 
M etac _syndrome_ de f. pdf. 
1 00. Okoson I, Cooper R, Rotimi C et al. Association of waist circumference with 
ri sk of hypertension and type 2 diabetes in Nigeri an , Jam acians and African-
AmeJicans. Diabetes Care 1998;21: 1836-42 
I 0 I. Okoson 1, Rotimi C, Forrester T et al. Predictive value of abdomi nal obesity cut-
offs for hypertension in Blacks from West African and Caribbean Islands 
nat ions. l nt JObes 2000;24: 180-86 
205 
102. Seidell J, Perusse L, Despres Jet al. Waist and hip circumferences have 
independent and opposite effects on cardiovascular disease risk factors: the 
Quebec Family Study. Am J Clin Nutr 2001 b;74:315-321 
103. World Health Organization. Physical Status: The Use and Interpretation of 
Anthropometry. Technical Report Series 854. Geneva Switzerland: World 
Health Organization; 1995 
I 04. Bigaard J, Frederiksen K, Tjonneland A et al. Waist and hip circumferences and 
all-cause mortality: Usefulness of the waist-to-hip ratio? lnt JObes 
2004;28:741 -47 
105. YusufS, Hawken S, Ounpuu Setal. Obesity and the risk of myocardial 
infarction in 27 000 pmiicipants from 52 countries: a case control study. Lancet 
2005;366(9497): 1640-49 
I 06. Klipstein-Grobusch K, Georg T, Boeing H. Interviewer variability in 
anthropometric measurements and estimates of body composition. Jnt J 
Epidemiol1997;26(S l):S174-180 
107. Deurenberg. P, Deurenberg-Yap M, Guricci S. Asians are different from 
Caucasians and from each other in their body mass index/body fat percent 
relationship. Obes Rev 2002;3: 141-146 
108. Swinbum BA, Ley SJ, Cannichael HE, Plank LD. Body size and composition in 
Polynesians.Jnt JObes 1999;23(11 ): 1178-83 
109. Rush E, Plank L, Coward W. Energy expenditure of young Polynesian and 
European women in New Zealand and relations to body composition. Am J Clin 
Nutr.1999:69(1 ):43-8 
II 0. Flynn M, Gibney M. Obesity and health: why slim? Proc Nutr 
Soc.1991 ;50(2):413-32 
Ill. Prentice A, Jebb S. Beyond Body Mass Index. Obe Rev 2001 :2(3); 141-7 
112. Stevens J, Cai J, Jones D. The effect of decision rules on the choice of a body 
mass index cutoff for obesity: example from African American and white 
women. Am J Clin Nutr 2002;75:986-92 
113. WHO Expe1i Consultation. Appropriate body-mass-index for Asian populations 
and its implications for policy and intervention strategies. Lancet 
2004;363(9403): 157-63 
206 
114. Van Pelt RE, Evans EM, Schechtman KB et al. Waist circumference versus 
body mass index for prediction of disease in postmenopausal women. Jnt JObes 
2001 ;25: 1183-8 
115. Depres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on 
high 1isk abdominally obese patients . BMJ2001;322:716-20 
116. Wellens R, Roche A, Khamis H et al. Relationships between the body mass 
index and body composition. Obes Res 1996;4(1 ):35-44 
117. Pi-Sunyer FX. Obesity: crite1ia and classification. Symposium on body weight 
regulation and obesity: metabolic and clinical aspects 151 plenary session: 
obe ity. Proc Nutr Soc 2000;59(4):505-09 
11 8. Health Canada. (2003). Canadian guidelines for body weight cia sification in 
adults. Accessed on July 2 1, 2004 www.hc-sc.gc.ca/hpfb-dgp a/onpp-
bppn/weight book tc e.html 
11 9. Williams Textbook of Endocrinology 10111 ed. Philadelphia, Pa:Saunders;2003 
120. Wil son P, D' Agostino R, Sullivan Let al. Overweight and obesity as 
detem1inants of cardiovascular risk: the Framingham experience. Arch Intern 
Med 2002;162:1 867-72 
12 1. Brown C, Higgins M, Donato K et al. Body mass index and the prevalence of 
hypertension and dyslipidemia. Obes Res 2000;8:605- 19 
122. Burt V, Cutler J, Higgins Metal. Trends in the prevalence, awareness, treatment 
and control of hypertension in the adult US population. Hypertension 
1995;26:60-9 
123. Reeder B, Angel A, Ledoux Metal. Obesity and its relation to cardiovascular 
disease risk factors in Canadian adults. Canad ian Heart Health Surveys Research 
Group. CMAJ 1992;146( II ):2009-19 
124. Abbasi F, Brown B Jr, Lamendola C et al. Relation hi p between obesity, in ulin 
resistance and coronary heart di ease risk. JAm Col! Cardia/ 2002; 40(5):937-
43 
125 . Bogers R, Bemelmans W, Hoogenveen R et al. As ociation of overweight with 
increased ri sk of coronary heart disease partly independent of blood pressure and 
cholesterol levels: a meta-analysis of2 1 coho1i studies including more than 300, 
000 person . Arch Intern Med 2007; 167(1 6); 1720-8 
207 
126. Manson J, Colditz F, Stampfer Metal. A prospective study of obesity and risk 
of coronary heart disease. NEJM 1990;322:882-89 
127. Rexrode K, Hennekens C, Willett Wet a!. A prospective study of body mass 
index, weight change and risk for stroke in women. JAMA 1997;277:1539-45 
128. Hansson P, Eriksson J, Welin Let al. Smoking and abdominal obesity: risk 
factors for venous thromboembolism among middle aged men" the study of men 
born in 1913." Arch Intern Med 1999;159: 1886-90 
129. Pi-Sunyer F. Medical hazards of obesity. Ann Intern Med 1993;119:655-60 
130. Huang Z, Jankinson S, Colditz F eta!. Dual effects of weight and weight gain on 
breast cancer risk. JAMA 1997;278: 1407-11 
131. Potter J, Slattery M, Bostick Ret al. Colon cancer: a review of the 
epidemiology. Epidemiol Rev 1993;15:499-545 
132. Carmichael A. Obesity and prognosis of breast cancer. Obes Rev 2006;7:333-
40 
133. Astrup A, Finer N. Redefining type 2 diabetes: diabesity or obesity dependent 
diabetes mellitus. Obes Rev 2000;1:57-59 
134. Chan J, Rimm E, Colditz Get al. Obesity, fat distribution, and weight gain as 
risk factors for clinical diabetes in Men. Diabetes Care 1994;17:961-69 
135. Colditz G, Willett W, Rotnitzky A et al. Weight gain as a risk factor for clinical 
diabetes mellitus in women. Ann Intern Med 1995;122:481-86 
136. Must A, Spadano J, Coakley E eta!. The disease burden associated with 
overweight and obesity. JAMA 1999;282(16): 1523-29 
137. Winkleby M, Jautilus D, Frank E eta!. Socioeconomic status and health: how 
education income and occupation contribute to risk factors to cardiovascular 
disease. Am J Public Health I 992;82(6):816-20 
138. Grundy et al. Diagnosis and management of the metabolic syndrome, An 
American Heart Association/National Heart Lung and Blood Institute Scientific 
Statement Circulation 2005 accessed December 14111 , 2006 
http://circ.ahajournals. orglcgilreprint/CIRCULATIONAHA. 105.1 69404v 1 
139. FordE, Giles W, Dietz W . Prevalence ofthe Metabolic Syndrome among US 
Adults. lAMA 2002;287:356-59 
208 
140. Brien S, Katzmarzyk P. Physical activity and the metabolic syndrome. Appl 
Physio Nutr Metab 2006;31(1):40-7 
141 . Pearson-Ceo! J. Literature review on the effects of obesity on knee osteoarthtitis. 
Orthop Nurs 2007;26(5):289-92 
142. Cicuttini F, Baker J. Spector T. The association of obesity with osteoarthritis of 
the hand and knee in women: a twin study. J Rheumatol 1996;23: 122 1-26 
143. Enzi G. The socioeconomic consequences of obesity: the effect of obesity on the 
individual. Pharmacoeconomics 1994;5(S 1 ):S54-7 
144. Gortmaker S, Must A, Perrin J. Social and economic consequences of 
overweight in adolescence and young adulthood. NEJM 1993;329(24): 1008-12 
145. Lee I-M, Manson J. Body weight and m01tality: What is the shape ofthe curve? 
Epidemiology 1998: 9(3);227-28 
146. Manson J, Stampfer J, Hennekens C et al. Body weight and longevity: a 
reassessment. lAMA 1987:257-358 
147. Manson J, Willett V, Stampfer Metal. Body weight and mottality among 
women. NEJM 1995;333:677-85 
148. Stevens J, Cai J, Pamuk E et al. The effect of age on the association between 
body-mass index and mortality. NEJM 1998: 338; 1-7 
149. Sojostrom L. Impacts of body weight, body composition and adipose ti ssue 
disttibution on morbidity and mottality in Obesity: Theory and therapy, 2nd ed 
A.J. Stundard and TA Wadden,New York, Raven Press 
150. Romero-Con·al A, Montori V, Somers Vet a!. Association of bodyweight and 
total mortality with cardiovascular events in coronary artery disease: a 
systematic review of cohort studies. The Lancet 2005;368:666-78 
151 . Rossner S, Lagerstrand L, Persson H et al. The sleep apnea syndrome in 
obesity: risk of sudden death. J Intern Med 199 1 ;230(2): 135-141 
152. Mulrow C, Chiquette E, Angel Let al. Dieting to reduce body weight for 
controlling hypertension in adults. Cochrane Database Syst Review 2000; 
(2):CD000484 
153. Goldstein D. Beneficial health effects of modest weight loss. 1nt J Obesity 
1992;16(6):397-415 
209 
154. Ben-Dove I, Grossman E, Stein A eta!. Marked weight reduction lowers resting 
and exercise blood pressure in morbidly obese subjects. Am J Hypertens 
2000;13:251 -55 
155. Dattilo A, Kiis-Etherton P. Effects of weight reduction on blood lipids and 
lipoproteins: a meta-analysis. Am J Clin Nutri 1992;56(2):320-28 
156. Sojostrom C, Lissner L, Wedel H eta!. Reduction in incidence in diabetes, 
hype1iension, lipid disturbances after intentional weight loss induced by bariatric 
surgery: the SOS intervention study. Obes Res 1999;7(5):477-84 
157. Wei M, Kampert J, Barlow C eta!. Relationship between low cardiorespiratory 
fitness and mortality in normal-weight, overweight, and obese men. JAMA 
1999;282(16): 1547-53 
158. Sui X, LaMonte M, Laditka J eta!. Cardiorespiratory Fitness and adiposity as 
mortality predictors in older adults. JAMA 2007;298(21):2507- 16 
159. Janssen l , Katmarzyk P, Ross R. Body mass index is inversely related to 
mortality in older people after adjustment for waist circumference. J Am Ge1iatr 
Soc 2005;53(12):2112-28 
160. Baskin M, Ard J, Franklin F eta!. Prevalence of obesity in the United States. 
Obes Rev 2005;6:5-7 
161 . Flegal K, Toriano R. Changes in the distribution ofthe body mass index of 
adults and children in the US population. Jnt JObes 2000;24:807-18 
162. Belanger-Duchanne F, Tremblay A. Prevalence of obesity in Canada. Obes Rev 
2005;6: 183-86 
163. Tremblay M, Katzmarzyk P, Willms J. Temporal trends in overweight and 
obesity in Canada 1981-1996, lnt JObes Relat Metab Disord 2002;26(4):538-43 
164. Willms J, Tremblay M, Katzmarzyk P. Geographic and demographic variation 
in the prevalence of overweight Canadian children. Obes Res 2003;11(5):668-73 
165. Canning P, Courage M, Frizell L. Prevalence of overweight and obesity in a 
provincial population of Canadian preschool children. CMAJ 2004;171(3 ):240-2 
166. Twells L, DayS, Newhook LA. Does breastfeeding protect preschool children 
from obesity? Atlantic Networks for Prevention Research Conference, St. 
John's, NL (Abstract) 2007 
210 
167. Lissner L. Causes, diagnosis and risks of obesity. Pharmacoeconomics 
1994;5(Suppl 1 ):8-17 
168. Pi-Sunyer F. Obesity: criteria and classification. Symposium on body weight 
regulation and obesity: metabolic and clinical aspects 1st plenary session obesity. 
Proc Nutr Soc 2000;59:505-09 
169. Canadian Population Health Initiative (2004). Improving the Health of 
Canadians. Canadian Institute for Health Information. Ottawa 
170. Prentice A, Jebb S. Obesity in Britain: gluttony or sloth? BMJ 
1995;311(7002):437-9 
171. Schulze L, Bennett P, Ravussin E et al. Effects oftradition and western 
environments on prevalence of Type II diabetes in Pima Indians in Mexico and 
the USA. Diabetes Care 2006:29(8):1866-71 
172. O 'Dea K, WhiteN, Sinclair A. An Investigation of nutrition - related tisk factors 
in an isolated Aboriginal community in northern Australia - advantages of a 
traditionally oriented lifestyle. Med J Aust 1988;148: 177-180 
173. HarrisS, Gittelsohn J, Hanley A eta!. The prevalence ofNIDDM and 
associated risk factors in native Canadians. Diabetes Care 1997;20: 185-7 
174. Young TK., Reading J , Elias Band 0 ' Neil JD. 2000 Type 2 diabetes mellitus in 
Canada's First Nations: status of an epidemic in progress. CMAJ 163;561-66 
175. Delisle H. Rovard M , Ekoe J. Prevalence estimates of diabetes and other 
cardiovascular risk factors in the two largest Algonquin communities in Quebec. 
Diabetes Care 1995;18:1255-9 
176. Hill J , Catenacci V, Wyatt H. Obesity. Etiology in Modern Nutrition in Health 
and Disease I Oth ed. Lippincott Williams & Wilkins:2006 
177. Kromhout D . Changes in energy and macronutrients in 871 middle-ages men 
during I 0 years of follow-up (the Zutphen study). Am J Clin Nutr 1983:37:287 
178. Nova Scotia Heart Health Program. ( 1993). Repott of the Nova Scotia Nutrition 
Survey. Nova Scotia: Nova Scotia Department of Health 
179. University of Saskatchewan. (2001 ). Saskatchewan Nutrition Survey. Report of 
a Survey in the province of Saskatchewan, 1993- 1994. Saskatoon: University of 
Saskatchewan 
2 11 
,------------------------------------------------------------------------------------··----
180. Taylor J, Van TilL, MacLellan D. (2002). Prince Edward Island Nutrition 
Survey. Charlottetown: University of Prince Edward Island and Prince Edward 
Island Health and Social Services 
181 . Gray-Donal K, Jacobs-Starkey L, Johnson-Down L. Food habits of Canadians: 
Reduction in fat intake over a generation. Ca J Public Health 2000;91 :381-385 
182. Stephen A, Sieber G. Trends in individual consumption of dietary fat in the 
United States, 1920-1984. Am J Clin Nutr 1994; ,52:457-469 
183. Statistics Canada(2003). Food Statistics,2002. Volume 2, number I. Ottawa; 
Statistics Canada. www.statcan.ca/english/freepub/21-020-XIE/2 1-020-
XIE02001.pdf 
184. Roebothan B Nutrition Newfoundland and Labrador: The Repo11 of a Survey of 
Residents ofNewfoundland and Labrador, 1996. St. John ' s, Newfoundland: 
Depa11ment of Health and Community Services, Province ofNewfoundland and 
Labrador 2003 
185. Fogelholm M, Mannisto S, Vartianen E eta!. Determinants of energy balance 
and overweight in Finland 1982 and 1992. Jnt JObes Relat Metab Disord 
1996;20:1 097-104 
186. US Department of Health and Human Services. Physical Activity and Health: A 
Report of the Surgeons General. Atlanta, GA: US Department of Health and 
Human Resources, 1996 
187. Viswanaath K, Bond K. Social detenninants and nutrition: reflections on the 
role of communication. J Nutr Edu Behav 2007;39(Suppl 2): S20-4 
188. Sobal J, Stunkard A. Socioeconomic status and obesity: a review of the 
literature. Psycho/ Bulll989;105(2):260-75 
189. Ball K, Crawford D. Socioeconomic status and weight change in adu lts: a 
review. Soc Sci Med 2004;60(9): 1987-20 I 0 
190. Bell , C, Walley A, Froguel P. The genetics of human obesity. Nat Rev Genet 
2005;6:221-34 
191. Zhang Y, Proenca R, Maffei R et al. Positional cloning of the mouse obese gene 
and its human homologue. Nature 1994;372(6505):425-32 
212 
192. Bamess L, Opitz J, Gilbert-Bmness E . Obesity: Genetic, Molecular, and 
Environmental Aspects. Am J of Medical Genetics Part A2007;143A:3016-34 
193. Allison D, Mentore J, Heon M et al. Antipsychotic - induced weight gain: a 
comprehensive synthesis. A m J Psychiatry 1999;156:1 686-96 
194. Bouchard C. Etiology of obesity: genetics factors. Arch Latinoam Nutr 
1992;42(3 Suppl): 127S-l 30S 
195. Rankinen T, Zuberi A, Chagnon Y et al. The human obesity gene map: the 2005 
update. Obesity 2006;14(4):529-644 
196. Stunkard A, FochT, Hrubec Z et al. A twin study of human obesity. JAMA 
1986;256( I ):51 -4 
197. Meyer J, Stunkard A. Twin studi es of human obesity. In Ed: Bouchard C. The 
genetics of obesity. Boca Raton: CRC Press. l 994:63-78 
198. Bouchard C, Tremblay A, Despres J et al. The response to long-term 
overfeeding in identical twins. NEJM 1990;322(2 1 ) : 1477-82 
199. Jacobson P, Torgerson J , Sjostrom L et al. Spouse resemblance in body mass 
index: effects on adult obesity prevalence in the offspring generation. Am J 
Epidemio/ 2007 ;1(1 65):101-8 
200. Stati stics Canada: Canadian Community Health Survey 200 l located at 
www.statcan.ca/engli sh/sdds/ instrument/3226 0 I VI E. pd f 
201. Statistics Canada: Canadian Community Health Survey 200 l located at 
http://www.statcan.ca/engli sh/conccpts/hs/index.htm 
202. Stati stic Canada: Canadian Community Health Survey 200 I located at 
http://www.statcan.ca/english/freepub/82-22 1-XIE/frec.htm 
203. Canadi an Institute fo r Health Infonnation: Resource Inten ity Weights 
http://www.c ibi .ca/cihiweb/dispPage.jsp?cw page=casemix riw e 
204. Financial Perfonnance Indicators 1999-2000 to 2001 -2002 Canadian Institute for 
Health Information. Canadian MIS Database Hospital 
205. Ba reham G, Robson P, Gallagher A et al. Tracking of physical activity, fitness, 
body composition and diet from adolescence to young adulthood. The Young 
Hearts Project, Northern Ireland. lnt J Behav Nutr Phys Act 2004; 1 ( I ): 14 
2 13 
206. Kyaavik E, Tell G, Klepp K. Predictors and tracking of body mass index from 
adolescence into adulthood: follow up of 18 to 20 years in the Oslo Youth 
Study. Arch Pediatr Ado/esc Med 2003;157(12): 1212-18 
207. Fuentes R , Notkola I, Shemeikka S. Tracking of body mass index dUiing 
childhood: a 15 year prospective population-based family study in eastern 
Finland. lnt JObes Relat Metab Disord 2003; 27(6):7 16-2 1 
208. Erikson J, Forsen T, Tuomilehto J et al. Size at birth, childhood growth and 
obesity in adult life. Jnt JObes ReLaL Metab Disord 2001 ;25(5): 735-40 
209. Shields M, Tjepkema M. Trends in adult obesity in Health Reports (Statistics 
Canada, Catalogue 82-003) 2006;17(3):9-25 
210. Kirkwood Betty. Essentials of Medical Statistics. Oxford. Blackwell Science 
Ltd.; 1988 
2 11. Munroe, B Statistical M ethods for Health Care Research 3rd ed. Lippincott 
2 12. Hanison G, Feehan J, Edwards A et al. C igarette smoking and the cost of 
hospital and physician care. Can Public Policy 2003;29( I): 1-20 
213. Ramsey F, Schafer D. T he Statistical Sleuth: A Course in Methods of Data 
Analysis. 2nd ed. New York. Duxbury 2002 
214. Hurley J, Hutchison B, Buckley Get al. Needs-based Funding for Home Care 
and Community Support Services in Ontario: A New Approach Based on 
Linked Survey and Administrative Data. CHEPA Working Paper Series, paper 
03-0 1 2003 
2 15. MacKinnon D, Krull J , Lockwood C. Equivalence of the Mediation 
Confounding and Suppression Effect. Prevention Science 2000;1(4): 173-8 1 
216. Beaglehole R , Bonita R, Kjellstrom T. Basic Epidemio logy. I 51 ed. Geneva: 
World Health Organization; 1993 
2 17. Borg S, Persson U, Odegaard K et al. Obesity , survival and hospital cost -
findings from a screening project in Sweden. Value Health 2005;8(5):562-71 
2 18. Arterbum D, Maciejewski M, Tsevat J. Impact of morbid obesity on medical 
expenditures in adults.lnt J o.fObes 2005;29:334-39 
2 14 
219. Catford J. Chronic disease: preventing the world's next tidal wave - the 
challenge for Canada 2007. Health Prornot lnt 2007;22:1 -4 
220. LauD, Douketis J, Morrison Ketal. 2006 Canadian clinical guidelines on the 
management and prevention of obesity in adults and children [ ummary] . CMAJ 
2007; 176(8):S 1-13 
22 1. Raine K. Overweight and obesity in Canada. A population health perspective. 
2004. Canadian Institute for Health Information, Canadian Population Health 
Initiative [Ottawa] 
222. Kumanyika S. Minisymposium on Obesity: Overview and some strategic 
considerations Annu Rev Public Health 2001 ;22:293-308 
223. Hirsh J . Magic bullet for obesity. Clinical Review BMJ 1998;317: 1136-8 
224. Butchko H, Petersen B. T he Obesity Epidemic: Stakeholder Initiatives and 
Cooperation. Nutr Today 2004;39(6):235-44 
2 15 
APPENDIX A 
Andersen's Behavioral Model of 
Health Services Use 
216 
ENVIRONMENT POPULATION 
CHARACTERISTICS 
Health Care 
System 
External 
Environment 
Predisposing 
Characteristics 
Enabling 
Resource ----+ Need 
HEALTH 
BEHAVIOR 
Personal 
Health 
Practices 
Use of Health 
Services 
OUTCOMES 
Perceived Health 
Status 
Evaluated Health 
Status 
Consumer 
satisfaction 
Andersen (1995) Journal ofHealth and Social 
Behavior vol. 36 (1) pp.1-1 0. 
APPENDIXB 
Detailed Linkage Process 
218 
Detailed Linkage Process 
The linkage of the database took place in four steps and was conducted using SPSS for 
Windows version I 1.5.0. Step I involved linkage of the "share file" to the " link fi le" and 
extraction of the health insurance numbers from the " link fil e." In step two, the health 
survey study sample was linked to the physician claims database. ln step three the health 
survey study ample was linked to the hospital separation database and in step four the 
health survey study sample was linked to the Provincial Mortality Surveillance System. 
Step I Linkage of share file to link file 
The household ID and person 10 vari ables in the 2000/2001 CCHS "share file" and 
2000/2000 I CCHS " link fil e" were concatenated to fonn a new composite ID variable. 
The "share fil e" was linked to the " link fil e" o that the date-of-birth variable in the 
"share fil e" could be added to the " link fil e." The " link file" (containing MCP number, 
name, date-of-birth) was linked to the MCP " master fi le" via the MCP number in order to 
detennine the validity of the MCP numbers in the " link fil e." Out of a potential 3734 
survey respondents, 2883 individual records were linked (82% of the link fil e and 76% of 
the share fil e). Records with missing or invalid MCP numbers could not be linked. For 
the 614 individual records in the " link fi le," w hich could not be linked via MCP numbers, 
a second link was conducted to obtain valid MCP numbers for as many as possible of the 
remaining survey participants . A composite variable was created in the " link file" using 
the fi rst 4 characters of the first name, the first 4 characters of the last name and the date-
of-birth. This wa done in both the CCHS " link fil e" and the MCP " master fi le." This 
vari able was used to link the remaining records in the " link fi le" to the MCP " master 
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file. " A total of382 additional records were linked using this procedure. As a result the 
new "link file" contained the original valid MCP numbers provided (2833), plus the 
additional 382 valid MCP numbers obtained form the MCP "master file" to make up a 
total "linkable" sample of3265, bringing the proportion of records with valid MCP 
numbers to 93% ofthe " link file" and 87% of the "share fil e." The final step included 
linkage of the new "NLCHJ link file" with its cotTesponding valid MCP numbers to the 
CCHS study sample (n=2345) to detem1ine how many of the CCHS study sample 
(n=2345) had valid MCP numbers. When this link was completed 2 177 (92.8%) of the 
CCHS study sample had valid MCP numbers and were linked to the health admi nistration 
databases. 
Step II : CCHS L inkage to the Medical Care Plan database 
Objective health services use for physicians was ascetiained through linkage of the 
CCHS to the MCP database via a unique identifier (Medical Care Plan number). A fi le 
with the MCP health insurance number and the survey respondent 10 was linked to the 
MCP database to obtain physician uti lization for the study sample. Data were obtai ned on 
physician visits, fee code, physician fee claimed, and provider' s specialty for a five year 
period (1998-2002). 
Step lll : CCHS 1.1 Linkage to C linical Database Management System 
Objective health ervices hospital use was ascertained through the linkage of the CCHS 
"l ink fi le" to the MCP number in the CDMS. Survey respondents with a valid MCP 
number were linked to the CDMS. Utilization of hospital services data were collected 
through the number of hospital separation information on main diagnoses, type of 
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procedures, length-of-stay, resource intensity weights and provider information for those 
CCHS respondents who had either an admission to hospital or a visit to surgical day care. 
Step 4: Linkage Mortality Surveillance System 
Using a valid MCP number, 2200 CCHS respondents were linked to the Mortality 
Surveillance System, to detennine mortality and cause of death. 
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Table la: Select Variables Measuring Health Behavior (i.e., Health 
Services Utilization) from the 2000/2001 CCHS 
Health Services Utilization variables 
Ovemight pa tient In the past 12 months, have you been a patient ovemight in a hosp ital, 
nursing o r convalescent home? 
(1-ICUA 0 1) l=yes, 2= no 
Number of nights as a Number of nights respondent was in hospital as a patient in the 12 month 
pa tient period prior to the survey interview? 
(H CUAGO I A) 
Family doctor Number of consultations with family doctor in the 12 months period prior to 
the survey interview 
(HCUAG02A) 
O ther medical doctor Number o f consultations with another medical doctor in the 12 months prior 
to the survey interv iew? 
(HCIAGMDC) 
A ny hea lth professiona l Have you had a consultation with any hea lth professiona l in the 12 month 
(HCUAFHPC) period prior to the interview? 
Mental health professional Have you consulted a me nta l health professio na l in the past 12 mo nths? 
(CMH A_Ol K) 
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Table lb: Select Variables Measuring Population Characteristics from 
the 2000/2001 CCHS 
Variable Population Health Characteristics 
Predisposing Variables 
Age Age 
(DHHA AGE) 
Sex 0 = Male, I = Female 
(DHHA SEX) 
Marital Status l=man·ied, 2 = common-law, 3=widowed,4=separated,5=divorced , 6=sing le 
(DHHA MS) 
Education level (D) I =<secondary, 2= secondary, 3=o ther post secondary graduate, 4- ost 
secondary graduate 
(EDUADI-l04) 
Body mass index (D) We ight in kilograms/height in metre squared 
I= no m1a l BMl 2: 18.5 and <25, 2= ove1weight BM I 2:25 and <30 
3= obese BM I 2:30 
Enabling Variables 
Health Services Do you have a regular medical doctor? 
(TWDA 5) I =yes, 2=no 
Income (D) != lowest, 2= lower middle, 3=middle, 4=upper middle, 5= hig hest 
(JNCADIA5) 
Rural and Urban I = urban, 2= rural 
(GEOADUR2) 
Health region I 00 I =St. John 's, I 002=Eastem, I 003=Cenlral, I 004=Westem, I 005=Grenfell, 
I 006= Labrador 
(GEOA PRY) 
Need Variables 
Chronic condition Do you have a chronic condition? 
!=yes, 2= no 
(CCCAJ:- 1) 
Number of chronic conditions (D) We are interested in long-term conditions that have lasted or arc expected to 
last 6 months or more and have been diagnosed by a hea lth professional. 
(CCCADTOT) 
Do you have? 
food allergies, any other allergies, asthma, Fibromya lg ia , arthritis or 
rheumatism, back prob lems excluding arthritis and Fibromyalgia, high blood 
pressure, migraine headaches, chronic bronchitis or emphysema or chronic 
obstructive pulmonary disease, diabetes, epi lepsy, heart disease, cancer, 
sto mach or intestinal ulcers, effects of a stroke, urinary incontinence, a bowel 
d isease (Crohn's or colitis), Alzheimer 's disease or other de mentia, cataracts, 
gla ucoma, thyro id condition , any other long-term condi tion that has been 
diagnosed by a hea lth professional 
For arthrit is or rheumatism respondents were asked if they suffered from 
rheumatoid arthritis, osteoarthritis or other arthritic problems? 
For heart disease, respondents were also asked if they had su ffered a heart 
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attack, angina or congestive heart failure 
For cancer, respondents were asked about specific cancers (breast, prostate, 
colorectal , skin cancer (melanoma and non melanoma) and other 
Need Variables- Health Status 
Physical Activity Index (D) Derived physical activity index (based on estimated energy expenditure) 
I= Active, 2= moderately active, 3= inactive 
(PACDPAI) 
Fruit and vegetable Daily consumption of total fruits and vegetables 
consumption(D) I= :S5 servings per day, 2= =>6 and < I 0, 3= > I 0 servings per day 
(FVCAGTOT) 
Alcohol (D) Type of drinker 
I= regular, 2= occasional, 3= never 
(ALCADYTP) 
Smoking Type of smoker 
(SMKA_202) I= daily, 2= occasional, 3= not at all 
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Does Body Mass Index Change Over Time? 
The CUITent study identifies obese, overweight and nonnal weight individuals at a 
particular point in time and tracks their HSU over a two and a half year period pre and 
post survey data collection. The possibili ty that subjects found to be obese in this CCHS, 
but were not obese pre and or post the survey must be considered. 
To further investigate whether BMI/obesity status remains constant over a five-
year period, the longitudinal portion of the NL sample of the National Population Health 
Survey (NPHS) Cycles 1 (94/95) and 5 (02/03) were analyzed. The NPHS was first 
administered to the Canadian population in 1994/95 and has since been repeated every 
two years. This survey collects information on health status, health behavior and health 
services utilization at the provincial level, with both longitudinal and cross-sectional 
components. The total Canadian sample size was 17,625 in 1994/95. The ample 
population size for the NL component over this time period was 806. Calculated BMI 
values were available for 429 individuals between 18 and 64 years of age who were part 
of the longitudinal component. This infonnation was used to detennine the percentage of 
people classified as obese in 1994/1995 who remained classified as obese in 2002/2003. 
Table I presents a cross-tabulation of individuals in 199411995 and in 2002/03 with their 
corresponding weight classification. 
As the table demonstrates, in 1994/ 1995, seventy-five adult respondents were 
classified as obese. In 2002/2003, fifty eight (77%) of these same re pondents were 
classified as obese. Fourteen, two and one respondent(s) had moved into the overweight, 
nom1al weight and underweight categorie respectively. In 1994/1995, one hundred and 
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seventy-eight adults were classified as nonnal weight and in 2002/2003, one hundred and 
ten (62%) of these were classified as normal weight. Eight were classified as obese, fifty-
seven as overweight and three respondents were classified as underweight. These 
findings suggest that between 1994/95 and 2002/03, 80% obese individuals remained 
obese, 20% overweight individuals had become obese, 33% nonnal weight individuals 
had become overweight. Less than 10% overweight individuals had moved into the 
nonnal range. 
Table l NPHS Cross-tabulation ofBMI Cycle 1 ( 1994) and Cycle 5 (2003) 
BMI Class - Cycle 5 (2002-2003) 
BMI Class Underweight Normal weight Ovenveight Obese Total 
Cyclel (%) (%) (%) (%) 
(1994/1 995) 
Underweight 1 (16.7) 5 (83) 0 0 6 
Normal 3 (I. 7) 110 (61.8) 57 (32) 8 (4.5) 178 
Overweight 0 15 (8.8) 120 (71) 35 (21) 170 
Obese I ( 1.3) 2 (2.7) 14 (18.7) 58 (77.3) 75 
Total 5 132 191 101 429 
These analy es are supported by a national study recently published by Statistics 
Canada in 2005.Using the longitudinal component of the National Population Health 
Survey for the entire country, researchers found between 1993/ 1994 and 2002/2003: 25% 
of overweight individuals had become obese; 33% of nom1al weight individuals had 
become overweight and I 0% of overweight individuals had moved into the nom1al range. 
This analysis reported that men were more likely to go from nonnal weight to overweight 
and women were more likely to go from overweight to obese. These specific Canadian 
228 
findings support the use of obesity measured as a cross sectional parameter, as a valid and 
reliable measure of weight class over time in this population. 
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Table 1: Distribution of Physicians in NL 1999/2000 
GP Specialist Total Total FFS 
FFS Salary FFS Salary FFS physicians % 
Health Board 
Eastern 
St. Johns 142 13 173 48 315 376 84% 
Avalon 13 5 0 0 13 18 72% 
Trinity/conce~tion 27 2 5 7 32 41 78% 
Burin 13 13 3 9 16 38 42% 
Clarenville 18 6 2 15 20 41 49% 
total 213 39 183 79 396 514 77% 
Central 
Gander and District 16 18 14 18 30 66 45% 
Central 22 12 17 5 39 56 70% 
Port Saunders 1 2 0 0 1 3 33% 
Baie Verte 5 0 0 0 5 5 100% 
Green Bay_ 4 2 0 0 4 6 67% 
Notre Dame Bay 1 5 0 0 1 6 17% 
Buchans 0 1 0 0 0 1 0% 
total 49 40 31 23 80 143 56% 
Western 
Western 29 13 27 21 56 90 62% 
Stephenville 8 6 3 7 11 24 46% 
Port Aux Basques 3 6 0 0 3 9 33% 
total 40 25 30 28 70 123 57% 
Grenfeii/Labrador 
St. Anthony/Goose Bay 5 27 0 22 5 54 9% 
Labrador City/Wabush 6 0 4 3 10 13 77% 
total 11 27 4 25 15 67 22% 
0 0 
Total 313 131 248 155 561 847 66% 
Source: Annual Report 1999/2000 Med1cal Care: Plan Table 5 
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Table 2:Analysis of #of Visits to a FFS Physician by Fee-Code (n=2177) 
Fee-code Total GP visits Specialist visits 
n 0/o n o;o n o;o 
Office 
consultation 39116 56 34477 87 4639 15 
Home 
consultation 553 1 546 1 7 0 
In-patient 
consultation 1222 2 250 1 972 3 
Out-patient 
and 
emergency 4881 7 1060 3 3821 12 
Diagnostic 
and 
therapeutic 
procedures 4765 7 2394 6 2371 8 
In-hospital 
diagnostic 
procedures 2674 4 1 0 2673 9 
Radiology 13198 19 66 0 13132 43 
Surgical 
procedures 3703 5 614 2 3089 10 
Total 70112 100 39408 100 30704 99 
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Table 3a: Urban Region 
Morbidly Obese* Obese* O verweight* Normal* 
Self r eport I Actual Self report I Actual Self repor t I Actual Self •·eport I Actual 
n=81 n= l97 n=463 n=505 
X (SD) I X (SD) X (SD) J X_(SD)_ X_(SDl J X(SD X(SD) I X (SD) 
GP 5.15(4.99) I 5.45(4.69) 4.38(5.46) I 4.3 1 (3.67) 4.00(5.47) I 4.19(4.06) 4.06(6.66) I 4.65(7.98) 
n=38 n= l29 n=263 n=2 15 
Specialist * .88(2.7 1) I 3.2 1(3.2 1) .99(2.79) l 3.26(4.34) .82(2.26) I 3.32(5.53) .87(2.15) I 3.40(4.12) 
*p<.05 for spec1ahst only 
Table 3b: Rural Region 
Morbidly Obese* Obese* Overweight* Nor mal* 
Self •·eport I Actual Self repo•·t I Actual Self •·eport I Actual Self report I Actual 
n=33 n= l l 5 n=230 n=2 12 
X (SD) I X (SD) X (SD) I X (SD) X (SD) I X (SD X (SD) I X (SD) 
GP 5.64(4.83) I 6.s 1 (6.63) 5.10(6.03) I 3.84(4.12) 4.27(5.80) I 3.54(3 .68) 4.02(4.55) I 3.58(3.30) 
n=83 n=2 10 n=458 n=48 1 
Specialist * 1.05(2.45) I 3.88(4.90) .99(2.69) 1 3.44(4.0 1) .59( 1.78) 1 3.04(4.20) .44(.86) 1 3.11 (6.59) 
*p<.05 for specialist only 
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Table 4a: Eastern Health Region 
Morbidly Obese* Obese* Overweight* Normal* 
Self report I Actual Self report I Actual Self r·eport I Actual Self r eport I Actual 
n=46 n= l40 n=326 n=38 1 
X (SD) I X (SD) X (SD) I X (SD) X (SD) I X (SD X (SD) I X (SD) 
GP 5.74(4.86) I 7 .35(5.55) 5.06(6.28) I 4.67(3.61) 4.40(5.73) I 4.55(4.22) 4.34(6.98) I 4.57(4.52) 
n=46 n= l29 n=3 19 n=346 
Specialist * 1.33(3.62) I 3.77(3.53) 1.29(3.22) 1 3.83(4.38) .96(2.68) 1 3.65(4.8 1) .91(2.13) I 3.88(6.19) 
*p<.05 for spec1altst only 
Table 4b: Central Health Region 
Morbidly Obese* Obese* Overweight* Normal* 
Self report I Actual Self report I Actual Self report I Actual Self report I Actual 
n=29 n=6 1 n= l35 n= IOO 
X (SD) I X (SD) X (SO) I X (SD) X (SD) I X (SD X (SO) I X (SD) 
GP 5.45(3 .87) I 6.06(6.08) 4.41 (4.15) I 3.77(3.47) 4.07(4. 14) I 3.73(2.98) 4.00(4.82) I 5.45(3.87) 
n=30 n=67 n= l35 n= I05 
Specialist * .50( 1.07) I 4.33(5.65) 1.21(2 .96) I 3.9 1(5.54) .50( 1.06) I 3.22(4. 15) .69( t.8 1)) 1 3.02(3.55) 
*p<.05 for spec1altst only 
Table 4c: Western Health Region 
Morbidly Obese* Obese* Overweight* Normal* 
Self report J Actual Self report I Actual Self report I Actual Self r eport I Actual 
n= l8 n=56 n= l27 n= l37 
X (SD) I X (SO) X (SO) I X (SO) X (SO) I X (SO X (SO) I X (SD) 
GP 5.28(6.47) 1 5.82(4.04) 4.43(4.37) 1 4.74(4.94) 4. 19(6. 17) 1 4. 11 (4.44) 3.82(5.74) 1 5.28(6.47) 
n= l9 n=52 n= l25 n- 124 
Specialist * .32(.82) I 2.63(2. 18) .83(2. 76) I 3.33(3 .26) .7 1(2.05) I 3.55(7..94) .57( 1.59) I .32(.82) 
*p<.05 for spec1alist onl y 
Table 4d: No•·thern Health Region 
Morbidly Obese1 Obese* Overweight* Normal* 
Self report I Actual Self report I Actual Self r eport I Actual Self rell_ort I Actual 
n=2 1 n=55 n= l05 n=99 
X (SO) I X (SO) X (SO) I X (SO) X (SO) I X (SD X (SO) I X (SD) 
GP 4. 10(5.03) I !.79(1 .44) 4 .05(6.70) I 2.58(3.04) 3.04(4.78) I 2.3 1(2.93) 3.25(3.73) I 4. 10(5.03) 
n=26 n=82 n= l42 n- 12 1 
Specialist * 1.19(2.59) 1 2.34(2.0 1) .43( 1.35) I 2.07(2.77) .50( 1. 12) I 1.96(2.40) .45( 1.1 7) I t. I9(2.59) 
* . ' ' 
I .. p<.05 fo1 spec1ahst only, p<.05 for 11101 b1dly obese group and GP VISits only 
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Hunun Investigation Committee 
Research .and Graduate Studies 
Faculty of Medicine 
The Health Sciences Centre 
November 16, 2005 
Reference #05.197 
Ms. L. Twells 
C/o Dr. B. Barrett 
Patient Research Centre 
151 Floor, Health Sciences Centre 
Dear Ms. Twells: 
--· .. - -· ·. _ ..';). 
rr · ~ ~~: .. ·u .;..~ _· ~ ..... -..,..J 
This will acknowledge your correspondence dated November 11, 2005, wherein you 
~ clarify issues and provide a letter granting permission to access the data from data 
guardians for your research study entitled uHealth services utilization, associated 
factors, and direct cost of health services among obese vs. non-obese populations in 
Newfoundland and Labrador". 
At the meeting held on October 13, 2005, the initial review date of this study, the 
Human Investigation Committee (HIC) agreed that the response could be reviewed 
by the Co-Chairs and, if found acceptable, full approval of the study be granted. 
The Co-Chairs of the HIC reviewed your correspondence, and under the direction of 
the Committee, granted full approval of your research study. This will be reported to 
the full Human Investigation Committee, for their information at the meeting 
scheduled for November 24, 2005. 
- Full approval has been granted for one year. You will be contacted for annual update 
before October 13, 2006. 
l'v!odifications of the protocol/consent are not permitted ~vithout prior approval 
from the Human Investigation Committee. Implementing changes in the 
protocol/consent without HIC approval may result in the approval of your research 
study being revoked, necessitating cessation of all related research activity. 
Request for modification to the protocoljconsent must be outlined on an 
amendment form (available on the HIC website) and submitted to the HIC for 
review. 
St. John's. NL. CanaJa AlB 3V6 • Tel. : 1709) 777-6974 • F.u:: 17091 777·8776 • email: hic@mun .c.l • www. med . mun.o;r.•~ 
s as 
h Ethics Board (the HIC) has reviewed and approved the appli:ation and 
t form ior the study which is to be conducted by you as the qualified 
tigator named above at the specified study site. This approval and the \·ie .. ,·s of 
Research Ethics Board have been documented in writing. In addition, please be 
· ed that the Human Investigation Committee currently operates according to the 
·Tri-Council Policy Statement and applicable laws and regulations. The membership 
of this research ethics board complies with the membership requirements for research 
ethics boards defined in Division 5 of the Food and Drug Regulations. 
Notwithstanding the approval of the HIC, the primary responsibility for the ethical 
conduct of the investigation remains with you. 
We wish you every success with your study. 
6~ · · Sincerely, 
John D. Harnett, MD, FRCPC 
Co-Chair 
Human Investigation Corrunittee 
JDH;RSN\jd 
· hard S. Neuman, PhD 
Co-Chair 
Human Investigation Committee 
C Dr. C. Loomis, Vice-President (Research), tvfVN 
f'..U. \V. !vliller, Director of Planning & Research, HCCSJ 
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.._ ,_ ,' 30 / 05 13: 09 FAX 7097572411 NLCHI 
_ _ L------ ---- ------------- --- --
GOVERNMENT OF 
NEWFOUNDLAND AND LABRADOR 
Department of Health and Community Services 
Planning and Evaluation Divisjon 
Laurie K. Twells 
Division of Clinical Epidemiology 
School of Medicine 
September 30, 2005 
Memorial University ofNewfoundla.nd 
St. John's NL AlB 3V6 
Dear Mrs. Twells: 
~004 
I am WTiting in support of your study entitled <'Health services utilization, associated 
factors, and direct cost of health services among obese vs. non-obese populations: 
Newfoundland and Labrador,' . 
Tbe Department of Health and Community Services, Newfoundland and Labrador 
r~cognizes the value in investigating "obesity'' in the province ofNewfoundland and Labrador, 
specifically as it relates to our strategic direction to improve population health il1 our province. I 
grant you permission to use the CCHS 1.1 link file for this study and look forward to the final 
report. 
/cmt 
Sincerely, 
Regina Co(tdy 
Director 
1?.0. ox S7QO, St . John's, Nawfoundland, Canada. A l 4JB, Telephone: 7Z9-0 730. Facs <rnile: 729-3940 
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"'- '\. ~\\TO .. Jr'dldnd & ;..ab:;;dor 
Centre for 
Health Information 
August 26, 2005 
Laurie K.. Twells 
Division of Clinical Epidemiology 
School of Medicine 
Memorial University of Newfoundland 
Dear Mrs. Twells: 
I4J 002 
I am writing in support of your study entitled "Health senices utilization, associated 
factors, and direct cost of health services among obese vs. non-obese populations: 
Newfoundland and Labrador". 
The Newfoundland and Labrador Centre for Health Information recognizes the value in 
investigating "obesity" in the province ofNewfoundland and Labrador. I look forward to 
reading your final report. 
Sincerely, 
../'St e O'Reilly 
ChiefExecutive Officer 
/ 
Jlf' Crosbie Building 
1 C rosbie Place 
St. John's, Nl A1B 3Y8 
Te lephone: (709) 757- 2400 
Facsimile: (709) 757-2411 
C Registry Integ rity Unit 
Harbour lodge ,'-Jursing Home 
86 HighroJd South 
Carbon ear, Nl A 1Y 1A4 
Telephone: (709) 945-5332/1/ 5 
Facsimile: (709) 945-5340 
November 11 1h, 2005 
Laurie K Twells 
Clinical Epidemiology Unit 
Faculty of Medicine 
Memorial University of Newfoundland 
300 Prince Philip Drive 
St. John's, NL A 1 B 3V6 
Dear~, 
Telephone: 709-945·5335 • Facsimile: 709·945·5340 
The Centre for Health Information, on behalf of the Department of Health and 
Community Services, is the guardian of three datasets that will be utilized for your study 
entitled "Health services utilization, associated factors, and direct cost of health 
services among obese vs. non-obese populations in Newfoundland and 
Labrador". By way of this letter, I approve limited access to data in the Canadian 
Community Health Survey (CCHS 1.1 ), the Medical Care Plan database (MCP) and the 
Clinical Database Management System (CDMS) for the purposes of your study. Please 
note that your access to this data will be limited to de-identified, anonymous 
information only. 
The Newfoundland and Labrador Centre for Health Information supports your research 
on obesity in this province. I look forward to reading your final report. 
Sincerely, 
' I 
--------f--------------------------------------------------------------------------------------· 
www.nlchi.nl.ca • www.healthy.nl.ca 
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September 12, 2005 
Laurie K. Twells 
GOVERNMENT OF 
NEWFOUNDLAND AND LABRADOR 
Department of Health and Community Services 
Audit and Claims Integrity 
NL Centre for Applied Health Research 
95 Bonaventure Avenue Suite 300 
St. John's NL AlB 3V6 
Dear Mrs. Twells: 
I am writing in support of your study entitled "Health services utilization, associated factors, and 
direct cost of health services among obese vs. non-obese populations: Newfoundland and 
Labrador". 
The Newfoundland Medical Care Plan (MCP) supports this project as we feel it would facilitate 
important research specific to obesity in this province. I wish you every success. 
Sincerely, 
J ~==~==~===-~~---TONY MAHER, C.A. 
Executive Director 
Belvedere Building • 57 Margaret's Place 
P.O. Box 8700 · St. John's · Newfoundland and Labrador • Canada · A1 B 4J6 
Telephone: (709)758-1599 • Facsimile: (709)758-1575 • E-mail: tonymaher@gov.nl.ca • www.gov.nl.ca/health 
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poisson_reg_utili zation.txt 
MODEL1A- ACTUAL GP VISITS (BMI ONLY) 
====================================== 
> model1a <- glm(FFS_G PVS- BMI_4CAT+DHHA_SEX+DHHA_AGE+EDUADH04 +INCADIA5+INST_NEW1 
+SMKA_202 +DHHA_MS+GEOHR 2_R+PACADPAI+ALCADTYP+FAV_ LRV1, weight=WTSA_S,data=newdata, 
fami l y=poi sson) 
call: glm(formula FFS_GPVS - BMI_4CAT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_ LRV1, fami ly = poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
DHHA_ SEXma l e 
DHHA . ...AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST-SEC. 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_ MSCOMMON-LAW 
DHHA_ MSWIOOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
2.3409646 
0. 0622520 
- 0.0035596 
0.4269449 
-0.6051510 
0.0144896 
- 0.1248718 
0. 0008133 
0.0514084 
0.1748392 
- 0.0379547 
- 0.2164000 
- 0.2617300 
-0.1194637 
-0.158 5911 
0.1500639 
- 0.7764669 
0. 0345338 
0. 5041350 
o. 0139847 
0.0844064 
- 0.1618910 
0.2459173 
0. 4767913 
0.1327632 
0.1533851 
- 0.1533460 
0.0263981 
- 0.0115251 
0.3348397 
0.2166951 
0. 3707696 
- 0.0537634 
std. Error 
0.1899245 
0. 0568 754 
0.0691163 
0. 0871131 
0.0531523 
0.0023982 
0.0838556 
0.1195328 
0. 0688113 
0. 3816503 
0.1061748 
0.0999094 
0.1033523 
0 . 1190542 
0.1500044 
0.0586947 
0.1160570 
0.0652154 
0.1150122 
0.0574108 
0. 0861314 
0.1539440 
0 . 1806905 
0.1170116 
0.0800236 
0. 0503311 
0.0864265 
0.0732186 
0.1654510 
0.0595149 
0. 0722688 
0.0856700 
0.0555837 
z value Pr(>lzl) 
12.326 < 2e-16 *** 
1.095 0.27372 
-0.052 0.95893 
4.901 9.53e- 07 *** 
- 11.385 < 2e-16 *** 
6.042 1.52e- 09 *** 
-1.489 0 . 13645 
0.007 0.99457 
0.747 0.45501 
0.458 0.64687 
-0.357 0.72074 
- 2.166 0.03031 * 
-2.532 0.01133 * 
- 1.003 0. 31565 
- 1.057 0.29040 
2.557 0 . 01057 ~: 
- 6.690 2.23e-11 *** 
0.530 0.59643 
4.383 1.17e- 05 *** 
0.244 0.80755 
0.980 0.32710 
-1.052 0.29297 
1.361 0.17352 
4.075 4.61e - 05 *** 
1.659 0.09711 
3.048 0 . 00231 ** 
-1.774 0.07601 
0.361 0.71844 
- 0.070 0.94447 
5.626 1.84e- 08 *** 
2.998 0.00271 ** 
4.328 1.51e- 05 *** 
- 0.967 0 . 33342 
sign if • codes: 0 I ~:1:1: I 0 • 001 I ~:1: I 0 • 01 I I: I 0, 05 I I 0, 1 I I 1 
(Dispers ion parameter for poisson family taken to be 1810 . 236) 
Number of Fisher scoring iterations: 6 
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poisson_reg_utilization . txt 
MODELlB- ACTUAL GP VISITS (CC ONLY) 
===================================== 
> modellb< - glm(FFS_GPVS-CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEW1+ 
SMKA_ 202+DHHA_MS+GEDHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newda ta, 
family=poisson) 
call: glm(formula = FFS_GPVS - CRNC_TOT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_ R + PACADPAI + 
ALCADTYP + FAV_LRV1, family = poisson, data = newdata, weights = WTSA_S) 
coefficients: Estimate Std. Error z value Pr(>lzl) 
(Intercept) 2.357994 0.179413 13.143 < 2e - 16 
-1:-f:'i: 
CRNC_TOT 0. 210327 0.012438 16.911 < 2e-16 
"1:-t:"fc 
DHHA_ SEXma 1 e - 0.540167 0.049641 - 10.881 < 2e-16 
-1:-!c-1: 
DHHA_AGE 0.005074 0.002376 2.136 0.032687 
1
' 
EDUADH04SECONDARY GRAD. -0.077421 0 . 078864 -0.982 0.326245 
EDUADH040THER POST-SEC. -0.014665 0.112676 -0.130 0.896449 
EDUADH04POST-SEC. GRAD. 0.084743 0.064648 1. 311 0.189911 
EDUADH04NOT STATED 0.108242 0.357658 0.303 0.762164 
INCADIA5LOWER MIDDLE -0.040992 0.099599 -0.412 0.680654 
INCADIA5MIDDLE -0.127599 0.093511 - 1.365 0.172399 
INCADIA5UPPER MIDDLE -0.158789 0.096583 - 1. 644 0. 100164 
INCADIA5HIGHEST - 0.019311 0.110749 - 0.174 0.861578 
INCADIA5NOT STATED -0.135312 0.139680 -0.969 0.332683 
INST_NEWlEastern 0.173829 0.054895 3.167 0.001542 
1<1: 
INST_NEW1Northern -0.798695 0.108945 - 7.331 2.28e - 13 
1dd: 
INST_ NEW1Western 0.066543 0. 061332 1.085 0.277936 
SMKA_202DCCASIONALLY 0.522323 0.107924 4. 840 1. 30e- 06 
-!: -!~ -1: 
SMKA_202NOT AT ALL 0.038385 0.053832 0.713 0.475812 
DHHA_ MSCOMMON - LAW 0.064113 0.080550 0.796 0.426069 
DHHA_ MSWIDOWED -0.068102 0.144030 -0.473 0.636331 
DHHA_ MSSEPARATED 0.285127 0.168633 1.691 0.090873 
DHHA_MSDIVORCED 0.492934 0.110432 4.464 8.06e-06 
-tr -fc"!: 
DHHA_MSSINGLE 0.109758 0.076402 1. 437 0.150833 
GEOHR2_Rurban 0.143785 0.047206 3.046 0.002320 
1dr 
PACADPAIMODERATE -0 .193277 0.080829 - 2.391 0.016793 * 
PACADPAIINACTIVE - 0.019497 0.068719 - 0.284 0.776623 
PACADPAINOT STATED - 0.084802 0.155336 - 0.546 0.585117 
ALCADTYPOCC. DRINKER 0.309003 0.055671 5.550 2.85e-08 
'ic-!:'1: 
ALCADTYPFORMER DRINKER 0.168682 0.067830 2.487 0.012889 * 
ALCADTYPNEVER DRANK 0. 311200 0. 080339 3.874 0.000107 
1<1:* 
FAV_ LRV1< 5 servings per day - 0.008733 0.052128 -0.168 0.866956 
signif. codes: 0 ' fdd: ' 0.001 '1:1: ' 0.01 ' 1' ' 0 .05 '.' 0.1' '1 
(Dispersion parameter for poisson family taken to be 1590.012) 
Number of Fi s her s coring iterations: 6 
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poisson_reg_utilization.txt 
MODEL1C- ACTUAL GP VISITS (BMI+CC) 
================================== 
> model1c<-glm(FFS_GPVS~BMI_4CAT+CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEW 
1+SMKA_202+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
family=poisson) 
call: 
glm(formula = FFS_GPVS ~ BMI_4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04 + INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + 
PACADPAI + ALCADTYP + FAV_LRV1, family = poisson, data = newdata, 
weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_4CATobese 
BMI_4CATmorbid obesity 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST-SEC. 
EDUADH04POST-SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_NEW1Eastern 
INST_NEW1Northern 
INST_NEW1Western 
SMKA_2020CCASIONALLY 
SMKA_202NOT AT ALL 
DHHA_MSCOMMON - LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
2.333339 
0.046741 
- 0.058001 
0.293544 
0.206491 
- 0.528978 
0.005565 
- 0.062678 
- 0.023311 
0.097741 
0.141665 
- 0.070982 
- 0.160866 
- 0.177534 
- 0.034828 
- 0.147092 
0.193871 
- 0.787013 
0.078593 
0.538984 
0.027371 
0.058105 
- 0.075465 
0. 321303 
0.481440 
0.106654 
0.135659 
- 0.190291 
- 0.026138 
-0.117027 
0. 314067 
0.155770 
0.316214 
- 0.016345 
Std. Error z value Pr(>lzl) 
0.179372 13.008 < 2e- 16 *** 
0.053104 0.880 0.378763 
0.064793 -0.895 0.370691 
0.082031 3.578 0.000346 *** 
0.012510 16.506 < 2e- 16 *** 
0.050008 - 10.578 < 2e- 16 *** 
0.002370 2.348 0.018877 * 
0.078744 -0.796 0.426045 
0.112234 -0.208 0.835463 
0.064447 1.517 0.129364 
0.356465 0.397 0.691061 
0.099588 - 0.713 0.475996 
0.093426 - 1.722 0.085094 
0.096358 -1.842 0.065410 
0.110383 -0.316 0.752369 
0.139318 - 1.056 0.291060 
0.055102 3.518 0.000434 *** 
0.108558 - 7.250 4.18e- 13 *** 
0.061323 1.282 0.199976 
0.107550 5.011 5.40e-07 *** 
0.053944 0.507 0.611883 
0.080232 0.724 0.468934 
0.143534 - 0.526 0.599054 
0.168509 1.907 0.056555 
0.109888 4.381 1.18e-05 *** 
0.076162 1.400 0.161405 
0.047094 2.881 0.003969 ** 
0.080735 - 2.357 0.018424 * 
0.068600 - 0.381 0.703193 
0.154904 -0.755 0.449962 
0.055548 5.654 1.57e- 08 *** 
0.067997 2.291 0.021973 * 
0.080129 3.946 7.94e- 05 *** 
0.052044 - 0.314 0.753483 
Signif. codes: 0 '***' 0.001 ' **' 0.01 ' * ' 0.05 '. 1 0.1 1 1 1 
(Dispersion parameter for poisson family taken to be 1577.281) 
Number of Fisher scoring iterations: 6 
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poisson_reg_utilization.txt 
MODEL2A- ACTUAL VISITS WITH SPECIALIST ( BMI ONLY) 
=========================================== 
> model2a<-glm(FFS_ SPEC- BMI_4CAT+DHHA_ SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEWl+SMKA 20 
2+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_ LRV1, weight=WTSA_S,data=newdata, -
fami 1 y=poi s son) 
call: glm(formula = FFS_SPEC - BMI_4CAT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_ LRV1, family= poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
DHHA_SEXma l e 
DHHA_j,GE 
EDUADH04SECONDARY GRAD . 
EDUADH040THER POST- SEC . 
EDUADH04POST-SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIASNOT STATED 
INST_ NEW1Eastern 
INST_ NEWlNorthern 
INST _ NEW1Western 
SMKA_2020CCASIONALL Y 
SMKA_ 202NOT AT ALL 
OHHA_ MSCOMMON - LAW 
OHHA_ MSWIDOWED 
DHHA_ MSSEPARATED 
OHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
1.523506 
0 . 094175 
- 0.021141 
0.185704 
-0.316710 
0.029248 
- 0.235502 
- 0.185489 
- 0.094227 
- 0.224637 
-0.321848 
- 0.364202 
- 0. 368614 
-0 . 396563 
- 0.420483 
- 0.200685 
-0.515259 
- 0.227293 
- 0.271299 
0.161290 
- 0.024140 
- 0.384762 
0.955212 
- 0.055880 
0.287884 
0.058892 
0.121799 
0.357911 
0. 361342 
0.140784 
0.038034 
0.339649 
- 0.092140 
Std. Error 
0.233208 
0.068473 
0.083507 
0 . 116096 
0.063359 
0.002946 
0. 099136 
0.151695 
0.080464 
0.492539 
0.127870 
0.116731 
0.120586 
0.143434 
0.183128 
0.070413 
0.118626 
0.078527 
0.191482 
0.070740 
0.114059 
0.191123 
0.171135 
0.177569 
0.096896 
0.060274 
0.113142 
0.098469 
0.184046 
0.074879 
0.088570 
0.097943 
0.066791 
z value Pr(>l z l) 
6.533 6.45e- 11 *** 
1. 375 0.169024 
- 0.253 0.800139 
1 . 600 0.109693 
-4.999 5.77e- 07 *** 
9.928 ~ 2e- 16 *** 
- 2. 376 0.017523 * 
-1.223 0~ 221413 
-1. 171 0. 241581 
- 0.456 0.648333 
-2.517 0.011836 * 
- 3. 120 0.001808 ** 
- 3 . 057 0.002237 ** 
-2.765 0.005696 ** 
-2.296 0.021669 * 
-2.850 0.004371 ** 
-4.344 1.40e- 05 *** 
-2 .894 0.003798 ** 
- 1.417 0.156530 
2.280 0.022604 * 
- 0.212 0.832384 
- 2.013 0.044097 * 
5.582 2.38e -08 *** 
- 0.315 0. 752994 
2.971 0.002968 ** 
0.977 0.328529 
1. 077 0. 281694 
3.635 0.000278 *** 
1.963 0 . 049609 * 
1. 880 0. 060086 
0.429 0.667615 
3.468 0 .000525 *** 
- 1.380 0.167734 
signif. codes: 0 · ~dd: ' 0.001 · ~d' ' 0.01 · ~, · 0.05' '0.1' '1 
(Dispersion parameter for poisson family taken to be 1934.381) 
Number of Fisher scoring iterations: 6 
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MODEL2B - ACTUAL VISITS WITH SPECIALIST (CC ONLY) 
============================================= 
> model2b<-glm(FFS_SPEC- CRNC_TOT+DHHA_ SEX+DHHA_AGE+EDUADH04+INCADIA5 +I NST_NEW1+SMKA_2 0 
2+DHHA_MS+GEOHR2_R+PACADPAI +ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newda t a , 
fami 1 y=poi sson) 
call: glm(formula = FFS_SPEC - CRNC_TOT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_ NEW1 + SMKA_ 202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_LRV1, family = po i sson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
CRNC_TOT 
DHHA_SEXma 1 e 
DHHA_AGE 
EDUADH04SECONDARY GRAD . 
EDUADH040THER POST- SEC . 
EDUADH04POST-SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_NEW1Eastern 
INST_NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
DHHA_ MSCOMMON - LAW 
OHHA_ MSWIDOWED 
OHHA_ MSSEPARATED 
OHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC . DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPN EVER DRANK 
FAV_LRV1< 5 servings per day 
Estimate 
1. 49514 
0.22869 
- 0 . 22987 
0.01946 
-0.16467 
-0.23604 
- 0.05727 
- 0.27441 
- 0 . 34240 
- 0.27257 
- 0.22236 
- 0.23777 
- 0.42800 
- 0.15767 
- 0.52757 
- 0.15185 
- 0.18176 
0.17011 
- 0 . 04877 
- 0 . 26835 
0.96036 
- 0.01986 
0.275 26 
0.02795 
0.06732 
0. 27870 
0. 27150 
0.13043 
- 0 . 03940 
0.27509 
- 0.03147 
Std. Error 
0.22033 
0.01416 
0.05938 
0.00292 
0.09364 
0.14290 
0.07573 
0.46218 
0.12052 
0.11000 
0.11330 
0.13414 
0.17073 
0.06599 
0.11161 
0.07405 
0. 17983 
0.06658 
0.10692 
0 . 17900 
0.15986 
0.16713 
0.09263 
0.05662 
0 . 10625 
0.09267 
0.17 266 
0 . 07021 
0.08378 
0.09204 
0.06284 
si gni f. codes : 0 ' *** ' 0 . 001 ' ** ' 0 . 01 ' * ' 0.05 
z value Pr(>lz l ) 
6.786 1.15e- 11 *** 
16.150 < 2e - 16 *** 
- 3.871 0.000108 *** 
6.665 2.64e- 11 *** 
-1.759 0. 078657 
- 1.652 0.098577 
-0.756 0.449471 
- 0.594 0.552694 
-2 . 841 0.004498 ** 
- 2.478 0.013215 * 
- 1.963 0.049698 * 
- 1.773 0. 076297 
- 2.507 0.012178 * 
- 2.389 0.016887 * 
-4.727 2.28e-06 *** 
- 2.050 0.040321 * 
- 1.011 0.312133 
2.555 0.010623 1' 
-0.456 0.648279 
- 1.499 0.133835 
6.007 1.89e- 09 *** 
- 0.119 0.905409 
2.972 0 . 002962 ** 
0.494 0.621603 
0.634 0.526320 
3.007 0.002635 ** 
1. 573 0.115831 
1.858 0.063222 
- 0.470 0.638176 
2.989 0.002801 ** 
- 0.501 0.616484 
' ' 
0,1 I I 1 
(Di s per s ion parameter for poisson f amily taken to be 1702. 554) 
Number of Fi s he r scoring ite r a t i on s : 6 
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MODEL2C- ACTUAL VISITS SPECIALIST(BMI+CC) 
===================================== 
2> model2c< - glm(FFS_SPEC- BMI_4CAT+CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5 +I NST_NEW 
1+5MKA_202+DHHA_MS+GEOHR2_R+PACADPAI +ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
family=poisson) 
call: glm(formula = FFS_ SPEC - BMI_4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04 + INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + 
PACADPAI + ALCADTYP + FAV_LRV1, family= poisson, data = newdata, 
weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST-SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_NEW1Eastern 
INST_NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_MSCOMMON - LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
1. 482100 
0.083906 
- 0.097490 
0.005933 
0.231293 
- 0 .227690 
0 . 019321 
- 0.155650 
-0.236686 
- 0.049522 
- 0.251503 
- 0.355817 
-0.281827 
- 0.235298 
- 0.258584 
- 0.427492 
- 0.150353 
- 0.522894 
- 0.154314 
- 0 . 175646 
0 .178549 
- 0 . 050715 
- 0.261826 
0.990619 
- 0.025671 
0.279371 
0.025679 
0.060597 
0.275694 
0.257949 
0.134391 
- 0.035577 
0.272835 
-0 .031127 
Std. Error 
0.221556 
0.064304 
0.078781 
0.110699 
0.014365 
0.060039 
0.002923 
0.093715 
0.142917 
0.075883 
0.462175 
0.120798 
0.110296 
0.113432 
0.134410 
0.170747 
0.066328 
0.111564 
0.074260 
0.179686 
0.067104 
0.106876 
0.178977 
0.160390 
0.167066 
0.093035 
0.056727 
0.106282 
0.092670 
0.172977 
0.070178 
0.084211 
0.092017 
0.062892 
z value Pr(>lzl) 
6.690 2.24e-11 *** 
1.305 0.191955 
-1.237 0. 215909 
0.054 0.957256 
16.101 < 2e- 16 *** 
-3 .792 0.000149 *** 
6.609 3.86e-11 *** 
-1.661 0.096736 
- 1.656 0.097700 
- 0.653 0.514004 
- 0.544 0.586323 
-2.946 0.003224 ** 
-2.555 0.010613 * 
- 2.074 0.038046 * 
-1.924 0.054375 
-2.504 0.012292 * 
-2 .267 0.023402 * 
-4 .687 2.77e - 06 *** 
- 2.078 0.037708 * 
- 0.978 0.328313 
2.661 0.007796 ** 
-0.475 0.635127 
-1.463 0.143493 
6.176 6.56e - 10 *** 
- 0.154 0.877878 
3.003 0 . 002675 ** 
0.453 0.650787 
0.570 0.568574 
2.975 0.002930 ** 
1. 491 0 .13 5902 
1. 915 0. 05 5492 
-0.422 0.672683 
2 . 965 0.003026 ** 
- 0.495 0.620647 
signif . codes: 0 ' 1'~d' ' 0.001 ~ ~'* 1 0.01 ~ ~, ~ 0 . 05 I . I 0.1 I I 1 
(Di s persion parameter for poisson family taken to be 1699.571) 
Number of Fisher Scoring iterations: 6 
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poisson_reg_utilization.txt 
MODEL3A: ACTUAL ACUTE VISITS (BMI ONLY) 
======================================= 
> model3a< - glm(ACUTE_VS-BMI_4CAT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEW1+SMKA_20 
2+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
fami l y=poi sson) 
> summary(model8a, dispersion=model8a$deviance/model8a$df . residual ) 
call: glm(formula = ACUTE_VS - BMI_4CAT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_ LRV1, family = poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_4CATobese 
BMI_ 4CATmorbid obesity 
DHHA_SEXmale 
DHHA__AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST _NEW1Eastern 
INST_NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
DHHA_MSCOMMON - LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRVl< 5 servings per day 
Estimate 
- 0.628609 
-0.025819 
-0.191561 
0.257252 
-0.518765 
0.001377 
- 0.086984 
0.068674 
0.088915 
- 0.937840 
0.040146 
- 0. 386334 
-0.328858 
-0.787049 
- 0.793375 
- 0.407040 
0.575277 
- 0.036480 
-0.326842 
0.051245 
0.101500 
- 0.462239 
0.478670 
0.129734 
0 . 297985 
- 0.072176 
-0.050029 
0.195429 
0.610537 
0.420308 
0. 346611 
0.532961 
- 0.130568 
Std. Error 
0.337349 
0.102003 
0.127179 
0.154234 
0.096210 
0.004294 
0.151568 
0.200302 
0.124028 
1.021406 
0.185069 
0.181694 
0.184471 
0.235585 
0.289299 
0.115717 
0.126556 
0.118094 
0.280171 
0.100721 
0.148666 
0. 338490 
0. 296316 
0.259051 
0.133675 
0.089913 
0.161972 
0.137120 
0.234248 
0.107932 
0.131728 
0.145956 
0.100067 
z value Pr(>lz l ) 
-1.863 0.062409 
-0.253 0.800173 
-1.506 0.132009 
1.668 0.095329 
-5.392 6.97e-08 *** 
0.321 0.748530 
- 0.574 0. 566041 
0.343 0.731708 
0 . 717 0.473441 
- 0.918 0.358522 
0.217 0.828266 
-2.126 0.033479 * 
-1.783 0.074635 
- 3 . 341 0.000835 * ** 
- 2 . 742 0.006099 ** 
- 3 . 518 0.000436 *** 
4 . 546 5.48e-06 *** 
-0.309 0.757394 
- 1.167 0.243381 
0. 509 0. 610903 
0.683 0.494771 
-1.366 0.172067 
1. 615 0.106223 
0.501 0.616508 
2.229 0.025802 1' 
- 0.803 0.422127 
-0.309 0.757419 
1. 42 5 0. 154088 
2.606 0.009151 ** 
3.894 9.85e - 05 *** 
2.631 0 . 008507 •• 
3.652 0.000261 *** 
-1.305 0.191961 
signif. codes: 0 ' ldd• ' 0.001 ' 1d' ' 0.01 ' 1' ' 0.05' '0.1' '1 
(Dispersion parameter for poisson family taken to be 144.0259) 
Number of Fisher scoring iterations: 6 
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MODEL3B : ACTUAL ACUTE VI SITS (CC ONLY) 
====================================== 
> model3b<- glm(ACUTE_VS- CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+I NCADIA5 +INST_NEW1+SMKA_2 0 
2+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S ,data=newdata, 
fami 1 y=poi sson) 
call: glm(formula = ACUTE_VS - CRNC_TOT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_LRVl, family = poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST-SEC. GRAD . 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_ MSCOMMON - LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPN EVER DRANK 
FAV_ LRV1< 5 servings pe r day 
Estimate 
- 0.626620 
0.238310 
- 0.470127 
- 0 . 009323 
- 0.030007 
0.054725 
0.111469 
- 1.059954 
- 0.016062 
- 0.312116 
- 0.220193 
- 0.676800 
- 0 . 783549 
- 0.372397 
0.556643 
0.028716 
- 0.221691 
0.085916 
0.074912 
- 0.359412 
0.475622 
0.144341 
0.250281 
- 0.088382 
- 0.113456 
0.132928 
0.510109 
0.351557 
0. 242241 
0.434751 
- 0.103212 
Std . Error 
0 . 329972 
0.022611 
0.092926 
0.004455 
0.148045 
0.195698 
0 . 121399 
0.993684 
0.180560 
0.176529 
0.179058 
0.228345 
0.280522 
0.112712 
0.123625 
0.115105 
0. 272997 
0. 098338 
0.143965 
0. 329134 
0.287056 
0.252897 
0.132509 
0.087642 
0.157543 
0.133625 
0.228550 
0.105111 
0 . 128471 
0.142036 
0. 097134 
z value Pr(>l z l) 
- 1.899 0.057563 
10.540 < 2e - 16 *** 
- 5.059 4 .21e- 07 *** 
- 2.093 0.036384 * 
-0.203 0.839376 
0.280 0.779753 
0.918 0.358511 
- 1.067 0.286111 
-0.089 0. 929118 
- 1.768 0. 077049 
- 1.230 0. 218799 
- 2.964 0.003037 ** 
- 2.793 0.005219 ** 
- 3.304 0.000953 *** 
4.503 6.71e - 06 *** 
0.249 0.802990 
- 0.812 0.416755 
0 . 874 0. 382290 
0.520 0.602820 
- 1.092 0.274837 
1. 657 0. 097541 
0. 571 0. 568169 
1.889 0.058920 
- 1.008 0.313240 
- 0.720 0. 471427 
0.995 0.319842 
2 . 232 0.025620 1' 
3.345 0.0008 24 *** 
1.886 0.0593 53 
3.061 0.002207 --
- 1.063 0. 287975 
signif. codes: 0 ' 1:1:1: ' 0 . 001 ' 1' 1' ' 0.01 ' 1' ' 0.05' '0.1' '1 
(Di s pe r s ion parame t e r for poisson family taken to be 136.3736) 
Number of Fi sher scoring iterations: 6 
Page 8 
poisson_ reg_utilization.txt 
MODEL3C: ACTUAL ACUTE VISITS (BMI +CC) 
======================================== 
> model3c< - glm(ACUTE_VS-BMI_4CAT+CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+I NST_ NEW 
1+5MKA_202+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
family=poisson)HR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,dat Warning 
message:y=poisson) 
> summary(model8c, dispersion=model8c$deviance/ model8c$df.residual) 
call: glm(formula = ACUTE_VS - BMI_ 4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04 + INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + 
PACADPAI + ALCADTYP + FAV_LRV1, family= poisson, data = newdata, 
weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
CRNC_ TOT 
DHHA_ SEXmale 
DHHA__AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST- SEC. GRAD . 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_ MSCOMMON-LAW 
DHHA_ MSWIDOWED 
DHHA_ MSSEPARATED 
DHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_ Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
-0 . 597965 
- 0.044114 
- 0.235328 
0.153535 
0.237892 
-0.434086 
- 0.009114 
- 0 . 004344 
0.045573 
0.133307 
- 0.985173 
- 0.037131 
- 0.342040 
- 0.243522 
-0.693028 
-0.807401 
- 0.365076 
0.570850 
0.030954 
- 0.223153 
0.081530 
0.066064 
- 0.355746 
0.499317 
0.122545 
0.239611 
- 0.103884 
- 0.095713 
0.134724 
0.471432 
0.364798 
0. 247734 
0.437050 
- 0.099278 
std. Error 
0. 331703 
0.099196 
0.124093 
0.150855 
0. 022732 
0 . 094238 
0.004456 
0.148756 
0.195908 
0.121851 
0.993231 
0.181309 
0.177346 
0.179395 
0.228355 
0. 280412 
0.113320 
0.123625 
0.115384 
0.272810 
0.098805 
0.143962 
0.328969 
0.288406 
0.252512 
0.132677 
0.087969 
0.157664 
0.133745 
0 . 228909 
0.105096 
0.129675 
0.142128 
0.097334 
z value Pr(>lzl) 
-1.803 0.071433 
- 0.445 0.656525 
-1.896 0.057910 
1.018 0.308790 
10. 465 < 2e- 16 *** 
-4.606 4.10e - 06 *** 
-2.045 0.040844 * 
- 0.029 0.976703 
0.233 0.816054 
1. 094 0. 273947 
- 0.992 0.321253 
-0.205 0.837735 
-1.929 0.053773 
-1.357 0.174633 
- 3.035 0.002406 ** 
- 2.879 0.003985 ** 
- 3.222 0.001275 ** 
4.618 3.88e-06 *** 
0 . 268 0.788489 
- 0.818 0. 413369 
0.825 0.409279 
0.459 0.646306 
-1.081 0. 279520 
1. 731 0. 083398 
0.485 0.627461 
1. 806 0. 070923 
- 1.181 0. 237638 
-0.607 0.543805 
1.007 0.313781 
2. 059 0. 039449 f: 
3.471 0.000518 *** 
1. 910 0. 056078 
3.075 0.002105 ** 
- 1.020 0.307745 
signif. codes: 0 ' 1' 1' 1' ' 0.001 •t:t: ' 0.01 ' t' ' 0.05 '.' 0.1 ' ' 1 
(Dispersion parameter for poisson family taken to be 136.1035) 
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Number of Fisher scoring iterations : 6 
MODEL4A: ACTUAL VISITS LOS ( BMI ONLY) 
=~~=================================== 
> model4<-glm(ACUTE_ LO- BMI_4CAT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEW1+SMKA_202 
+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
fami 1 y=poi sson) 
call: glm(formula = ACUTE_ LO - BMI_ 4CAT + DHHA_SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_LRV1, family= poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_ 4CATobese 
BMI_4CATmorbid obesity 
DHHA_ SEXma 1 e 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC . 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_NEW1Eastern 
INST_ NEW1Northern 
INST_NEW1Western 
SMKA_2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_ MSCOMMON-LAW 
DH HA_ MSWIDOWED 
DHHA_ MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
-1.066287 
-0 . 203312 
-0.629870 
-0.205329 
- 0.677907 
0.037086 
0.282306 
0. 077378 
0. 461396 
- 1.555127 
- 0.796619 
- 1.063631 
- 1.011284 
-2.035191 
- 1.994241 
- 0.140038 
0. 911028 
0.036488 
- 0.176175 
0.083637 
0.838739 
- 0.459901 
0.642423 
0.621599 
1.242737 
0.083080 
0.236582 
0.790910 
2.055568 
0 . 328181 
0.286058 
0.812373 
0 . 108310 
std. Error 
0.395346 
0.112430 
0.154618 
0.190021 
0.112435 
0.004814 
0.161296 
0.244620 
0.137956 
1. 860592 
0.168110 
0.153486 
0.160124 
0. 278716 
0.347470 
0.134833 
0.143628 
0.139805 
0.300855 
0.114175 
0.153602 
0.354941 
0. 346772 
0.242960 
0.143543 
0 . 102510 
0. 227273 
0.194292 
0.240179 
0.124490 
0.157939 
0.150668 
0.121470 
z value Pr(>lzl) 
- 2.697 0.006995 ** 
- 1.808 0.070553 
- 4.074 4.63e - 05 *** 
- 1.081 0.279893 
- 6.029 1 . 65e- 09 *** 
7.703 1.33e- 14 *** 
1. 750 0.080077 
0.316 0.751759 
3.345 0.000824 *** 
- 0.836 0 . 403254 
- 4.739 2.15e-06 *** 
- 6.930 4.21e- 12 *** 
- 6.316 2.69e- 10 *** 
-7.302 2.83e- 13 *** 
- 5.739 9.51e- 09 *** 
- 1.039 0.298988 
6.343 2.25e- 10 *** 
0.261 0.794097 
- 0.586 0 . 558157 
0.733 0.463841 
5.460 4.75e-08 *** 
- 1.296 0.195075 
1.853 0.063942 
2.558 0 . 010514 1' 
8.658 < 2e- 16 *** 
0.810 0.417677 
1. 041 0. 297893 
4 .071 4.69e - 05 *** 
8.558 < 2e- 16 *** 
2 . 636 0.008384 ** 
1.811 0 . 070110 
5 . 392 6 . 98e - 08 *** 
0 . 892 0 . 372576 
signif. codes: 0 1 1rH: I 0.001 l ,•(1: l 0.01 1 1' 1 0 . 05 1 I 0 . 1 I I 1 
(Dispersion parameter for poisson family taken to be 1114.435) 
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MODEL4B: ACTUAL ACUTE LOS (CC ONLY) 
=================================== 
> model4b<-glm(ACUTE_ LO- CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+I NST_NEW1+SMKA_2 0 
2+DHHA_MS+GEOHR2_ R+PACADPAI+ALCADTYP+FAV_ LRV1, weight=WTSA_S,data=newda t a , 
family=poisson) 
call : glm(formula = ACUTE_ LO - CRNC_TOT + DHHA_ SEX + DHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_ R + PACADPAI + 
ALCADTYP + FAV_ LRV1, family = poisson, data = newdata, weights = WTSA_S ) 
coefficients: 
(Intercept) 
CRNC_TOT 
DHHA_SEXma 1 e 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_ MSCOMMON - LAW 
DHHA_ MSWIDOWED 
DHHA_ MSSEPARATED 
DHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCAOTYPOCC. DRINK ER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
- 1.127294 
0.301845 
- 0.604013 
0.024167 
0.421262 
- 0.012976 
0.454333 
-1. 654119 
- 0.905971 
- 1.0043 55 
- 0.837389 
- 1.817744 
- 1.889484 
- 0.094693 
0.883524 
0.161006 
0.017599 
0.078301 
0.848022 
- 0.336366 
0.415221 
0.608895 
1. 234416 
0.053605 
0.087360 
0.648442 
1.785045 
0.234478 
0.067594 
0.672358 
0.075712 
std. Error 
0.386370 
0.024042 
0.109400 
0.004998 
0.156629 
0.236489 
0 . 133570 
1. 795511 
0.165141 
0.148320 
0.154847 
0. 269143 
0.335531 
0.130497 
0.139104 
0.136355 
0.291522 
0.110484 
0.147328 
0. 343218 
o. 340451 
0.234736 
0.143686 
0.099066 
0 . 219208 
0.187822 
0. 234278 
0.120865 
0.152936 
0.145066 
0 . 117363 
z value Pr(> lzl) 
- 2.918 0.003527 ** 
12.555 < 2e - 16 *** 
- 5.521 3.37e- 08 *** 
4.835 1.33e- 06 *** 
2.690 0.007155 ** 
- 0.055 0 . 956241 
3.401 0 . 000670 *** 
- 0.921 0.356919 
- 5.486 4.11e - 08 *** 
- 6.772 1.27e- 11 *** 
- 5.408 6.38e - 08 *** 
- 6.754 1.44e- 11 *** 
- 5.631 1 . 79e - 08 *** 
- 0 . 726 0.468062 
6.352 2.13e- 10 *** 
1.181 0.237686 
0.060 0.951860 
0.709 0.478504 
5.756 8.61e- 09 *** 
- 0.980 0.327069 
1.220 0.222609 
2.594 0.009488 ** 
8.591 < 2e- 16 *** 
0.541 0.588436 
0.399 0 . 690242 
3.452 0 . 000556 *** 
7.619 2 . 55e- 14 *** 
1. 940 0. 052381 
0.442 0.658507 
4.635 3 . 57e- 06 *** 
0 . 645 0.5188 59 
signif . codes: 0 ' 1dd: ' 0 . 001 ' 1:1: ' 0.01 ' 1' ' 0.05' '0 .1' '1 
(Di s pe rsion parameter f or poisson f amily taken to be 1038 . 505) 
Number of Fisher scoring ite rations: 7 
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MODEL4C: ACTUAL ACUTE LOS (BMI + CC) 
===================================== 
> model4C< - glm(ACUTE_ LO- BMI_4CAT+CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04 +I NCADIA5 +INST_NEW 
1+5MKA_202+DHHA_MS+GEOHR2_ R+PACADPAI+ALCADTYP+FAV_ LRV1, weight=WTSA_S ,data=newda ta, 
family=poisson) 
> summary(model9c, di s persion=model9c$deviance/ model9c$df.residual) 
call: glm(formula = ACUTE_ LO - BMI_ 4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04 + INCADIA5 + INST_ NEW1 + SMKA_ 202 + DHHA_MS + GEOHR2_R + 
PACADPAI + ALCADTYP + FAV_LRV1, family = poisson, data = newdata, 
weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC . 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST _NEW1Eastern 
INST_ NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_MSCOMMON- LAW 
DHHA_ MSWIDOWED 
DHHA_ MSSEPARATED 
DHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRIN KE R 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_LRV1< 5 servings per day 
Estimate 
- 1.025232 
- 0.182979 
- 0.649896 
- 0.280339 
0. 305881 
- 0.533563 
0.023623 
0.418586 
- 0.037582 
0.442093 
- 1.528528 
- 0.883201 
- 0.970571 
- 0.817781 
- 1.798047 
- 1.869330 
- 0.100377 
0.916886 
0.136858 
o. 028413 
0.116477 
0.815991 
- 0.275395 
0. 355318 
0 . 604929 
1. 222225 
0.029781 
0.147409 
0.675981 
1. 737475 
0.264606 
0.149843 
0. 698121 
0.092908 
std. Error 
0.390524 
0.109013 
0.149617 
0.185092 
0.024262 
0.110222 
0.005026 
0.156585 
0.236290 
0.133121 
1. 785793 
0.166937 
0.149998 
0.155483 
0.268609 
0.333622 
0.131088 
0.139085 
0.136458 
0.290358 
0.112035 
0.147372 
0 . 341794 
0.343759 
0.233636 
0.144444 
0.099585 
0.218650 
0.187144 
0 .234102 
0 . 119960 
0 . 154376 
0.144891 
0.117113 
z value Pr(>lzl) 
- 2.625 0.008658 ** 
- 1.679 0. 093248 
- 4.344 1.40e- 05 *** 
-1.515 0.129877 
12.608 < 2e-16 *** 
- 4.841 1 . 29e- 06 *** 
4.700 2.60e- 06 *** 
2.673 0.007513 ** 
- 0.159 0.873629 
3.321 0.000897 *** 
-0.856 0.392032 
- 5.291 1.22e-07 *** 
- 6.471 9 . 76e- 11 *** 
- 5 . 260 1.44e-07 *** 
- 6.694 2.17e- 11 *** 
- 5.603 2 . 10e- 08 *** 
- 0.766 0 . 443845 
6.592 4 . 33e- 11 *** 
1. 003 0. 315893 
0.098 0.922046 
1.040 0.298506 
5.537 3.08e-08 *** 
- 0 . 806 0 . 420397 
1. 034 0. 301311 
2.589 0 . 009620 ** 
8.462 < 2e- 16 *** 
0.299 0.764899 
0. 674 0 . 500199 
3.612 0.000304 *** 
7.422 1 . 15e-13 * ** 
2 .206 0.027399 J. 
0.971 0.331728 
4.818 1. 45e- 06 ** * 
0 . 793 0 . 427591 
signif. codes: 0 ' 1"~ 1' 1 0 . 001 ' 1' 1' 1 0.01 1 1' 1 0.05 I. I 0.1 ' ' 1 
(Dispersion parameter for pois son family taken to be 1026 . 980) 
Number of Fisher scoring iterations: 7 
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MODEL5A: ACTUAL ACUTE SOC (BMI ONLY) 
===~================================= 
> model5a<- glm(SDC_VSTS- BMI_4CAT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADI A5 +INST_NEW1+SMKA_20 
2+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata , 
family=poisson) 
call: glm(formula = SDC_VSTS - BMI_4CAT + DHHA_SEX + OHHA_AGE + EDUADH04 + 
INCADIA5 + INST_ NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_ LRV1, family = poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_4CAToverweight 
BMI_4CATobese 
BMI_4CATmorbid obesity 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
DHHA_MSCOMMON - LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2_ Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_ LRV1< 5 servings per day 
Estimate 
-2.088341 
0.260275 
0.228591 
0.001941 
-0.547964 
0.021738 
-0.177872 
- 0.200807 
- 0.150481 
0.862524 
0.471479 
0.239356 
0.173757 
0.295517 
0.234946 
0.189150 
- 0.098127 
- 0.269842 
-1.083640 
- 0.043794 
0.164881 
- 0.676355 
0.478001 
- 0.167100 
- 0.093595 
-0 . 073788 
0.050583 
0.152617 
- 0.526497 
0.239273 
0.143169 
0.054640 
- 0.0333 20 
Std. Error 
0.375291 
0.105382 
0.123769 
0.200568 
0.097939 
0.004496 
0.148792 
0. 234112 
0.123176 
0.431359 
0.231475 
0.222836 
0.228640 
0.254188 
0.320919 
0.106230 
0.163583 
0.131607 
0.411389 
0.102842 
0.152373 
0.326530 
0. 311847 
0.294855 
0 . 162438 
0.090533 
0.164509 
0.143973 
0.386358 
0.110765 
0.132007 
0.167755 
0.103811 
z value 
- 5.565 
2.470 
1.847 
0.010 
-5.595 
4.835 
- 1.195 
- 0.858 
-1.222 
2.000 
2.037 
1.074 
0.760 
1.163 
0.732 
1. 781 
- 0.600 
-2.050 
-2.634 
-0.426 
1. 082 
- 2.071 
1.533 
- 0.567 
- 0.576 
- 0.815 
0. 307 
1.060 
- 1.363 
2.160 
1. 085 
0. 326 
- 0.321 
Pr(>lzl) 
2. 63e - 08 1d'* 
0 . 0135 2 1' 
0.06476 
0.99228 
2. 21e- 08 ~d' * 
1. 33e- 06 1:1'* 
0. 23192 
0.39103 
0. 22183 
0. 045 55 1' 
0.04167 * 
0. 28276 
0. 44728 
0.24500 
0.46411 
0.07498 
0.54860 
0.04033 1' 
0. 00844 ·H 
0.67023 
0.27921 
0.03833 ~ 
0.1253 2 
0.57091 
0. 56449 
0.41505 
0 . 75848 
0. 28912 
0.17297 
0. 03076 ~: 
0. 27812 
0. 74464 
0 .748 24 
Signif. codes : 0 ' 1:i'* ' 0 . 001 · ~dr ' 0.01 ' 1' ' 0.05' '0.1' '1 
(Dispersion parameter for poisson family taken to be 123.019) 
Number of Fisher scoring iterations: 6 
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MODEL5B: ACTUAL ACUTE SOC ( CC ONL Y) 
~~==================================== 
> model5b< - glm(SDC_VSTS- CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+I NST_NEW1+SMKA_20 
2+ DHHA_MS +GEOHR2_R+PACADPAI+ALCADTYP+FAV_L RV1, weight=WTSA_S,data=newdata, 
fami l y=poi sson) 
> summary(model10b, dispersion=model10b$deviance/model10b$df.residual) 
call: glm(formula = SOC_VSTS - CRNC_TOT + OHHA_SEX + OHHA_AGE + EDUADH04 + 
INCADIA5 + INST_NEW1 + SMKA_202 + DHHA_MS + GEOHR2_R + PACADPAI + 
ALCADTYP + FAV_ LRV1, family = poisson, data = newdata, weights = WTSA_S) 
coefficients: 
(Intercept) 
CRNC_TOT 
OHHA_S EXma l e 
DHHA_AGE 
EOUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EOUADH04POST- SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
INCADIA5MIDDLE 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_NEW1Eastern 
INST_NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
DHHA_ MSCOMMON - LAW 
DHHA_ MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_ MSDIVORCED 
DHHA_ MSSINGLE 
GEOHR2_Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_LRV1< 5 servings per day 
Estimate 
- 2.0411139 
0.1935180 
-0.4441761 
0 . 0141684 
- 0.1367027 
-0.2155553 
- 0.0995108 
0.8429553 
0.4359935 
0.3000487 
0.2584447 
0. 4071812 
0 . 1896954 
0.2363303 
- 0.0881692 
- 0.2103572 
- 1.0330822 
-0.0262724 
0.1376341 
- 0.5768532 
0. 5066644 
- 0.1316941 
-0.1465718 
- 0.1179543 
0.0248815 
0.1106938 
- 0.6085588 
0. 2200003 
0. 0718515 
0.0009991 
0.0278848 
std. Error 
0.3704344 
0.0235414 
0.0959302 
0.0046302 
0.1472525 
0.2311582 
0.1217675 
0.4250432 
0.2281097 
o. 2193108 
0. 2246040 
0.2492520 
0.3144755 
0.1047445 
0.1613208 
0.1300899 
0.4048501 
0 . 1014758 
0.1492647 
0.3209179 
0. 3060526 
0.2904878 
0 .1614577 
0 . 0892717 
0 . 1620869 
0.1421834 
0.3804542 
0 . 1087140 
0.1307840 
0.1656270 
0.1025146 
z value 
- 5. 510 
8.220 
-4 .630 
3.060 
- 0.928 
- 0.933 
- 0.817 
1. 983 
1. 911 
1. 368 
1.151 
1. 634 
0.603 
2.256 
- 0.547 
-1. 617 
- 2.552 
- 0.259 
0.922 
- 1.798 
1. 655 
- 0.453 
-0.908 
- 1.321 
0 . 154 
0. 779 
- 1.600 
2.024 
0. 549 
0.006 
0.272 
Pr(>lzl) 
3.59e- 08 1ddt 
< 2e-16 * 1:1' 
3. 65e - 06 1'** 
0.00221 H 
0.35322 
0.35108 
0.41380 
0.04734 J. 
0.05596 
0.17127 
0.24987 
0 .10234 
0.54637 
0 . 02405 ~' 
0. 58469 
0.10588 
0 . 01072 ~: 
0.79571 
0.35649 
0.07225 
0 . 09783 
0.65029 
0.36398 
0.18640 
0.87800 
0.43626 
0 . 10970 
0.04300 " 
0 . 58274 
0 . 99519 
0.78562 
signif. codes: 0 ' 1:t:t: ' 0.001 ' 1:1'' 0.01 ' '' ' 0.05' '0.1' '1 
(Dispersion parameter for poisson family taken to be 119.0912) 
Number of Fisher scoring iterations: 6 
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MODEL5C: ACTUAL VISITS SOC (BMI ~ CC) 
=============================== -- ~==== 
> model5C< - glm(SDC_VSTS-BMI_4CAT+CRNC_TOT+DHHA_SEX+DHHA_AGE+EDUADH04+INCADIA5+INST_NEW 
1+5MKA_202+DHHA_MS+GEOHR2_R+PACADPAI+ALCADTYP+FAV_LRV1, weight=WTSA_S,data=newdata, 
fami l y=poi sson) 
call : glm(formula = SDC_VSTS - BMI_4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04 + INCADIA5 + INST_NEW1 + SMKA_2 02 + DHHA_MS + GEOHR2_R + 
PACADPAI + ALCADTYP + FAV_ LRV1, family = poisson, data = newdata, 
weights = WTSA_S) 
coefficients: 
(Intercept) 
BMI_ 4CAToverwei ght 
BMI_4CATobese 
BMI_4CATmorbid obesity 
CRNC_TOT 
DHHA_SEXma l e 
DHHA_AGE 
EDUADH04SECONDARY GRAD. 
EDUADH040THER POST- SEC. 
EDUADH04POST-SEC. GRAD. 
EDUADH04NOT STATED 
INCADIA5LOWER MIDDLE 
I NCAD IA 5MIDDL E 
INCADIA5UPPER MIDDLE 
INCADIA5HIGHEST 
INCADIA5NOT STATED 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_NEW1Western 
SMKA_2020CCASIONALLY 
SMKA_202NOT AT ALL 
DHHA_MSCOMMON-LAW 
DHHA_MSWIDOWED 
DHHA_MSSEPARATED 
DHHA_MSDIVORCED 
DHHA_MSSINGLE 
GEOHR2 Rurban 
PACADPAIMODERATE 
PACADPAIINACTIVE 
PACADPAINOT STATED 
ALCADTYPOCC. DRINKER 
ALCADTYPFORMER DRINKER 
ALCADTYPNEVER DRANK 
FAV_LRV1< 5 servings per day 
Estimate 
-2.112285 
0. 261107 
0.179969 
- 0.149755 
0.197743 
- 0.480412 
0.013371 
-0.132188 
- 0.213092 
- 0.105059 
0.804322 
0.426611 
0.298540 
0.244423 
0.382826 
0.206323 
0.249581 
- 0.090600 
- 0.200668 
-1.032102 
-0.017381 
0.149434 
-0.562798 
0.530918 
- 0.098383 
-0.120039 
-0.112997 
-0.009222 
0.097549 
-0.609303 
0.212545 
0.079393 
- 0.008837 
0.015530 
std . Error 
0. 371316 
0.103586 
0.122092 
0.199077 
0. 023774 
0.096837 
0.004638 
0.146942 
0.230696 
0.121792 
0.424827 
o. 228094 
0.219397 
0.224560 
0.249406 
0. 314052 
0.105123 
0.161128 
0.130165 
0.404312 
0.102024 
0.149234 
0.320389 
0.305692 
0.290466 
0.161738 
0.089152 
0.162077 
0.141917 
0. 380189 
0.108772 
0.130618 
0.165311 
0.102541 
z value 
- 5 . 689 
2.521 
1. 474 
- 0.752 
8. 318 
-4 .961 
2.883 
- 0.900 
- 0.924 
- 0.863 
1. 893 
1. 870 
1. 361 
1.088 
1. 535 
0.657 
2.374 
-0.562 
- 1.542 
-2. 553 
- 0.170 
1. 001 
- 1. 757 
1.737 
- 0.339 
- 0.742 
- 1.267 
- 0.057 
0.687 
- 1.603 
1.954 
0 .608 
- 0.053 
0.151 
Pr(>lzl) 
1. 28e-08 1ddr 
0. 01171 * 
0.14047 
0.45190 
< 2e-16 1ddr 
7. 01e - 07 1ddr 
0. 00394 1:1' 
0.36834 
0 . 35565 
0.38835 
0.05832 
0.06144 
0.17360 
0.27640 
0.12480 
0 . 51120 
0.01759 •. 
0.57392 
0.12316 
0. 01069 1' 
0. 86472 
0. 31666 
0.07898 
0.08243 
0 .7 3483 
0.45798 
0. 20499 
0.95462 
0.49185 
0.10902 
0.05070 
0.54331 
0.95737 
0.87962 
Signif. codes: 0 ' 1' 1:1'' 0.001 ' 1:1' ' 0 . 01 ' 1' ' 0.05' '0.1' '1 
(Dispersion parameter for poisson family taken to be 118.6257) 
Number of Fisher scoring iterations: 6 
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APPENDIXL 
Multiple Regression Models 6a-7c 
Physician and Hospital Costs 
262 
poisson_reg_costs.txt 
Model 6a: MULTIPLE REGRESSION ON TOl AL DOCTOR COSTs-TOTAL VISITS ( BMI on ;1 , , ISITS 
>0 
================================================================================== 
> model14a<- lm(LOGTOT_ FFS-BMI_4CAT+DHHA_ SEX + DHHA_AGE +EDUADH04.NA+INST_NEW1 + 
SMKA_202+GEOHR2_R, data=newdata,subset=LOGTOT_FFS>O, weights = 
WTSA_S, na.action=na.omit) 
Call :lm(formula = LOGTOT_ FFS- BMI_4CAT + DHHA_ SEX + DHHA_AGE + EDUADH04.NA + 
INST_NEW1 + SMKA_202 + GEOHR2_R, data = newdata, subset = LOGTOT_FFS > 
0, weights = WTSA_S, na.action = na.omit) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_4CATobese 
BMI_ 4CATmorbid obesity 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04.NASECONDARY GRAD. 
EDUADH04.NAOTHER POST- SEC. 
EDUADH04.NAPOST- SEC. GRAD. 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
GEOHR2 Rurban 
Estimate Std. Error t value Pr(>ltl) 
5.149462 0.175598 29.325 < 2e - 16 *** 
0.043761 
0.066607 
0.439183 
- 0.748200 
0.026964 
- 0.182814 
0.040249 
- 0.002438 
-0 . 069041 
- 0.888078 
0.014021 
- 0 . 086021 
0.084124 
0.198575 
0.077528 
0. 093166 
0.139658 
0.066399 
0.002853 
0.115933 
0.172329 
0.094643 
0.082531 
0.121487 
0.090315 
0.181922 
0.073555 
0.068216 
0. 564 
0. 715 
3.145 
- 11.268 
9.451 
- 1.577 
0.234 
- 0.026 
- 0.837 
- 7.310 
0.155 
- 0.473 
1.144 
2. 911 
0.57253 
0.47476 
0.00169 ** 
< 2e- 16 1:fd: 
< 2e - 16 1:f:f: 
0.11503 
0.81536 
0.97945 
0.40298 
4. 32e- 13 1'*1< 
0.87665 
0.63639 
0.25293 
0.00366 1'* 
signif. codes: 0 ' ***' 0.001 ' * *' 0.01 '*' 0.05 
Multiple R- Squared: 0.1808, Adjusted R- squared: 0.1732 
F- statistic: 23.76 on 14 and 1507 OF, p- value: < 2.2e- 16 
Pa ge 1 
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Model 6b: MULTIPLE REGRESSION ON TOTAL DOCTOR COSTS- TOTAL VISITS (CHRONIC 
CONDITIONS ONLY) VISITS >0 
==================================================================================== 
> model6bc- lm(LOGTOT_ FFS-CRNC_TOT+DHHA_ SEX + DHHA_AGE +EDUADH04.NA+INST_NEW1 + 
SMKA_202+GEOHR2_R, data=newdata,subset=LOGTOT_FFS>O, weights = WTSA_S, 
na.action=na.omit) 
call :lm(formula = LOGTOT_FFS- CRNC_TOT + DHHA_SEX + DHHA_AGE + EDUADH04.NA + 
INST_NEW1 + SMKA_ 202 + GEOHR2_R, data = newdata, subset = LOGTOT_FFS > 
0, weights = WTSA_S, na.action = na.omit) 
coefficients: 
(Intercept) 
CRNC_TOT 
DHHA_SEXma l e 
DHHA....AGE 
EDUADH04.NASECONDARY GRAD. 
EDUADH04.NAOTHER POST-SEC. 
EDUADH04.NAPOST- SEC. GRAD. 
INST_NEW1Eastern 
INST_ NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
GEOHR2_Rurban 
Estimate Std. Error t value Pr(>ltl) 
5.070464 0.163113 31.086 < 2e- 16 * ** 
0.302874 
- 0.640994 
0.017291 
-0.082666 
0.022233 
0.085686 
- 0.029087 
- 0.925441 
0.055346 
-0.004298 
0.123581 
0.187339 
0.022353 13.549 < 2e - 16 *** 
0.062833 
0.002772 
0.109983 
0.163108 
0.089696 
0. 077840 
0.114960 
0.085130 
0.172333 
0.069319 
0.064391 
- 10.202 < 2e- 16 *** 
6.237 5.76e-10 *** 
-0.752 0.45239 
0.136 0.89160 
0.955 0.33958 
-0.374 0.70870 
-8.050 1.66e- 15 *** 
0.650 0.51570 
-0.025 0.98010 
1. 783 0. 07482 
2.909 0.00367 ** 
Signif. codes: 0 ' *** ' 0.001 '**' 0.01 ' * ' 0.05 
Multiple R- Squared: 0.2648, Adjusted R- squared: 0.259 
F-statistic: 45.3 on 12 and 1509 DF, p- value: < 2.2e- 16 
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Model 6c: MULTIPLE REGRESSION ON TOTAL DOCTOR COSTS TOTAL VISITS (BMI & CHRONIC 
CONDITIONS )VISITS >0 
==================================================================================== 
=============== 
> model6c<-lm(LOGTOT_FFS- BMI_4CAT+CRNC_TOT+DHHA_SEX + DHHA_AGE 
+EDUADH04.NA+INST_NEW1 + SMKA_2 02+GEOHR2_R, data=newdata,subset=LOGTOT_FFS>O, weights= WTSA_S, 
na.action=na.omit) 
lm(formula = LOGTOT_F FS - BMI_4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04.NA + INST_NEW1 + SMKA_2 02 + GEOHR2_R, data = newdata, 
subset = LOGTOT_F FS > 0, weights = WTSA_S, na.action = na.omit) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_4CATmorbi d obesity 
CRNC_TOT 
DHHA_ SEXma 1 e 
DHHA_AGE 
EDUADH04.NASECONDARY GRAD. 
EDUADH04.NAOTHER POST-SEC. 
EDUADH04.NAPOST- SEC. GRAD. 
INST_ NEW1Eastern 
INST_NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
GEOHR2_Rurban 
Estimate 
5.0206821 
0. 0413052 
-0.0014855 
o. 2826877 
0.2992767 
- 0.6361334 
0.0175635 
- 0.0776993 
0.0274680 
0.0977544 
-0.0165636 
- 0.9167431 
0.0663751 
-0 .0001326 
0.1142107 
0.1809450 
std. Error 
0.1664193 
0.0733515 
0.0882950 
0.1326548 
0.0224629 
0.0633825 
0.0027901 
0.1099710 
0.1630474 
0.0898597 
0.0781841 
0.1149621 
0.0855393 
0.1722424 
0.0696289 
0.0645550 
signif. codes: 0 '*i:*' 0.001 '**' 0.01 ' * ' 0.05 
t value 
30.169 
0. 563 
- 0.017 
2.131 
13.323 
- 10.036 
6.295 
- 0.707 
0.168 
1.088 
-0.212 
-7.974 
0. 776 
-0.001 
1.640 
2.803 
Pr(>ltl) 
< 2e- 16 'lr-fr'f( 
0.57344 
0.98658 
0.03325 i; 
< 2e- 16 'lr"!r'ir 
< 2e-16 fddr 
4 . 03e-10 iddr 
0 . 47996 
0.86624 
0.27683 
0.83225 
3. 01e-15 fr*i: 
0.43789 
0.99939 
0.10116 
0. 00513 ** 
Multiple R- Squared: 0.2672, Adjusted R- squared: 0.2599 
F- statistic: 36.61 on 15 and 1506 DF, p- value: < 2.2e-16 
Page 3 
poisson_ reg_costs.txt 
MODEL 7A: MULTIPL E REGRESSION ON TOTAL HOSPITAL COSTS - IN - PATI ENT VISITS ON LY ( BMI 
ONL Y) 
==================================================================================== 
========== 
> model6a<- lm ( LOGRIW_AC- BMI_4CAT+DHHA_SEX + DHHA_AGE +EDUADH04.NA+INST_NEW1 + 
SMKA_202+GEOHR 2_R, data=newdata,subset=LOGRIW_AC>O, weights = WTSA_S, 
na.act i on=na.omit) 
Call:lm(formula = LOGRIW_AC- BMI_4CAT + DHHA_SEX + DHHA_AGE + EDUADH04.NA + 
INST_NEWl + SMKA_ 202 + GEOHR2_R, data = newdata, subset = LOGRIW_AC > 
0, weights = WTSA_S, na.action = na.omit) 
coefficients: 
Estimate std. Error t value Pr(>ltl) 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
DHHA_SEXmale 
DHHA_ . ..AGE 
EDUADH04.NASECONDARY GRAD . 
EDUADH04.NAOTHER POST- SEC . 
EDUADH04.NAPOST- SEC. GRAD. 
INST _ NEWlEastern 
INST_ NEWlNorthern 
INST_ NEWlWestern 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
GEOHR2_Rurban 
8.036485 
0.011373 
- 0.198899 
0.178410 
- 0.012913 
0.013474 
0.186879 
0.053696 
0.103637 
- 0.039464 
0.079018 
0.005885 
- 0.013897 
- 0.052659 
- 0.164849 
0.210350 38 .205 < 2e - 16 *** 
0.096806 
0.120334 
0.150510 
0.090027 
0.003443 
0.144892 
0.189311 
0.109832 
0.107392 
0.134382 
0.108645 
0.244503 
0.092439 
0.085837 
0.117 0.906532 
- 1.653 0.099085 
1.185 0. 236527 
- 0.143 0.886018 
3. 913 0. 000106 
1. 290 0.197821 
0.284 0.776823 
0.944 0.345906 
- 0. 367 0. 713447 
0.588 0.556835 
0.054 0.956827 
- 0.057 0.954701 
- 0.570 0.569201 
- 1.920 0.055459 
signif . codes: 0 '*** ' 0.001 '**' 0.01 '*' 0.05 
Residual standard error: 8.643 on 429 degrees of freedom 
(110 observations deleted due to missingness) 
Multiple R- Squared: 0.05625, Adjusted R- squared: 0 . 02545 
F- stati s tic: 1 . 826 on 14 and 429 OF, p- value: 0.03284 
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MODEL 78: MULTIPLE REGRESSION ON TOTAL HOSPITAL COSTS - IN - PATIENT VISITS ONLY 
(CHRONIC CONDITIONS ONLY) 
==================================================================================== 
======================== 
> model6b<- lm(LOGRIW_AC- CRNC_TOT+DHHA_SEX + DHHA_AGE +EDUADH04.NA+INST_NEW1 + 
SMKA_202+GEOHR2_R, data=newdata,subset=LOGRIW_AC>O, weights = WTSA_S, 
na.action=na.omit) 
Call:lm(formula = LOGRIW_AC- CRNC_TOT + DHHA_SEX + DHHA_AGE + EDUADH04.NA + 
INST_NEW1 + SMKA_202 + GEOHR2_R, data = newdata, subset = LOGRIW_AC > 
0, weights = WTSA_S, na.action = na . omit) 
coefficients: 
(Intercept) 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04.NASECONDARY GRAD. 
EDUADH04.NAOTHER POST- SEC. 
EDUADH04.NAPOST- SEC. GRAD. 
INST_ NEW1Eastern 
INST_NEW1Northern 
INST_NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_202NOT AT ALL 
GEOHR2_Rurban 
Estimate Std. Error t value Pr(>ltl) 
8.020889 
0.113014 
-0.024847 
0.007918 
0. 224787 
0.043597 
0.124446 
-0.026355 
0.064730 
0.041234 
0.008319 
-0.038791 
- 0.154006 
0.195356 41.058 < 2e- 16 *** 
0.024057 
0.086930 
0.003570 
0.141422 
0.185043 
0.107390 
0.104785 
0.131591 
0.105377 
0 . 238055 
0.090461 
0.083312 
4.698 3.54e- 06 *** 
- 0.286 
2. 218 
1. 589 
0.236 
1. 159 
-0.252 
0.492 
0. 391 
0.035 
- 0.429 
- 1.849 
0.7751 
0.0271 * 
0.1127 
0.8139 
0. 2472 
0.8015 
0.6230 
0.6958 
0.9721 
0.6683 
0.0652 
signif. codes: 0 ' ** *' 0.001 '**' 0.01 '*' 0.05 
Multiple R- Squared: 0.09016, Adjusted R-squared: 0.06482 
F- statistic: 3.559 on 12 and 431 DF, p - value: 4.556e-05 
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MODEL 7C: MULTIPLE REGRESSION ON TOTAL HOSPITAL COSTS - IN - PATIENT VISITS ONLY 
(BMI & CHRONIC CONDITOINS) 
==================================================================================== 
============================== 
> model6c<-lm(LOGRIW_AC- BMI_4CAT+CRNC_TOT+DHHA_SEX + DHHA_AGE 
+EDUADH04.NA+INST_NEW1 + SMKA_202+GEOHR2_R, data=newdata,subset=LOGRIW_AC>O, weights = WTSA_S, 
na.action=na.omit) 
call :lm(formula = LOGRIW_AC- BMI_4CAT + CRNC_TOT + DHHA_SEX + DHHA_AGE + 
EDUADH04.NA + INST_NEW1 + SMKA_202 + GEOHR2_R, data newdata, 
subset = LOGRIW_AC > 0, weights = WTSA_S, na.action = na.omit) 
coefficients: 
(Intercept) 
BMI_ 4CAToverweight 
BMI_ 4CATobese 
BMI_ 4CATmorbid obesity 
CRNC_TOT 
DHHA_SEXmale 
DHHA_AGE 
EDUADH04.NASECONDARY GRAD. 
EDUADH04.NAOTHER POST- SEC. 
EDUAOH04.NAPOST-SEC. GRAD. 
INST_ NEW1Eastern 
INST_ NEW1Northern 
INST_ NEW1Western 
SMKA_ 2020CCASIONALLY 
SMKA_ 202NOT AT ALL 
GEOHR2_ Rurban 
Estimate Std. Error t value Pr(>ltl) 
8.0495155 0.2053895 39.191 < 2e- 16 *** 
0.0001471 
-0.2269788 
0.1175686 
0.0945447 
0.1176376 
0.1475178 
0.1130989 0.0240835 
0.0038326 
0.0079246 
0.2660297 
0.0458323 
0.1411636 
-0.0391718 
0.0688345 
0.0331522 
0.0127589 
- 0.0442212 
- 0.1829029 
0.0879681 
0.0035632 
0.1424630 
0.1848377 
0.1075294 
0.1048498 
0.1312189 
0.1062321 
0.2387835 
0.0902688 
0.0838931 
0.002 
-1.929 
0.797 
0.9988 
0.0543 
0.4259 
4.696 3.58e- 06 *** 
0 . 044 
2.224 
1. 867 
0.248 
1.313 
-0.374 
0. 525 
0.312 
0.053 
- 0 . 490 
- 2.180 
0.9653 
0.0267 * 
0.0625 
0.8043 
0.1900 
0.7089 
0.6001 
0.7551 
0.9574 
0.6245 
0.0298 1' 
signif. codes: 0 ' ·H* ' 0 . 001 ' H ' 0.01 ' 1' ' 0.05 ' '0.1' ' 1 
Multiple R- Squared: 0.1025, Adjusted R- squared: 0.07104 
F- statistic: 3.258 on 15 and 428 OF, p- value: 3.716e- 05 
Page 6 




